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Abstract 
Methicillin-resistant Staphylococcus aureus (MRSA) strains have spread in Saudi Arabia, 
increasing morbidity, mortality, and financial burdens. Recent studies have suggested the 
phenotyping methods typically used to classify MRSA as either health care MRSA (HA-
MRSA) or community-associated MRSA (CA-MRSA) cases are unreliable, because they 
lack concordance with the results of genotyping. Yet the expense associated with 
genotyping precludes its use in the Saudi Aramco population in Saudi Arabia. The 
absence of a standardized and affordable method to classify MRSA into CA-MRSA and 
HA-MRSA has been a challenge for infection control programs in Saudi Arabia. The 
objective of this quantitative, secondary data analysis was to determine the most reliable 
phenotyping approach to strain identification using stored samples from John Hopkins 
Aramco Hospital. The ecological and antibiotics selection pressure theories framed this 
research. The results of concordance, and sensitivity and specificity tests, suggested 
hospital admission profiles and susceptibility pattern were the most reliable phenotypic 
predictors of genotype-based classifications. Multiple logistic regression for 
susceptibility pattern (OR = 15.47, p < .001) and hospital admission profile (OR = 2.87, p 
= .008) confirmed those results, whereas all other variables were not found to be 
statistically significant. These results can be used to clarify the epidemiological and 
molecular factors that affect the transition of MRSA from health care facilities to the 
Saudi Aramco community. Implications for positive social change include faster and 
more reliable classification of MRSA to aid in disease surveillance and the selection of 
appropriate treatments to reduce MRSA-related morbidity and mortality.  
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Chapter 1: Introduction to the Study  
In the early 1960s, Methicillin-resistant Staphylococcus aureus (MRSA) strains 
were first isolated from patients exposed to health care risk factors such as 
hospitalization, surgery, dialysis, and indwelling devices (David et al., 2006). Like 
infection by other multidrug resistant organisms, MRSA infection increases patients’ 
morbidity and mortality risk and health care costs (Centers for Disease Control and 
Prevention, 2013a). From the mid-1970s through the 1990s, the incidence of MRSA in 
health care settings dramatically increased (Panlilio et al., 1992). MRSA cases that were 
isolated within health care settings or from those who received recent care from such 
settings are referred to as health-care-associated MRSA (HA-MRSA). Then, in the late 
1990s, a new strain of MRSA without health care risk factors was isolated. This new 
MRSA strain shares genetic background with Staphylococcus aureus. However, it has a 
distinct genetic code that had not previously existed (David et al., 2006). The new MRSA 
strains identified among individuals outside of health care settings and those who have 
not received recent care from such settings is referred to as community-associated MRSA 
(CA-MRSA).  
CA-MRSA has been a growing problem with increasing incidence and prevalence 
in Saudi Arabian communities, and it has migrated into health care settings (Bukharie, 
2010). Besides having resistant genes, CA-MRSA is known to acquire toxin-producing 
genes such as Panton-Valentine leukocidin (PVL). PVL is lethal to white blood cells and 
can cause tissue necrosis including necrotizing pneumonia in young patients (Gillet et al., 
2002). Phenotyping and genotyping methods have been used to classify strains. 
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Phenotyping methods classify strains as HA or CA based the organism’s observed 
characteristics, such as health care risk factor classification, infection type classification, 
and susceptibility pattern classification. Genotyping methods that classify strains using 
the organism’s genetic code include pulsed field gel electrophoresis (PFGE) and 
polymerase chain reaction (PCR). However, phenotyping methods have become less 
reliable due to the increased incidence of CA-MRSA in health care settings and the 
continuous rise in antibiotic resistance among CA-MRSA strains (McCarthy et al., 2010). 
Several studies have demonstrated that CA-MRSA strains originating from 
patients with no antecedent hospital exposure were clonally distinct from hospital 
endemic MRSA strains (Naimi et al., 2013; Vandenesch et al., 2003). The apparent 
phenotypic and genotypic differences between CA-MRSA and HA-MRSA were noted in 
anecdotal reports, case series, and outbreak studies, which often compared few CA-
MRSA strains to historical HA-MRSA control isolates from worldwide collections 
(Enright et al., 2002; Vandenesch et al., 2003). Such comparison of contemporary cases 
to historical controls is flawed, as it does not allow for elimination of potential biases due 
to other factors that may have changed over time (e.g., clonal shifts). Thus, concurrent 
molecular genetic characterization of MRSA strains combined with well-designed 
epidemiologic studies will enable the identification of the transmission dynamics of CA-
MRSA and HA-MRSA. 
The aim of this study was to assess the molecular characteristics of the MRSA 
strains that cause infection within Saudi Aramco community and to compare and contrast 
the concordance/discordance of genotyping methods with the three common phenotyping 
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classifications. An assessment of each phenotyping method’s validity in the identification 
and management of MRSA was needed to develop a potent infection control strategy that 
can address the needs of a community. 
The findings of this study offer new insights into the epidemiological and 
molecular factors that affect the transition of MRSA from health care facilities to Saudi 
Aramco community settings. This study may make significant contributions to the 
international community by in elucidating the epidemiological and molecular forces 
affecting variations in MRSA disease frequency and disease severity (Chambers, 2005; 
Enright et al., 2002; Oliveira, Tomasz, & deLencastre, 2002).  
Background 
The number of cases of multidrug-resistant Staphylococcus aureus continues to 
increase, particularly MRSA, which is now a leading cause of nosocomial infection 
worldwide. A nosocomial infection is defined as any infection that develops during, or as 
a result of, an admission to an acute care facility (hospital) and which was not incubating 
at the time of admission (Siegel et al., 2006). MRSA is responsible for up to 60% of 
nosocomial infections in intensive care units (ICUs), likely due to carrying exogenous 
mobile genetic elements, inadequate antibiotic therapy, and contaminated hands 
(Inweregbu, Dave, & Pittard, 2005).  
Treatment of MRSA infection has been challenging due to the inefficiency of first 
and second line antibiotics, making the only treatment choice the use of more toxic, 
expensive, and less effective antibiotics (Centers for Disease Control and Prevention 
(CDC), 2013a). The CDC has reported an encouraging decrease in the rate of HA-MRSA 
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in the United States with approximately 31,000 fewer cases and 9,000 fewer deaths 
between 2005 and 2013 (CDC, 2013b).However, in Saudi Arabia, the MRSA prevalence 
in hospitals increased from 5% in 1995 to 35% in 2013(Al Yousef, Mahmoud, & Taha, 
2013).  
Molecular epidemiology studies indicate that the massive geographic spread of 
MRSA resulted from the dissemination of relatively few epidemic clones. Five major 
lineages have been defined, which were mainly disseminated in southern and eastern 
Europe, Latin America, and the United States (Oliveira et al., 2002). The five major 
MRSA lineages are Iberian, Brazilian, Hungarian, New York/Japan, and pediatric 
(Stefani & Varaldo, 2003). The continuing dissemination of these lineages indicates that 
they are successful in terms of ability to cause infection, to persist, and to spread from 
one geographic site to another, including across continents (Oliveira et al., 2002). As 
mentioned earlier, the increased rate of MRSA infections outside hospital setting led to 
categorization of MRSA into two distinct groups, HA-MRSA and CA-MRSA (CDC, 
2005). Nevertheless, several molecular and biological parameters have been involved in 
classifying MRSA.  
HA- MRSA has been reported among patients with certain risk factors including 
recent hospitalization, dialysis, residence in a long-term care facility, presence of invasive 
devices, and history of MRSA infection and colonization (Klevens et al., 2007). HA-
MRSA can cause a variety of diseases from noninvasive infection such as mild 
intermittent abscesses, to life threatening invasive systemic diseases such as necrotizing 
pneumonia, kidney infection, joint infection, and blood stream infection. Based on their 
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site of infection, HA-MRSA strains are classified into noninvasive and invasive types. In 
addition, the HA-MRSA strains, in particular the invasive form, are also typically 
resistant to multiple, non-beta-lactam antibiotics (Fey et al., 2003). The HA-MRSA strain 
types identified by PFGE are USA100, USA200, USA600, USA700, USA800, and less 
often USA500 (Klevens et al., 2007; McDougal et al., 2003). Other markers such as the 
presence of SCCmec I, II, and III, agr group II, and low PVL carriage have been used to 
distinguish HA-MRSA from CA-MRSA. PFGE genotyping aids in determining bacterial 
isolate identification by acting as DNA “fingerprinting.” In epidemiology, genotyping 
techniques can help track the spread of infections, monitor trends in types, and track 
seasonal outbreaks (Healy et al., 2005). With regard to HA-MRSA infections, genotyping 
techniques are excellent tools to investigate the genetic relationship between the different 
HA-MRSA strains and severe infections in health care settings.  
CA- MRSA has been described in patients without the established health care risk 
factors. CA-MRSA was first described occurring in specific populations with distinctive 
risk factors such as prisoners, intravenous drug users, athletes, military trainees, and men 
who have sex with men (Kazakova et al., 2005; McCaig et al., 2006). This form of 
MRSA usually presents as noninvasive infection, such as skin and soft tissue infections. 
CA-MRSA isolates are likely to be resistant to fewer antibiotics, produce different toxins, 
and have genetically distinct genes compared to HA-MRSA (McCaig et al., 2006). 
Genetic markers such as SCCmec IV, agr group I and high PVL gene carriage have been 
used to distinguish CA-MRSA from HA-MRSA (Tsuji, Rybak, Cheung, Amjad, & Kaatz  
6 
 
2007). Strains most frequently isolated from MRSA infection of community origin 
include PFGE USA300, USA400, USA1000, and USA1100 (Klevens et al., 2007). 
Certain genetic differences have been identified in the two types of MRSA, 
making HA-MRSA strains more resistant to beta lactams and other non-beta lactams 
groups of antibiotics than CA-MRSA strains. These genetic differences also make CA-
MRSA infections more necrotic and easy to spread from person to person (Gillet et al., 
2002). Distinct epidemiological, clinical, and pharmacological characteristics are used to 
classify MRSA infections as either health-care-associated (HA) or community-associated 
(CA) (CDC, 2005). On the epidemiologic and clinical side, HA-MRSA strains usually 
infect older, unhealthy people, whereas CA-MRSA strains have the tendency to infect 
healthy, younger people and to cause distinct clinical syndromes such as soft skin tissue 
infections (SSTIs) (CDC, 2005). However, an increased number of necrotizing 
pneumonia and severe sepsis cases have been reported, associated with CA-MRSA 
(Seybold et al., 2006). From the pharmacological side, HA-MRSA infections usually 
require intravenous antibiotic therapy administered in a hospital setting, whereas CA-
MRSA infections respond more to ambulatory oral antibiotics. The ambulatory treatment 
option reduces the length of hospitalization, lowers associated costs, and eliminates the 
potential side effects of intravenous antibiotics (Doebbeling et al., 1993; Fey et al., 2003). 
These epidemiological, biological, and clinical characteristics of MRSA have pushed 
hospitals and other health care settings to apply a variety of phenotyping and genotyping 
methods to classify MRSA infections as either HA-MRSA or CA-MRSA (CDC, 2005).  
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The distinct characteristics of MRSA guided CDC and the Clinical Laboratory 
Institute (CLSI) to create the three most popular phenotyping methods used currently to 
differentiate MRSA as CA-MRSA or HA-MRSA. According to the health care risk 
factors method, any MRSA infection identified after 48 hours of hospital admission is 
labeled as HA-MRSA (CDC, 2005). According to the infection type method, any MRSA 
isolated from an invasive site; blood; cerebrospinal fluid (CSF); pleural fluids from 
patients who have the following risk factors: hemodialysis, surgery, residence in a long-
term care facility or hospitalization during the previous year; or the presence of an 
indwelling catheter or a percutaneous device at the time of culture, is labeled as HA-
MRSA. However, any MRSA isolated from patients who lack the above risk factors is 
labeled as CA-MRSA (CDC, 2005). The last method is the susceptibility pattern method, 
where MRSA cases resistant only to β-lactams antibiotics are labeled as CA-MRSA, 
whereas cases resistant to additional antibiotics classes, such as carbapenems, 
aminoglycoside, and fluoroquinolones, are labeled as HA-MRSA (Clinical and 
Laboratory Standards Institute, 2005). Such classification is important to monitor trends 
in antimicrobial resistance among MRSA within health care settings and for the selection 
of appropriate antibiotics regimens. Although phenotyping methods are widely used, the 
emergence of invasive and multidrug resistant CA-MRSA strains as a cause of health 
care associated infection (Gillet et al., 2006; Seybold et al., 2006), and the increased 
circulation of HA-MRSA in the community (Miller et al., 2007; Seybold et al., 2006) 
might interfere with the sensitivity of these phenotyping methods. 
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CA-MRSA has been a growing problem with increasing incidence and prevalence 
in Saudi Arabia communities, and the migration of CA-MRSA into Saudi health care 
settings. In the Middle East and in particular in Saudi Arabia, most of the studies 
conducted between 1990 and 2008 to classify MRSA as CA-MRSA or HA-MRSA were 
based on phenotyping methods, in particular susceptibility pattern method (Monecke et 
al., 2012). According to Sievert (2008), only 20 % from 2151 cases in the United States 
were consistently classified as HA-MRSA by the three phenotyping methods (health care 
risk factor, infection type, susceptibility pattern) and 25% were consistently classified as 
CA-MRSA. However, the discrepancy in the classification as CA-MRSA or HA-MRSA 
exceeded 40% between the three methods. Several studies have shown that phenotyping 
markers are more prone to change in time than genotyping markers (Devita, Lawrence, & 
Rosenberg, 2009). Such a change is due to loss of extrachromosomal genetic elements 
and later their horizontal transmission (Devita et al., 2009) and can explain the 
discrepancy between the classification methods that depend on the phenotyping markers 
(Tenover et al., 1994).  
The revolution in genotyping methods that are based on DNA analysis has 
allowed for an accurate and precise MRSA classification due to markers that are less 
prone to change in time (Tenover et al., 1994). Therefore, genotyping methods have a 
discriminative power for MRSA typing. A recent genotyping study in Saudi Arabia has 
found that HA-MRSA resistance markers (e.g., aacA-aphD, aadD) are now common 
among CA-MRSA strains (Monecke et al., 2012). Clearly, the presence of these 
resistance markers in both HA and CA-MRSA will negatively affect the accuracy of the 
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susceptibility pattern method and therefore its role in monitoring the emergence of the 
new necrotic and invasive CA-MRSA strains. Moreover, these susceptibility methods are 
essential for the proper administration of the glycopeptide Vancomycin that is routinely 
used to treat HA-MRSA. However, the inappropriate and excessive usage of this 
antibiotic can lead to the emergence of vancomycin-resistant Staphylococcus aureus 
(VRSA) (Hiramatsu, Cui, & Kuroda, 2001).  
With the advent of highly sensitive and specific PCR, genotyping methods, in 
particular real time PCR, and the limitations of phenotyping methods due to the 
instability of phenotyping markers, new multiplex real time PCR methods have emerged 
as essential tools for studying the epidemiology of MRSA. These new genotyping 
methods have the capability to accurately classify MRSA strains as CA-MRSA or HA-
MRSA based on their staphylococcal chromosomal cassette mec (SCCmec) and the 
presence of the PVL virulence genes (Balkhy et al., 2007). CA-MRSA strains harbor the 
PVL virulence genes and a novel small mobile staphylococcal cassette chromosome mec 
(SCCmec) Type IV or V genetic element, which in turn harbors the methicillin resistance 
(mecA) gene. The SCCmec Type IV or V can more easily be transferred to other 
Staphylococcus aureus strains compared to the larger SCCmec Types I, II, and III that 
usually characterize HA-MRSA strains (Zhang et al, 2005). This easy chromosomal 
transfer can explain the tremendous increase in the CA-MRSA rate (Zhang et al., 2005). 
Unlike the conventional PCR methods that usually target one specific gene, multiplex 
real time PCR methods target several genes specific to either CA-MRSA or HA-MRSA 
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(Zhang et al., 2005). Therefore, multiplex PCR methods are highly sensitive and specific, 
minimizing the errors that the absence or deletion of one specific gene may produce. 
During the last two decades, several genotyping studies that target different genes 
were conducted in the United States and Europe to classify accurately MRSA as CA-
MRSA or HA-MRSA and to understand the molecular characteristics of the most 
predominant strains (Monecke et al., 2012). However, the health care settings in the 
Middle East, including Saudi Arabia, did not introduce the same types of genotyping 
studies until 2012 (Monecke el al., 2012). Although genotyping methods that target 
different genes are very sensitive and specific, they are expensive, and the majority of 
health care centers in Saudi Arabia cannot afford those (Monecke et al., 2012). 
Unlike methicillin-sensitive Staphylococcus aureus (MSSA) and HA-MRSA, CA-
MRSA is characterized by its evolutionary success, a series of events that occurred within 
its genome, making the new strains more fit, transmissible, and virulent (Rolo et al., 
2012). The SCCmec IV allele that characterizes CA-MRSA is probably responsible for 
such evolutionary success (Rolo et al., 2012). The high level of genetic diversity of CA-
MRSA strains in European and American regions and the emergence of new strains every 
few years can increase the impart of the pathogenicity of CA-MRSA strains in terms of 
its invasion capability and antimicrobial susceptibility, posing a real challenge to 
diagnostic and infection control (Hudson et al., 2013). The results of the first genotyping 
study in the central province of Saudi Arabia were surprising in terms of the high gene 
diversity of MRSA strains and the high prevalence of the PVL gene that usually 
characterizes CA-MRSA strains (Monecke et al., 2012). However, this first study was 
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limited to only the central region and therefore cannot be generalized to all Saudi regions. 
Similar population strain diversity has been found to be related to the disproportional 
distribution of CA-MRSA and HA-MRSA in the United States (Klevens et al., 2007; 
Rolo et al., 2012). Currently in Saudi Arabia, the selection of phenotyping method to 
guide infection control strategies in Saudi health care setting depends only on the 
methods validated for hospitals in the United States (Bukharie, 2010). It is essential to 
enact an evaluation policy implementing phenotyping methods where applicable and to 
establish new validation rules for health care settings that are planning to apply these 
methods. Such policy will serve as the basis of a continuous surveillance strategy aimed 
at detecting and controlling CA-MRSA in Saudi Arabia (Popovich, Hota, Rice, 
Aroutcheva, & Weinstein, 2007).  
Statement of the Problem 
Increasing cases of HA-MRSA and CA-MRSA isolated from health care systems 
and the communities require more effective methods of classification (Klevens et al., 
2007). Many investigators have classified MRSA infections into CA-MRSA and HA-
MRSA using approaches advocated by the CDC and the CLSI in order to guide decisions 
about antibiotics empirical treatment, and to contain the spread of MRSA infection 
(David et al., 2008). However, the circulation of both HA-MRSA and CA-MRSA in the 
community, the emergence of CA-MRSA as a nosocomial pathogen, and the 
identification of high-risk groups for MRSA in the community, including athletes, 
children, and incarcerated people, raise doubt about the utility of such approaches (David 
et al., 2008). The spread of multidrug resistant Staphylococcus aureus strains has made 
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the infection challenging and costly to treat (CDC, 2013b). The inherent limitations in 
therapeutic options necessitate implementation of infection prevention and control 
procedures in an attempt to limit MRSA spread (Monecke et al., 2011). The cost of such 
procedures and of the use of second-line antimicrobial medications amounts to billions of 
dollars/euros in the United States and Europe (Monecke et al., 2011). Different countries 
worldwide have applied different strain typing methods over the last 30 years to track 
MRSA spread and provide insight into its control (Monecke et al., 2011; Stefani et al., 
2012). However, Saudi Arabia still struggles with understanding the distinction between 
CA-MRSA and HA-MRSA infection types, risk factors and patients’ characteristics such 
as age distribution for each strain type, seasonality, and potential shifts in therapeutic 
drug resistance. Health care risk factor is currently the method most commonly used by 
the infectious disease specialists at the Johns Hopkins Aramco Hospital in Saudi Arabia 
to classify MRSA; however, no unified method has been adopted and classification by 
phenotype remains subject to individual physicians’ perspectives. As the prevalence of 
MRSA continues to increase along with its geographical diversity in colonization and 
infection rates, and as the number of available therapies decrease, health care providers 
should take notice of their local rates of resistance (Ezeanolue et al., 2008).  
This study aimed to fill the gap in understanding in Saudi Arabia with respect to 
distribution of MRSA in the community and the associated need for the development and 
testing of a rapid, efficient, inexpensive, and reliable method of identification of HA-
MRSA and CA-MRSA strains circulating in the region. 
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Purpose of the Study 
The purpose of this quantitative, secondary data analysis study was to characterize 
the MRSA strains within the Saudi Aramco community and to identify accurately MRSA 
strains infection as HA-MRSA or CA-MRSA by comparing and contrasting the three 
existing phenotyping methods against the gold standard Multiplex PCR method. 
Research Questions and Hypotheses 
The aim of this research study was to answer the following questions and 
associated hypotheses: 
1. What is the distribution of MRSA in Saudi Arabia Eastern Province based on 
genotyping? 
2. What is the concordance between each pair combination of three phenotyping methods 
(health care risk factor, infection type, susceptibility pattern) used to classify CA- MRSA 
vs HA -MRSA in Saudi Arabia? 
3. What is the sensitivity and specificity of each phenotyping method (health care risk 
factor, infection type, susceptibility pattern) used in Saudi Arabia as compared to the 
gold-standard used to classify CA- MRSA vs HA –MRSA? 
4. How well does a combination of demographic and phenotyping variables of the current 
three phenotyping methods (health care risk factors, infection type, and susceptibility 
pattern) predict MRSA genotyping classification as CA-MRSA or HA-MRSA?" 
H0: Demographic and phenotyping variables do not significantly predict MRSA 
genotyping classification. 
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Ha: Demographic and phenotyping variables significantly predict MRSA 
genotyping classification. 
Theoretical Framework 
My research study was grounded in the Ecological theory (Hardin, 1960; Kouyos, 
Klein, & Grenfell, 2013). In ecology, the competitive exclusion principle, or Gause's law 
of competitive exclusion, is a proposition that states, “Two species competing for the 
same resources cannot co-exist if other ecological factors are constant. When one species 
has even the slightest advantage or edge over another, then the one with the advantage 
will dominate in the long term” (Hardin, 1960, p. 1292). Based on the Ecological theory, 
coexistence of HA-MRSA and CA-MRSA would be possible in environments where 
ecological factors are constant. However, either CA-MRSA or HA-MRSA would out-
compete the other and predominate depending on different environmental conditions 
(Hardin, 1960; Kouyos et al., 2013). HA-MRSA is classically characterized by a broad 
resistance antibiotic resistance spectrum conferred by its relatively large Staphylococcal 
cassette chromosome (SCCmec); SCCmec is a complex mobile genetic element found in 
Staphylococcus aureus (Ito et al., 2014; Shore & Coleman, 2013). HA-MRSA usually 
carries either SSCmec II or III, which have acquired genes for resistance to antibiotic 
classes beyond the β-lactams (Hiramatsu et al., 2002). CA-MRSA strains tend to carry 
SSCmec IV and V, which are relatively small. Thus, CA-MRSA strains tend to be 
susceptible to clindamycin and other non-β-lactam antibiotics (Naimi et al., 2003). Under 
ecological theory, these factors would favor HA-MRSA in a health care environment 
where there is common use of antibiotics. The presence of SCCmec II or III correlates 
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with slower growth than elements IV or V. Thus in the community, in the absence of 
antibiotics, CA-MRSA carrying SCCmec IV or V may be at a selective advantage 
(Monecke et al, 2011). However, the contribution of Fluoroquinolones' selective pressure 
in the emergence of new CA-MRSA strains in the health care settings and their lower 
biological cost of resistance, makes them excellent candidates to replace HA-MRSA 
strains in health care settings (Kouyos et al., 2013; LeBlanc et al., 2006). The ecological 
theory was thus very useful to explain the tremendous increase in CA-MRSA rate within 
health care settings, and it can justify why there are misclassifications of certain strains of 
CA-MRSA. Understanding genotypic virulence factors for the two will aid in formulating 
critical intervention measures to reverse the current incidence trends by geographical 
location.  
In the application of Ecological theory, if the genotyping variables that influence 
the evolution and transmission of CA-MRSA and HA-MRSA were defined as bases of 
MRSA gold standard characterization methods (independent variables), and bases of 
phenotyping methods validation, then accurate MRSA characterization was expected to 
contribute to the regulation of MRSA acquisition, transmission, and eradication. As 
shown in Figure 1, two independent variables (mecA gene, and PVL gene) influence two 
dependent variables (CA-MRSA, and HA-MRSA), mediated by the influence of three 
intervening variables (Health care risk factor, infection type, and susceptibility pattern). 
The PVL gene and SCCmec gene influence the three phenotyping methods. For example, 
the presence of PVL gene makes MRSA more invasive and therefore affects the infection 
site while the SCCmec gene has direct effects on the antibiotics panel. The infection type, 
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health care risk factors, and antibiotics panel that were used to phenotypically classify 
MRSA are not independent of the genetic profile of the organism. The genetic profile 
influenced the phenotypic characteristics and the behavior of MRSA. 
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Figure 1. Conceptual framework for the independent, dependent variables, and the expected outcomes of the study. 
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Nature of the Study 
This study was a quantitative, secondary data analysis aimed at describing the 
current performance of three phenotyping methods used to classify MRSA strains. First, I 
classifed MRSA cases as either HA-MRSA or CA-MRSA based on the three-
phenotyping methods. Then, I measured the concordance of each pair combination of 
phenotypic methods. Finally, I described each method’s accuracy based on their 
sensitivity and specificity against a reference genotyping method (Multiplex PCR) as the 
gold standard and then determined the effectiveness of a predictive model using 
Goodness-of-Fit statistics. Multiplex PCR is characterized by its high sensitivity, 
specificity, positive predictive value (PPV), and negative predictive value (NPV) 
(Kimura et al., 2009). In this study, molecular phenotypes of the MRSA strains causing 
infection within the Saudi Aramco community in the Eastern province of Saudi Arabia 
were analyzed and compared to the genotypic information generated for the collected 
samples. It was the second such study in Saudi Arabia, since a study conducted in 2012 in 
the central province to accurately classify MRSA strains as CA-MRSA or HA-MRSA 
based on their staphylococcal chromosomal cassette mec (SCCmec) and their PVL genes 
simultaneously (Monecke et al., 2012). Besides the molecular characteristics of the 
MRSA strains, I assessed the utility of the current phenotyping methods in infection 
control and treatment management program by measuring concordance. A poor 
concordance supported the necessity of a full assessment of each phenotyping method 
separately through the measurement of its sensitivity and specificity against the 
genotyping gold standard method (Multiplex PCR) to assess its accuracy, and therefore, 
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its validity. A phenotyping method with good sensitivity and specificity emerged as a 
valid method in infection control management that primarily lack epidemiological studies 
about MRSA diversity in all the regions of Saudi Arabia (El-Mahdy, El-Ahmady, & 
Goering, 2013; Monecke et al., 2012). In addition, it will provide a simple, less 
expensive, accurate, and feasible method for full MRSA assessment in Saudi Arabia. 
For this study, I obtained the phenotypic characteristics of MRSA samples 
(admission profile, infection type, and susceptibility pattern) from 133 samples collected 
between January 2012 and December 2013, and stored within the John Hopkins Aramco 
Health Center epidemiology and microbiology database. During the period between 
January 2012 and December 2013, this center started collecting all MRSA samples in 
order to test the new multiplex PCR system. All isolated MRSA samples were analyzed 
for PVL gene and SCCmec gene to classify MRSA as CA-MRSA or HA-MRSA using 
new technology. However, no comparison between phenotyping methods and this new 
genotyping method had been conducted to date; this was the aim of this study. SAP 
health care system (SHC) within John Hopkins Aramco Health Center and the Molecular 
biology and Microbiology sections in John Hopkins Aramco Health Center were the 
source of demographic information (Age, gender, and survival), medical history of 
involved patients, and genotyping characteristics, respectively. 
Definition of Key Terms 
 The key terms included are used predominantly by medical and public health 
sectors and are terms that may require definition in order to be useful to the reader. The 
key terms used in the study were: 
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      Aminoglycosides: “Antibiotics containing two or more amino sugars in glycoside 
linkage with a hexose nucleus, which are bactericidal” (Spencer, 1986, p. 216)  
 Beta-lactam antibiotics: Class of antibiotics with a beta-lactam ring structure that 
inhibits bacterial growth by altering the synthesis of the cell wall. These antibiotics 
include penicillins, extended-spectrum penicillins, cephalosporins, imipenem, and 
aztrenonam (Meriam-Webster, 2013). 
 Biological cost of resistance: a reduction in bacterial fitness that can be expressed 
as lower growth, and altered virulence or transmission (Meriam-Webster, 2013). 
      Fluoroquinolone: Class of antibiotics of fluorinated derivatives (Meriam-Webster, 
2013).  
  Infectivity: Ability to produce infection; tendency to spread rapidly from host to 
host (Meriam-Webster, 2013).   
      Polymerase chain reaction (PCR): a genotyping technique based on synthesizing 
large quantities of well-defined DNA segment (Meriam-Webster, 2013). 
      Pulsed-field gel electrophoresis (PFGE): molecular typing method based on the 
separation of chromosomal DNA molecules after applying an electric field that change 
their directions (Meriam-Webster, 2013). 
Scope and Delimitations 
The study scope was to investigate the validity of the three phenotyping methods 
that are currently used to classify MRSA as CA-MRSA or HA-MRSA within John 
Hopkins Aramco Health Center in the eastern province of Saudi Arabia. Based on the 
disproportional distribution of CA-MRSA and HA-MRSA between countries and 
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populations (Klevens et al., 2007; Rolo et al., 2012) and the emerging of new CA-MRSA 
strains (Akoglu et al., 2007), I assumed that the Saudi population had distinct MRSA 
phenotype and genotype that need to be explored in a specific manner. 
This research study was delimited to patients at the John Hopkins Aramco hospital in the 
Eastern Province, Saudi Arabia. The population for this health center consists of 
approximately 350,000 employees, dependents or annuitants of the Saudi Aramco energy 
corporation. The study was further delimited to data and samples collected from January 
2012 and December 2013. 
Assumptions 
Assumptions for this research were that the phenotypic and genotyping 
characteristics data generated for the MRSA samples for the same strains were 
comprehensive and representative of the distribution across the population under study. I 
also assumed that the data stored at the John Hopkins Aramco Health Centre of Saudi 
Arabia had phenotypic and genotypic characteristics distinct from those observed in other 
countries, consistent with the genetic diversity existing in MRSA strains isolated from 
different populations (Hudson et al., 2013). 
Limitations 
Patients’ electronic medical records (EMR) were the only source of data. I did not 
conduct patients’ interviews; therefore, information on preexisting health conditions and 
health care risk factors were not available for some patients due to the recent 
implementation of the electronic health care information system. However, I attempted to 
access paper medical records to help minimize missing data after receiving approval from 
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the infection control department. From the geographical and temporal perspectives, the 
molecular characteristics of MRSA that are evolving are moving targets. Evolutionary 
success is an important characteristic of CA-MRSA strains that makes their growth rates 
1.33 faster than HA-MRSA strains (D’Agata, Webb, Horn, Moellering, & Ruan, 2009). 
Therefore, current strains may differ from strains that were analyzed two years before, 
making the ratio of CA-MRSA to HA-MRSA strains of the year 2012 and 2013 not fully 
representative for 2014 and 2015. Although, heterogeneity of strains does not have had a 
significant impact on the genotyping methods, which are based on DNA analysis, it does 
affect phenotyping methods. The phenotyping methods are based on the organism’s 
physical traits that can be altered by the evolution of new CA-MRSA strains (D'Agata et 
al., 2009). A comparison between phenotyping methods and genotyping methods 
minimized the impact of these limitations. The migration of CA-MRSA genes such as 
PVL gene into HA-MRSA strains makes the physical traits of HA-MRSA similar to CA-
MRSA. Thus, the SCCmec gene was included in the genotyping profile to increase 
accuracy in classification and minimize the impact of this evolution. 
Significance of the Research 
MRSA is a serious pathogen associated with various severe infections that affect a 
significant proportion of the world population (CDC, 2013a). However, the greatest cause 
for concern is the resistant nature of the bacterium (CDC, 2013a). MRSA drug resistance 
is a serious issue as it may threaten the safety of the world population by increasing 
morbidity and mortality rates associated with Staphylococcus aureus infections (CDC, 
2013b). In addition, the resistant nature of the infections has significant cost implications, 
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related to the treatment and management of the patients, as well as prevention and control 
measures. (Boyce, Landry, Deetz & DuPont, 1981; Monecke et al., 2011; Stefani et al., 
2012).  
MRSA infections are more severe when compared with methicillin-susceptible 
Staphylococcus aureus. Severe MRSA infections may require specialized medications 
and treatments including isolation, ventilation, hyperbaric therapy, and surgical 
debridement (Klevens et al., 2007). The severity of resistant infections reduces the 
available antibiotic options, which results in additional risk to the patient due to treatment 
toxicity and lengthy hospitalization (Lodise & McKinnon, 2005). In some cases, 
medications and treatments are ineffective and result in morbidity or mortality (Lodise & 
McKinnon, 2005).  
MRSA hospitalization cost is nearly double than that for non-MRSA infections 
(Elixhauser & Steiner, 2007). Thus, the screening of MRSA to identify strains is 
important in the prevention of disease transmission and the conservation of hospital 
resources. Understanding the dynamics of MRSA infection may assist physicians in 
selecting appropriate treatment, identifying interventions, and preventing transmission in 
the population. Better tracking of MRSA strains nationwide is necessary to observe and 
control their spread.  
Presently, the management of MRSA infections worldwide has become a priority 
in health care settings. Susceptibly pattern, patients’ age distribution for each strain type, 
and seasonal pattern of CA-MRSA and HA-MRSA infection are important factors in the 
management of MRSA infections. CA-MRSA, which is less resistant to non-beta-lactams 
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antibiotics, has a tendency to infect younger people in the summer months while HA-
MRSA, which is also resistant to non-beta-lactams antibiotics has a tendency to infect 
older people in the winter months (Klein et al., 2007). Most initiatives in MRSA 
management target reduction of the spread of MRSA in order to relieve the burden of 
high medical costs and reverse the trend of MRSA morbidity and mortality.  
At the molecular level, the role of genetic markers is important in mapping the 
Saudi Aramco population who may be at high-risk for MRSA infections. Genetic 
markers increase the accuracy of diagnoses needed to determine appropriate treatments 
(Healy et al., 2005). Such accuracy is essential for an effective treatment model, feasible 
and appropriate infection control strategies, and targeted prevention efforts for these 
emerging strains. My results contributed to the existing body of knowledge about health 
care settings and environmental factors that contribute to the predominance of CA-
MRSA or HA-MRSA infection in Saudi Arabia. The results of this study offered insights 
about MRSA and the Saudi Aramco populations that are at higher risk for subsequent 
MRSA infection. Further, the results of this study will ultimately help in the formulation 
of prevention strategies to reduce MRSA transmission, such as disease surveillance, and 
raise awareness of the scope of the problem. The potential for positive social change, 
associated with my study results, lay in its aim to demonstrate the differences between 
CA-MRSA and HA-MRSA infections types, patients’ age distribution for each strain 
type, the seasonality of MRSA infections, and any potential shifts in therapeutic drug 
resistance and identification of phenotyping variables that can be applied to distinguish 
between HA-MRSA and CA-MRSA and hence gauge distribution for each MRSA type, 
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seasonality, and potential shifts in therapeutic drug resistance. Patients will benefit from 
an increased understanding of the disease and identification of potential treatment 
modalities related to each strain. Non-infected individuals will benefit from a better 
understanding of the source of the strains and the resultant policies aimed at controlling 
the spread of MRSA. Thus my study contributed to positive social change among the 
Saudi Aramco population, as better management of existing MRSA will reduce incidence 
of the infection as well as the morbidity and mortality often associated with MRSA 
strains. A reliable and affordable MRSA screening program based on concordance of 
phenotyping classification with a genotyping gold standard provides a rational basis for 
MRSA surveillance and characterization. Extending the findings of this study to other 
health care facilities throughout the country would potentially contribute to the 
development of such a screening program. 
Potential strategies towards positive social change deriving from this research are 
the development of a MRSA screening program, and the education of health workers. 
The results of the study will help increase understanding of MRSA outbreaks through 
comparative analysis of data from previous studies worldwide. Findings from 
comparative analyses will advance knowledge on the diseases' genetic, epidemiological, 
and clinical characteristics.  
Summary 
MRSA infections can range from mild to life-threatening in human beings 
(Monecke et al., 2011; Stefani et al., 2012). The risk factors of HA-MRSA are well 
known, but the increase in CA-MRSA and the movement of CA-MRSA to health care 
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settings has changed the epidemiology of the disease. More research is necessary to 
elucidate the burden and impact of MRSA, in particular invasive MRSA, on communities 
as well as health care settings. In order to describe and target interventions among 
populations at risk, several infection control measures are necessary including an 
antimicrobial stewardship program and an increased understanding the epidemiology of 
MRSA in specific population. Poor assessment of CA-MRSA and HA-MRSA prevalence 
within a facility can lead to the administration of unnecessary and/or improper 
antibiotics, causing a selective pressure on the factors that are responsible for the high 
rate of multidrug resistance strains (MDR) in Saudi Arabia. Hence, my study was 
conducted within the Saudi Aramco community in the Eastern province of Saudi Arabia. 
It was the first study conducted to obtain data to assess the molecular characteristics of 
the MRSA strains causing infection in this population.  
Molecular methods such as genotyping are involved in classifying MRSA 
infections and identifying MRSA strains to arrive at preventive and control measures. In 
the absence of molecular methods, three phenotyping methods have been used to 
differentiate the strains. The purpose of this study was to identify a non-arbitrary, 
verifiable combination of phenotyping variables to allow reliable classification of MRSA 
in the Saudi Aramco region of Saudi Arabia into HA-MRSA or CA-MRSA.  
The underlying reason for carrying out the study was that this enhanced 
understanding would help to establish a feasible and effective screening and treatment 
program. An accurate and less expensive phenotypic method would help the infection 
control department to monitor and investigate the prevalence of CA-MRSA and HA-
27 
 
MRSA infections more precisely. The absence of a standardized phenotyping method for 
assessing MRSA is a real challenge for the infection control program in Saudi Arabia.  
Chapter 1 illustrated the gaps in the research this study sought to fill, the purpose 
and nature of the endeavor relative to the entire body of research, the research questions 
and hypotheses, the theoretical basis that provided a framework for the study, and an 
organizing model for the research questions. It also discussed the significance and social 
change implications this study may have relative to the research topic. This approach 
allowed more effective establishment of epidemiology of MRSA in the region, in order to 
help with surveillance and prediction/control of epidemic outbreaks, and allow 
appropriate antibiotic treatment regimens to be applied in a timely manner. 
In Chapter 2, I provide an overview of the current literature on MRSA in Saudi 
Arabia, Middle East, Europe, and the United States. The chapter briefly outlines the 
emergence of MRSA bacteria; considers the impact of the infection on populations from 
a cost, morbidity, and mortality standpoint; and identifies what current research is 
available regarding the epidemiology of MRSA. The chapter includes a general 
discussion on the traditional methods for defining CA-MRSA disease and the clinical and 
molecular epidemiology of CA-MRSA disease.  
Chapter 3 details the methodology I used while completing my research. The 
study design, data sources, abstraction instruments, and details of my analyses are 
discussed.  
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In chapter 4, I present the results of my analyses. I utilized John Hopkins Health 
Care Center MRSA infection data, and MRSA multiplex PCR classification data to 
conduct the statistical analyses used to answer the research questions in detail. 
In chapter 5, I summarize, interpret and discuss key research findings. In addition, 
I include recommendations for the application of the study findings and future research. 
Finally, I discuss the impact of my study results and its potential implications for positive 
social change.  
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Chapter 2: Literature Review 
CA-MRSA and HA-MRSA strains have spread into health care settings in Saudi 
Arabia, bringing increased morbidity, mortality, and financial burdens (Bukharie, 2010). 
Unfortunately, current prevention controls in Saudi Arabia rely on MRSA phenotyping 
methods imported from other countries without testing validity or effectiveness of those 
methods (Bukharie, 2010). This approach to MRSA typing poses additional health care 
concerns when attempting to treat the MRSA strains effectively. 
International consistency lacks in typing and naming MRSA strains, and 
uncertainty regarding what constitutes CA-MRSA is prevalent. In Saudi Arabia, there is a 
lack of studies on locally relevant strains. Currently, there is no MRSA national control 
program in Saudi Arabia despite increased prevalence of MRSA (Baddour et al., 2007; 
Bukharie, 2010). This dearth of information is highlighted by the limited number of 
reports identified by the National Library of Medicine of MRSA infections in Saudi 
Arabia when compared with other countries such as the United Kingdom or the United 
States (Baddour et al., 2007). A classification scheme for Saudi Arabia, appropriate for 
use at local, regional, and national levels, is needed to harmonize surveillance and 
treatment programs, in keeping with recommended best practice (Stefani et al., 2012). 
This need was the context for the research problem I addressed in this study.  
In this review, I provide an overview of the literature review search strategy, as 
well as review of the theoretical framework, and the current literature on risk factors, 
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epidemiology, and genetics for both HA-MRSA and CA-MRSA. I critically analyzed 
published studies on different genotypic and phenotypic methods used for classification. 
Literature Search Strategy 
Though I reviewed literature dating back to 1950 to explain the emergence of 
MRSA, I placed emphasis on including a substantial number of peer-reviewed 
publications in acceptably high-impact journals from the last 5 years. I also consulted 
reports and websites of reputable bodies including the CDC. 
I used the PROQUEST database and the PubMed search engine to identify the 
extant literature. Relevant electronic databases were accessed including Medline, Science 
Direct, and the Institute of Scientific Information (ISI) Web of Knowledge citation 
indexes. I used various keywords and phrases at different times in compiling sources for 
the literature review. I remained aware of issues such as the existence of synonyms for 
the search terms, as well as plurals, alternative spellings (e.g., U.S. versus U.K. English), 
and alternative and related terms. Having identified keywords, I used them singly or 
combined as search terms with Boolean operators AND, NOT, and OR. Truncation was 
often used in searches account for spelling variations, plural versus singular, and root 
words, commonly by using an asterisk or a question mark to replace a single letter or a 
string of letters. Keywords searched either singly or in various combinations included 
Staphylococcus aureus; Methicillin Resistant Staphylococcus aureus (MRSA); community 
associated or community-acquired or community onset; CA-MRSA; HA-MRSA; 
nosocomial, strain*; clonal complex*; phenotype; phenotyping classification; method; 
genotype; genotyping classification; concordance; antibiotic*; methicillin; vancomycin; 
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susceptibility; resistance; antibiogram; health care; risk factor* and appropriate articles 
with a specific reference to Saudi Arabia. Moreover, I also sought and scrutinized 
distinctive antibacterials through PubMed. Various other articles, which were procured 
from the reference section of source articles, were acquired through PubMed.  
Theoretical Foundation 
The ecological theory and antibiotics selection pressure (ASP) theory supported 
this study. In ecological theory, the competitive exclusion principle or Gause’s law of 
competitive exclusion states that “two species competing for the same resources cannot 
coexist if other ecological factors are constant. When one species has even the slightest 
advantage or edge over another, then the one with the advantage will dominate in the 
long term” (Hardin, 1960, p. 1292). Ecological theory thus dictates that both coexistence 
and competition can occur between CA-MRSA and HA-MRSA (Kouyos et al., 2013). 
HA-MRSA is classically characterized by a broad resistance antibiotic resistance 
spectrum conferred by its relatively large Staphylococcal cassette chromosome 
(SCCmec); SCCmec is a complex mobile genetic element found in Staphylococcal 
aureus (Ito et al., 2014; Shore & Coleman, 2013). In MRSA, it carries the PBP2a-
encoding mecA gene responsible for the β-lactam antibiotic resistance, that is absent in 
resistant MSSA strains (Hiramatsu et al., 2001). HA-MRSA usually carries either 
SSCmec II or III, which have acquired genes for resistance to antibiotic classes beyond 
the β-lactams (Hiramatsu et al., 2002). CA-MRSA, in contrast, tends to carry SSCmec IV 
and V, which are relatively small. Thus CA-MRSA strains tend to be susceptible to 
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clindamycin and other non-β-lactam antibiotics (Naimi et al., 2003). Under ecological 
theory, therefore, these factors would favor HA-MRSA in a health care environment 
where there is common use of antibiotics. Conversely, the presence of SCCmec II or III 
correlates with slower growth than elements IV or V. Thus in the community, in the 
absence of antibiotics, CA-MRSA carrying SCCmec IV or V may be at a selective 
advantage. This was proposed to explain why CA-MRSA out-competes HA-MRSA in 
the community (Monecke et al, 2011). The classification of HA-MRSA and CA-MRSA 
has been challenged by studies suggesting that MRSA isolates characterized as 
containing SCCmec IV and PVL, and. thus genotypically CA-MRSA are emerging in the 
health care environment (David et al, 2008a). CA-MRSA strains are characterized by a 
lower biological cost of resistance, making them viable candidates to replace HA-MRSA 
strains in health care settings (Kouyos et al., 2013). The ecological theory is thus useful 
in explaining the increase in CA-MRSA rates within healthc are settings, and in particular 
the emerging multidrug resistant CA-MRSA. This theory can also be used to explain why 
certain strains of CA-MRSA are misclassified as HA-MRSA. 
According to ASP theory, there is a link between increasing use of 
fluoroquinolones antibiotics and the emergence of new CA-MRSA strains (LeBlanc et al, 
2006). This supports the importance of establishing a correlation between commonly 
prescribed antibiotics and the occurrence of CA-MRSA infection. The theory of ASP is 
also very useful to explain why some CA-MRSA strains are becoming resistant to 
different groups of antibiotics, which might interfere with the susceptibility pattern 
classification of MRSA.  
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For this study, I focused on the potential CA-MRSA and HA-MRSA strains that 
could spread into health care settings in Saudi Arabia, specifically in the Saudi Aramco 
region of Saudi Arabia. Therefore, the study aligned with both the Ecological and ASP 
theory frameworks, as both of these theories helped explain patterns of CA-MRSA or 
HA-MRSA incidence and prevalence in the health care setting versus the community. 
Studies to date in Saudi Arabia, suggest the prevalence of CA-MRSA is increasing and 
the lines between ‘HA-MRSA’ and ‘CA-MRSA’ are blurring in terms of health care risk 
factors (Al‐Tawfiq, 2006; Baddour et al., 2007; Bukharie, 2010; David et al., 2008; 
Monecke et al; 2102; Moussa & Shibl, 2009; Stefani et al, 2012). The goal of this study 
was to identify accurate and reliable phenotyping methods to classify MRSA into HA-
MRSA and CA-MRSA in concordance with a genotyping gold standard. Previous studies 
on phenotyping and genotyping concordance suggested that antibiotic susceptibility 
patterns (Clinical Laboratory Standards Institute (Clinical and Laboratory Standards 
Institute, 2005) may be particularly helpful in classification, given the increasingly 
questioned predictability of health care risk factors (Campanile et al., 2011; David et al, 
2008a; Donnio et al, 2004; Hetem et al., 2012; Maree et al., 2007; Nair et al., 2011; Otter 
& French, 2011; Song et al., 2011). This study therefore used the existing Ecological and 
ASP theories as a suitable framework, but I was mindful of the plasticity of the 
definitions of what constitutes true HA-MRSA or CA-MRSA.  
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Literature Review MRSA 
Classification 
Staphylococcus aureus are Gram-positive cocci that colonize 20% to 30% of the 
human population (van Belkum et al., 2009) as well as many animal species including 
livestock and domestic animals (Lindsay 2014; Peton & Le Loir, 2014). It grows either 
singly, in pairs, or in irregular clusters. Staphylococcus aureus is often carried 
asymptomatically as a commensal organism. However, as a human pathogen it is 
opportunistic and causes infections ranging from mild skin and soft tissue infections to 
life- threatening sepsis, pneumonia, and toxic shock syndrome (TSS). The 
pathophysiology depends on the presence of virulence factors including those present on 
the cell surface or secreted factors.  
MRSA refers to a strain of Staphylococcus aureus that is resistant to the antibiotic 
methicillin. Methicillin and oxacillin resistance are due to the presence of a modified 
penicillin binding protein (PBP2’, or PBP2a), which is encoded by the mecA gene (Lim 
& Strynadka, 2002). This gene is found on complex mobile genetic elements called 
staphylococcal cassette chromosomes (SCCmec). In practice, PBP2a confers resistance to 
all β-lactam antibiotics (Fey et al., 2003), apart from ceftobiprole, including 
cephalosporins, penicillin derivatives such as ampicillin, amoxicillin, ticarcillin and 
piperacillin, and carbapenems (National Committee for Clinical Laboratory Standards 
(NCCLS), 1997). SCC mec also variably contains genes encoding resistance to 
aminoglycosides or macrolides (Ito et al., 2001; Oliveira, Wu & de Lencastre, 2000). 
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This high spectrum of antimicrobial resistance complicates treatment options (Wertheim 
et al., 2005).  
Historical Overview of MRSA Emergence 
In the 1940s, the major antibiotic available to treat Staphylococcus aureus 
infections was the then newly discovered penicillin (Chambers, 2001). However by 1944 
the first penicillin–resistant strain of Staphylococcus aureus had already been observed 
(Chambers, 2001). The prevalence of penicillin-resistant strains began to increase, 
prompting the development of new semi-synthetic penicillinase-resistant penicillins 
including methicillin and oxacillin (Lodise & McKinnon, 2005). By 1961, a new 
Staphylococcus aureus strain, which was resistant to methicillin, termed MRSA, had 
emerged and was observed in the UK (Jevons, 1961). MRSA subsequently spread 
throughout the world, although it was mainly observed as a hospital-acquired infection 
(Stewart & Holt, 1963). The first reports of MRSA acquired in the community outside of 
hospitals and health care facilities were in the 1980s (Levine, Cushing, Jui, & Brown, 
1982; Saravolatz, Markowitz, Arking, Pohlod, & Fisher, 1982). However, until the late 
1990s such reports remained infrequent. Since then, there has been a steady increase in 
reports of MRSA isolated from people in the community without recent treatment in a 
hospital or health care facility (Groom et al., 2001; Herold et al., 1998; Kaplan et al., 
2005; Ladhani & Garbash, 2005; Marcinak & Frank, 2003; Naimi et al., 2003; Zaoutis et 
al., 2006). Whereas at first it was suspected that this marked the spread of HA-MRSA 
from hospitals into the community, it became clear that in terms of antibiotic 
susceptibility, epidemiology and genetics, these community associated (CA)-MRSA 
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strains differed in important respects from HA-MRSA and in fact represented new strains 
that had arisen in the community (David et al. 2008a). 
Epidemiology and Risk Factors of HA-MRSA and CA-MRSA 
HA-MRSA and CA-MRSA can be distinguished by their differing epidemiology 
and risk factors. The CDC defines CA-MRSA based on the hosts' lack of health care risk 
factors; in the presence of such risk factors the CDC advocates classification as HA-
MRSA. MRSA is a common cause of hospitalized infections. Risk factors for HA-MRSA 
include surgery, hemodialysis, peritoneal dialysis, hospitalization, residency in a long-
term care facility within the last year, or presence of indwelling percutaneous devices or 
catheters at the time of diagnosis or previous isolation of MRSA (CDC 2005). By the 
CDC definition, CA-MRSA is diagnosed when MRSA is observed in an outpatient or 
within 48 hours of hospitalization, yet lacks the risk factors outlined for HA-MRSA 
(Naimi et al., 2003). The rapid and accurate identification of oxacillin-resistance in 
susceptibility tests (methicillin is no longer in use) is needed to determine appropriate 
antimicrobial therapy (Louie et al., 2001; Pantosti & Venditti, 2009). Studies on 
phenotype, genetics, and antibiotic susceptibility of MRSA suggest that the CDC 
definition of CA-MRSA may be too conservative (David et al., 2008a, 2008b).  
Currently, up to 85% of MRSA infections would be classified as HA-MRSA 
(CDC, 2005). HA-MRSA infection refers to patients isolated after 48-72 hours of 
admission to a hospital, those present at time of admission or health care workers of long-
term care facilities (CDC, 2005). Patients tend to be elderly, although pre-term babies are 
also susceptible (Cooke & Brown, 2010; Millar et al., 2007). Immunocompromised 
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patients are susceptible to HA-MRSA (Giamarellos-Bourboulis et al., 2009), as are 
patients with chronic diseases such as diabetes with skin ulcers, dialysis patients, and 
people working in health care settings who have poor hygiene (Cooke & Brown, 2010; 
Millar et al., 2007). HA-MRSA patients may develop pneumonia or serious invasive 
infections at surgical sites and wounds, and within the urinary tract and bloodstream 
(Gould et al., 2011). HA-MRSA can also become epidemic MRSA (EMRSA) and spread 
between hospitals when colonized patients or staff members move from one hospital to 
another. CDC guidelines suggest that transmission of HA-MRSA could be reduced by 
practices such as adequate hand hygiene among medical staff, use of protective clothing 
and equipment, and use of antimicrobial soap and ointment on all intensive-care unit 
(ICU) patients (CDC, 2005).  
The epidemiology of CA-MRSA differs from that of HA-MRSA, as the CDC 
exclusionary definition implies. Infections often occur among previously healthy, 
younger individuals either in an outpatient setting or within 48 hours of admission to a 
health care facility (Cooke & Brown, 2010; Naimi et al., 2003). However, recent studies 
suggest that these kinds of distinctions may be too limiting as strains of MRSA, which 
would be genotypically CA-MRSA, also arise within health care settings (David et al., 
2008a). CA-MRSA was first observed in the 1980s when it was noted as the cause of a 
sharp increase in infection among North American intravenous drug users (Minnesota 
Department of Health, 2004). Later outbreaks were recognized in separate community 
populations (Table 1) such as children attending day-care centers, soldiers, male 
homosexuals, Native Americans, athletes in close contact sports, prisoners, and again 
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intravenous drug users (Cooke et al., 2010; Cooke & Brown, 2010; Davis et al., 2007; 
Diep et al., 2008a; Hidron et al., 2009; Huang et al., 2008; Thomas et al., 2007). 
Table 1 
Groups Experiencing Outbreaks of CA-MRSA with Risk Factors 
Population or group Possible risk factors References- examples 
Inmates/prisoners Crowded living conditions, 
close contact 
MMWR, 2001; Pan et al., 
2003 
Men who have sex with men Close contact Diep et al., 2008a 
Athletes Close contact, skin 
abrasions, sharing of 
equipment 
Begier et al., 2004; 
Kazakova et al., 2005 
Military recruits Crowded living conditions, 
skin abrasions 
Ellis et al., 2004 
Native Americans  Close contact, crowded 
living conditions 
Groom et al., 2001 
Children (especially in day 
care centres) 
Close contact, skin 
abrasions 
Herold et al., 1998; Kaplan 
et al., 2005 
Intravenous drug users Poor skin hygiene, sharing 
needles 
Cooke et al., 2010 
Impoverished adults (inner 
city areas) 
Close contact, crowded 
living conditions, poor 
hygiene 
Charlebois et al., 2002 
 
Risk factors for development of CA-MRSA include crowded living conditions 
and poor hygiene, breaks in the skin, and skin-to-skin contact. Infections associated with 
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CA-MRSA also tend to be less serious, for example skin and soft tissue infections 
(SSTI), sometimes initially mistaken for an arachnid bite, which can often be treated by 
excision and drainage rather than antibiotic treatment. However, these conditions can be 
chronic or recurrent. Moreover, CA-MRSA is also associated with an expression of 
toxins and if left untreated can lead to serious conditions such as necrotizing pneumonia, 
sepsis, and osteomyelitis (Lina et al., 1999).  
Genetics of HA-MRSA and CA-MRSA 
HA-MRSA and CA-MRSA differ at the molecular genetic level. One major 
difference is in the Staphylococcal cassette chromosome (SCCmec) expressed. SCCmec 
is a complex mobile genetic element found in Staphylococcus aureus (Ito et al., 2014; 
Shore & Coleman, 2013). In MRSA it carries the PBP2a-encoding mecA gene 
responsible for the β-lactam antibiotic resistance, which is absent in resistant methicillin-
sensitive Staphylococcus aureus (MSSA) strains (Hiramatsu et al., 2001). There are 
currently eleven known SCCmec types for which there are complete nucleotide sequence 
data available, ranging in size from 20 to 60 kb (Garcia-Alvarez et al., 2011; International 
Working Group on the Classification of Staphylococcal Cassette Chromosome Elements 
(IWG-SCC), 2009; Li et al., 2011; Shore et al., 2011; Shore & Coleman, 2013). Each has 
been assigned a unique Roman numeral, reflecting the order in which it was identified 
(IWG-SCC, 2009). HA-MRSA is generally associated with expression of SCCmec types 
I, II or III while CA-MRSA is generally associated with types IV and V. In practice, most 
MRSA strains are either SCCmec II or IV (IWG-SCC, 2009; Shore & Coleman, 2013). 
40 
 
Another molecular distinction between HA-MRSA and CA-MRSA is the 
presence or absence of the bi-component toxin PVL (Kaneko & Kamio, 2004) which is 
harbored by some CA-MRSA strains but not by HA-MRSA (Otto, 2013). Cases of CA-
MRSA positive for PVL have been reported worldwide (Monecke et al., 2007). 
Epidemiologically, PVL expression in MRSA can be approximately divided into three 
groupings (Monecke et al., 2011). In Europe, the prevalence of PVL-expressing MRSA 
remains low and its expression in individuals may reflect international travel in and out of 
European countries. In Australia and Abu Dhabi, prevalence of PVL-expressing MRSA 
is high and may be the result of mass immigration into these countries by people from all 
over the world. Finally in the USA, one PVL- expressing MRSA strain, termed USA 300, 
predominates over all other strains, whether PVL expressing or not. 
Although PVL was identified in Staphylococcus aureus back in 1932 (Panton & 
Valentine, 1932), its presence in MRSA is relatively new (CDC, 1999). PVL is a two-
component leukocidin toxin that acts by forming pores in the mitochondria (Genestier et 
al., 2005). PVL subunit expression is considered to contribute to increased virulence in 
CA-MRSA although there have been conflicting results in animal models in this regard 
(Otto 2013; Lo & Wang, 2011). However, these PVL-expressing strains have been 
associated with necrotizing pneumonia in previously healthy young people (Gillet et al., 
2007; Labandeira-Rey et al., 2007; Lina et al., 1999).  
Genetic Elements of MRSA 
SCCmec elements have various well-defined features (Ito et al., 2001, 2014; 
IWG-SCC, 2009; Shore & Coleman, 2013). They integrate into the Staphylococcus  
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aureus chromosome at the integration site attB within its integration site sequence (ISS), 
which lies within the 3’ end of the orfX gene (Boundy et al., 2013; Ito et al., 2014); this is 
exploited in some genotyping strategies. SCCmec elements are flanked by repeat 
sequences and they include a cassette chromosome recombinase (ccr) and mec gene 
complex. The ccr genes encode the recombinases that facilitate site- and orientation-
specific SCCmec excision or integration. It is partially this capacity for mobile genetic 
element transfer and re-integration that helps the spread of antibiotic resistance among 
strains.  
Notably, in the context of MRSA, the SSCmec also includes the mec region that 
harbours, where present, the mecA gene and various mec regulatory genes including 
mecI and mecR1 (Hao et al., 2012; Lim and Strynadka, 2002; Shore & Coleman, 2013). 
There are currently five known mec classes and eight known ccr classes (Ito et al., 2014). 
Any regions other than ccr or mec in SCCmec are designated as "joining regions" (J-
regions), for which there are three known subgroups, J1-3 (Ito et al., 2014). In terms of 
the multiple antibiotic resistance profile observed particularly for HA-MRSA, SCCmec 
also frequently contains integrated insertions, for example plasmids or transposons from 
other resistant organisms, carrying genes for resistance to other antimicrobial agents such 
as aminoglycosides or macrolides (Ito et al., 2001; Oliveira, Wu & de Lencastre, 2000).  
Although mecA is the gene commonly associated with conferring methicillin 
resistance, the identification of a novel mecA homologue, now termed mecC, has 
complicated this association recently (Paterson, Harrison & Holmes, 2013). MecC was 
originally identified in an epidemiological study of bovine mastitis resulting in the 
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isolation of a Staphylococcus aureus isolate called LGA251, from a bulk tank milk 
sample in southwest England (Garcia-Alvarez, Webb, & Holmes, 2011). This was 
phenotypically MRSA but genotyping revealed the absence of mecA. 
Subsequent genome sequencing of LGA251 showed that the strain carried a novel 
mecA homologue initially termed mecALGA251 which was 69% identical to 
conventional mecA at the DNA level. The strain encoded a modified PBP2a/2′ that was 
∼63% identical to mecA-encoded PBP2a/2’ at the amino acid level (Garcia-Alvarez et 
al., 2011). This homologue has since been renamed mecC and has been identified in 
human strains in reports from the UK, Denmark, Belgium and Ireland (Deplano, 
Vandendriessche, Nonhoff, & Denis, 2014; Garcia-Alvarez et al., 2011; Shore et al., 
2011; Tsubakishita, Kuwahara-Arai, Baba, & Hiramatsu, 2010 ). 
SCCmec elements in HA-MRSA versus CA-MRSA. Of the eleven known 
SSCmec elements, HA-MRSA is generally associated with expression of SCCmec types 
II or III while CA-MRSA is generally associated with types IV and V. In practice, most 
MRSA strains are either SCCmec II or IV (IWG-SCC, 2009; Shore, & Coleman, 2013). 
SSCmec II and III are relatively large and, as mentioned above, contain genes for 
resistance to antibiotic classes beyond the β-lactams (Hiramatsu et al., 2002). SSCmec IV 
and V, in contrast, are relatively small and the CA-MRSA strains that carry them tend to 
be susceptible to clindamycin and other non-β-lactam antibiotics (Naimi et al., 2003). 
The antibiotic-resistance profiles of CA-MRSA and HA-MRSA are therefore dictated 
mainly by the SCCmec element. 
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The presence of SCCmec II or III correlates with slower growth than elements IV 
or V. It is postulated that in the health care environment, SCCmec II or III confers an 
advantage due to the multi-antibiotic resistance profile. However in the community, in 
the absence of antibiotics, SCCmec II or III-containing HA-MRSA may be at a selective 
disadvantage due to its slower growth. This is proposed to explain why CA-MRSA out-
competes HA-MRSA in the community (Monecke et al, 2011). The classification of 
‘HA-MRSA’ and ‘CA-MRSA’ meanwhile has been challenged by studies showing that 
MRSA isolates characterized as containing SCCmec IV and PVL, thus genotypically 
‘CA-MRSA’, are arising in the health care environment (David et al, 2008a). 
Virulence-associated genetic factors. The key to the success of MRSA lies not 
only in its antibiotic resistance profile but also in its virulence factors. Important 
virulence factors expressed by MRSA strain include Panton-Valentine toxin (PVL) 
(discussed below), phenol-soluble modulins (PSM), and the arginine catabolic mobile 
element (ACME; Hao et al., 2012; Otto, 2010). PSMs are proinflammatory cytolytic 
toxins. Seven PSMs are core genome encoded, but there is a novel PSM gene so far 
detected on SCCmec types II, III and VIII, associated with HA-MRSA (Chatterjee et al, 
2011; Monecke et al., 2012; Queck et al., 2009). This is the only SCCmec-encoded toxin 
gene identified currently.  
PSMs are produced by several staphylococcal species. However CA-MRSA 
produces larger concentrations of PSMs compared to other S. aureus types (Wang et al., 
2007). CA-MRSA can apparently manipulate neutrophil signaling in the host to mediate 
PSM pathogenesis (Clarke, 2010). The arginine catabolic mobile element (ACME) is a 
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pseudo-SCC more commonly observed in Staphylococcus epidermis and Staphylococcus 
haemolyticus than in Staphylococcus aureus (Shore & Coleman, 2013). However, it has 
been identified in the genome of SCCmec IV type MRSA strains, in particular in the 
USA300 strain of CA-MRSA that predominates in the USA (Hao et al,. 2012; Katayama, 
Ito & Hiramatsu, 2000). ACME consists of arc and opp3 gene clusters that together 
comprise an arginine deaminase pathway (Diep et al., 2008b). There have been some 
suggestions that it may contribute to virulence of USA300 but reports from animal 
models are conflicting (de Lencastre, Oliveira, & Tomasz, 2007; Montgomery, Boyle-
Vavra, & Daum, 2009). Carriage of other toxins including staphylococcal enterotoxins 
such as sec, sel, and sea, endotoxins and toxic shock syndrome toxin (TSST-1) varies 
considerably between MRSA strains (Monecke et al., 2011). 
Panton-Valentine toxin. Panton-Valentine toxin (PVL) is expressed in CA-
MRSA strains due to acquisition of the prophage-encoded adjacent lukS and lukF genes. 
These genes encode the dual leukocidin PVL toxin parts, LukS and LukF (Chambers, 
2005; Otto, 2013). PVL belongs to a β-barrel family of pore-forming cytolytic toxins also 
containing several other leukocidins, gamma-toxin, and alpha-toxin (Szmigielski et al., 
1999). In 1932, Panton and Valentine noted that there was an association between PVL 
production and abscess formation (Panton and Valentine, 1932). Recently, interest in 
PVL has increased due to the epidemiological association between the lukSF genes and 
CA-MRSA (Vandenesch et al., 2003). Most CA-MRSA strains contain lukSF genes. 
They are present in MSSA at a much lower frequency and are absent from HA-MRSA. 
PVL is now regarded as a relatively stable marker of CA-MRSA. 
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Agr two-component system. Virulence and resistance are regulated by two-
component systems in MRSA. Among the most important of these in controlling both 
virulence and resistance is the agr system. Four agr groups (I-IV) have been identified in 
MRSA, whose expressions vary with geography, antibiotic resistance profile, and 
virulence factors. Agr plays an important role in quorum-sensing and contributes to 
MRSA pathogenesis, including toxin expression, biofilm formation and heterogeneous 
resistance (Hao, Dai, Wang, & Yuan, 2012). Generally speaking, agr type I correlates 
with HA-MRSA and type II correlates with CA-MRSA while types III and IV correlate 
to other conditions such as TSST-1 and staphylococcal scaled skin syndrome (Hao, Dai, 
Wang, & Yuan, 2012; Nichol et al., 2011). Both agr types I and II are associated with 
multidrug resistance (Hao, Dai, Wang, & Yuan, 2012; Nichol et al., 2011). Type I 
predominates in Europe and South America while type II has been mainly found in Japan 
and North America (Hao, Dai, Wang, & Yuan, 2012). 
Antibiotic Resistance Profiles of MRSA 
Antibiotic resistance of MRSA is mainly dictated by elements of the SCCmec. All 
SCCmec elements carry genes that cause resistant to β-lactam antibiotics, in particular 
mecA (Lim and Strynadka, 2002; Shore & Coleman, 2013). MecC is a more recently 
identified homologue of mecA that also encodes β-lactam resistance (Garcia-Alvarez et 
al., 2011). All SCCmec elements carry genes for resistance to β-lactam antibiotics, in 
particular mecA, as well as mecRI and mecI genes for the regulation of expression of 
mecA (Hao et al., 2012). In addition, SCCmec Types II and III carry non-β-lactam 
antibiotic resistance genes on integrated plasmids and a transposon. These confer 
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resistance to antimicrobials including aminoglycosides, macrolides, tetracycline, 
mercury, and cadmium (Hiramatsu et al., 2002). This seriously complicates therapeutic 
options in HA-MRSA and limits physicians to drugs such as vancomycin, linezolid, 
clindamycin, sulfamethoxazole-trimethoprim, and rifampin (Monecke et al, 2011; So & 
Farrington, 2008). All of these drugs have potential issues including ease of 
administration, penetration, and toxicity (Monecke et al, 2011; So & Farrington, 2008). 
Beyond this, new problems are arising with the emergence of vancomycin-
resistant Staphylococcus aureus (VRSA). There are both vancomycin-intermediate 
Staphylococcus aureus (VISA) infections, in which HA-MRSA develops intermediate 
resistance to vancomycin, and full VRSA (Chang et al., 2003; MMWR, 1997 & 2000; 
Smith et al., 1999; Weigel et al., 2003). The resistance mechanisms are different and they 
do not progress from one to the other along a resistance continuum. VISA is suggested to 
result when an MRSA infection is intensively treated with vancomycin and as a result 
undergoes mutation in cell wall biosynthesis genes. This leads to a thicker cell wall that 
can partially exclude vancomycin, resulting in intermediate vancomycin resistance (Cui 
et al., 2003). VRSA, in contrast, relies on co-infection with both MRSA and vancomycin-
resistant Enterococcus (VRE), with subsequent transfer of the vanA vancomycin 
resistance gene on a plasmid or transposon from VRE to MRSA (Weigel et al., 2003). In 
any case, the rise of these vancomycin-resistant MRSA strains is a worrying development 
and has contributed to the continuing research efforts to identify new antimicrobials and 
new delivery strategies to try to combat multi-drug resistant bacteria (Burke & Rose, 
2014; Ndieyira et al., 2014). 
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Examples of new antimicrobials in development include the lipoglycopeptides 
oritavancin, telavancin, and dalbavancin. The pharmacokinetic and pharmacodynamic 
properties of these drugs mean that they have shown promise in targeting vancomycin-
resistant MRSA (Burke & Rose, 2014). A new strategy for targeting antibiotics to try to 
overcome resistance and optimize dosing includes use of nanoparticles (Ndieyira et al., 
2014). The multiplicity of MRSA strains and continual evolution of these bacteria make 
development of new antimicrobials and therapeutic strategies imperative and also dictates 
that there should be some consensus in typing and nomenclature of MRSA clones and 
strains. 
Overview of MRSA Strains 
An overwhelming variety of both CA-MRSA and HA-MRSA strains have been 
identified to date in humans, as well as many more that have been identified in livestock 
(Monecke et al., 2011). Global epidemiology varies for these strains and there is a need to 
harmonize methods and nomenclature used to describe strains in order to facilitate 
surveillance, identification of risk factors and investigation of suspected outbreaks, and 
identification of possible new strains (Stefani et al., 2011). At present, there is a 
multiplicity of MRSA typing methods which will be discussed in more detail in the 
succeeding sections. As summarized by Stefani et al., 2011, these include spa typing, 
multilocus sequence typing (MLST), SCCmec sequencing, macrorestriction pattern 
analysis, and multilocus VNTR analysis (MLVA). The genes targeted in these typing 
methods and their main advantages and disadvantages are summarized in Table 2.  
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Recently, researchers, involved in a major genotyping effort by DNA microarray 
analysis in laboratories in nine different countries, proposed assigning of MRSA isolates 
to 34 distinct lineages based on non-mobile genetic elements (Monecke et al., 2011). 
Monecke et al. (2011) demonstrated that the epidemiological distribution of MRSA 
strains could be approximately divided up into three groups based on PVL expression 
(Monecke et al., 2011). PVL-expressing MRSA prevalence is low in Europe but high in 
Australia and Abu Dhabi, while in the USA, one PVL expressing MRSA strain, termed 
USA300, predominates over all other strains. 
MRSA strains can be assigned to different clonal complexes based on a 
‘fingerprint’ of core or core variable genes (Monecke et al., 2011). The most commonly 
observed globally of these clonal complexes (CC) are CC5, CC8, CC22, CC30, and 
CC45 (Monecke et al., 2011; Stefani et al., 2011). Within these clonal complexes lie 
strains of both HA-MRSA and CA-MRSA. These strains have different names in 
different countries, making it difficult to apply uniform approaches to surveillance and 
treatment worldwide. One suggested nomenclature was to name strains by: sequence type 
(ST)-MRSA-SCCmec type (Enright et al., 2002). This naming convention would be a 
relatively simple and transferrable method; however assignment to strains in such a way 
is also complicated by, for example, very different strains sharing the same ST and 
SCCmec. Thus additional information, for example on PVL status, should also be 
considered (Monecke et al., 2011). 
Generally, prevalence of HA-MRSA is declining in some European countries or 
remaining stable in others, but is present at very high rates in parts of East Asia (Stefani 
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et al., 2011). Europe has remained relatively free of CA-MRSA, although there is now 
evidence of steady increases in, for example, incidence of USA300, probably as a result 
of international travel (Tietz, Frei, & Widmer, 2005). Meanwhile in East Asia, incidence 
of CA-MRSA varies considerably from one country to the next (Song et al., 2011). In 
terms of CA-MRSA, the number of cases has rapidly expanded in recent years in the 
USA (Maree et al., 2007; Pan et al, 2003 & 2005; Labandeira-Rey et al., 2007). The 
majority of cases can be assigned to strain USA300, which expresses the SCCmec type 
IV and is PVL positive, considered classic hallmarks of CA-MRSA (Fridkin et al., 2005; 
Pallin et al., 2008; Stefani et al., 2011). The other most commonly observed strain in the 
USA was from CC5. PVL in these CA-MRSA strains were associated with increases in 
necrotizing pneumonia (Gillet et al., 2007; Labandeira-Rey et al., 2007).  
There is doubt now as to what can be classified ‘HA-MRSA’ and what can be classified 
‘CA-MRSA’. s previously mentioned, the CDC advocates an exclusionary definition of 
CA-MRSA based on the absence of health care-associated risk factors including surgery, 
hemodialysis, peritoneal dialysis, hospitalization, residency in a long-term care facility 
within the last year, or presence of indwelling percutaneous devices or catheters at the 
time of diagnosis or previous isolation of MRSA (CDC, 2005). However, it is 
increasingly recognized that boundaries are blurring in terms of discriminating between 
HA-MRSA and CA-MRSA by way of health care-associated risk factors. This is because 
patients diagnosed with a genotypically CA-MRSA infection, for example expressing 
SCCmec IV and PVL, have shown to have exposure to a health care environment, 
indicating spread of CA-MRSA into hospitals both in the USA (David et al, 2008a; 
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Maree et al., 2007; Nair et al., 2011; Otter & French, 2011) and in Europe (Campanile et 
al., 2011; Donnio et al., 2004; Hetem et al., 2012). In East Asia, there has been spread in 
both directions, from the community to the hospital and from the hospital to the 
community (Song et al., 2011).  
It is clear that lack of international consistency in the use of typing methods and 
classification of MRSA strains brings considerable challenges. These are relevant to the 
issue addressed in this study, the establishment of a verified MRSA phenotyping method 
supported by a genotyping ‘gold standard’ classification method for MRSA strains 
isolated in the Saudi Aramco community. In terms of Saudi Arabia specifically, there 
have not been many studies on characterization of locally relevant strains of MRSA. One 
study, however, was carried out in the King Fahad Medical City in Riyadh on 102 patient 
isolates (Monecke et al., 2012). These samples were subjected to genotyping by DNA 
microarray analysis, resulting in identification of five different strains belonging to four 
clonal complexes of great diversity. Consistent with the findings in other countries, there 
was evidence of strains in the hospital-acquired samples which would be considered CA-
MRSA by the presence of PVL. In Table 2, I present the advantages and disadvantages of 
MRSA typing methods. 
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Table 2 
MRSA Typing Methods and their Advantages and Disadvantages 
Method Genes targeted Advantages Disadvantages 
Spa typing Polymorphisms 
in the X region 
of the surface 
protein P 
encoding spa 
gene 
Rapid, high throughput, 
portable, dynamic, 
standardized 
nomenclature 
Results in misclassification in 
some lineages 
MLST Core and core 
variable genes 
Defines the core 
genetic population; 
portable; standardized 
nomenclature 
Low throughput; expensive 
SCCmec 
sequencing 
Mobile genetic 
elements 
Standardized 
nomenclature 
Low throughput; expensive; 
protocols are not standardized 
PFGE Whole 
chromosome- 
restriction 
polymorphisms 
High discriminatory 
index 
Requires good technical skills; 
portability limited; multiple 
nomenclatures exist- not 
standardized; results in 
misclassification in some 
lineages 
MLVA Chromosomal 
VNTR 
polymorphisms 
Rapid, high throughput No internationally standardized 
protocols or nomenclature; 
results in misclassification in 
some lineages 
 
Note. Adapted from Stefani et al., 2011. 
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The following sections consider these phenotyping methods in more detail along 
with currently available genotyping methods. 
Phenotyping of MRSA  
The most common phenotyping methods for assignment as HA-MRSA or CA-
MRSA belong to three categories, health care risk factors, infection type (CDC, 2005), 
and susceptibility pattern (Clinical Laboratory Standards Institute (Clinical and 
Laboratory Standards Institute), 2005). The health care risk factors method advocated by 
the CDC (CDC, 2005) is a conservative method which dictates that CA-MRSA diagnosis 
is based on the host's lack of health care risk factors. If such risk factors are present, it 
advocates classification as HA-MRSA. Risk factors for HA-MRSA include surgery, 
hemodialysis, peritoneal dialysis, hospitalization, and residency in a long-term care 
facility within the last year, or presence of indwelling percutaneous devices or catheters 
at the time of diagnosis or previous isolation of MRSA (CDC, 2005). 
CA-MRSA is diagnosed when MRSA is observed in an outpatient or patient 
within 48 hours of hospitalization that lacks the risk factors outlined for HA-MRSA 
(Naimi et al., 2003). In terms of the infection method for phenotyping, there is overlap 
with the health care risk factors method. Any MRSA isolated from deep wounds or sterile 
body sites such as the blood, CSF, and pleural fluids from patients who have health care 
risk factors comprising hemodialysis, surgery, residence in a long-term care facility or 
hospitalization during the previous year, the presence of an indwelling catheter or a 
percutaneous device at the time of culture, is labelled as HA-MRSA. MRSA isolated 
from patients lacking those risk factors is labelled as CA-MRSA (CDC, 2005). 
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Finally, the susceptibility pattern method refers to susceptibility to antibiotics.  
As mentioned previously, HA-MRSA is associated with the larger SCCmec Types II and 
III, which feature plasmids and/or transposons encoding antibiotic resistance genes 
beyond the β -lactam antibiotic class. Thus, according to the susceptibility pattern 
phenotyping method, MRSA cases that are resistant only to β-lactams antibiotics are 
assigned to CA-MRSA while those that are resistant to additional antibiotics classes such 
as carbapenems, aminoglycosides, and fluoroquinolones are designated HA-MRSA 
(Clinical and Laboratory Standards Institute, 2005). 
Accurate phenotyping and the ability to rapidly and efficiently assign MRSA 
cases to HA-MRSA or CA-MRSA is important in monitoring trends in MRSA within 
health care settings and in the community in different countries. Accurate phenotyping 
directly affects choices of appropriate antibiotic treatment, monitoring of outbreaks, and 
prediction or recognition of epidemics. The phenotyping methods described are widely 
used within health care settings. Although each has some merit, the suitability of any 
single method for all situations is now in doubt. 
One complicating factor is the emergence of invasive and multidrug resistant CA-
MRSA strains in health care settings as a cause of health care associated infection (Gillet 
et al, 2010; Seybold et al, 2006), both in the USA (David et al, 2008a; Maree et al., 2007; 
Nair et al., 2011; Otter & French, 2011) and in Europe (Campanile et al., 2011; Donnio et 
al., 2004; Hetem et al., 2012). There is also evidence of increased circulation of HA-
MRSA in the community (Miller et al, 2007; Seybold et al, 2006). In East Asia, 
meanwhile, there is evidence of the spread of ‘HA-MRSA’ and ‘CA-MRSA’ from the 
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community to the hospital and from the hospital to the community (Song et al., 2011). All 
these factors would be expected to interfere with the sensitivity of the types of 
phenotyping methods described and their concordance with each other. This interference 
suggests a need to identify elements of the available phenotyping methods that would 
offer increased sensitivity in local situations and show better concordance with 
genotyping methods. 
In my study, I aimed to examine the suitability of phenotyping methods in the 
context of the Saudi Aramco community in the Eastern province of Saudi Arabia, test 
their concordance, and identify phenotyping elements that would contribute to increased 
sensitivity in diagnosis. I established concordance with information derived from a ‘gold 
standard’ genotyping multiplex PCR method.  
Genotyping of MRSA 
There have been a variety of methods described for genotyping of MRSA, all of 
which have their advantages and disadvantages (Biendo et al., 2013; Monecke et al., 
2011; Stefani et al., 2012; Tenover et al., 1994; Zimmerman et al., 2012). Some of the 
genotyping methods currently in common use were summarized in Table 2. The success 
of these methods depends on having an understanding of the basic genome structure of 
Staphylococcus aureus, the variation between Staphylococcus aureus strains, and how 
strains are evolving (Stefani et al., 2012). The basic genetic core of Staphylococcus 
aureus consists of a highly conserved set of core genes interspersed with a set of 
approximately 700 core variable (CV) genes, which are used to group Staphylococcus 
aureus into lineages. Lineages are currently defined on the basis of multilocus 
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sequencing type (MLST) clonal complexes (CC) from sequencing of a set of seven 
housekeeping genes. This is the basis of the ‘sequence type’ (ST) designation in 
Staphylococcus aureus terminology generally and MRSA terminology specifically. 
Sequence type refers to single nucleotide polymorphisms in MLST sequences of these 
seven housekeeping genes. Isolates that are identical will have the same ST number and 
closely related STs will be grouped together in the same CC (Stefani et al., 2012).  
However, as already mentioned, Staphylococcus aureus features mobile genetic 
elements that are essential in the evolutionary success of Staphylococcus aureus strains, 
as they carry genes conferring both increased virulence and resistance to antibiotics. The 
key to how HA-MRSA and CA-MRSA fit into both the Ecological and ASP framework 
of the current study is the mobile genetic elements of Staphylococcus aureus that have 
driven the emergence of MRSA. Some genotyping methods for MRSA consider the 
mobile genetic elements, particularly SCCmec, mecA, mecC, and PVL, as well as 
additional antibiotic resistance genes conferred by plasmids and transposons. Major 
methods currently used in MRSA genotyping are described in the following sections. 
Pulse Field Gel Electrophoresis. Macrorestriction pattern analysis by PFGE is a 
widely used genotyping method which scans the whole chromosome for restriction 
polymorphisms. The method entails lysing the bacterial cell wall, embedding the 
bacterial cells in agarose and partially digesting the bacterial DNA with a range of 
restriction endonucleases before separating bands by electrophoresis. This method has 
been validated epidemiologically and significant correlation has been observed between 
phenotyping by antibiogram and genotyping by PFGE (Blanc et al., 2001; Chomvarin et 
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al., 2005). PFGE is considered the gold standard MRSA genotyping method due to its 
high discriminatory power (Blanc et al., 2001; Chomvarin et al., 2005; Deurenberg et al., 
2007).). However, it is a technically complicated and time-consuming, its portability is 
very limited and there is no major consensus on nomenclature derived from the method 
(Mehndiratta & Bhalla, 2012; Narukawa et al., 2009; Stefani et al., 2012). As it is an 
image-based method, standardization and sharing of information between laboratories is 
challenging.  
Spa sequence typing. The spa gene of Staphylococcus aureus encodes the cell 
wall component Staphylococcus aureus protein A (Deurenberg et al., 2007). This gene 
consists of a number of 24 base repeats and exhibits polymorphisms which are exploited 
in the spa sequencing genotyping method (Deurenberg et al., 2007). This method has 
major practical advantages in terms of its high throughput, rapid turnaround, and lack of 
extreme technical difficulty, as it only involves sequencing one locus and it benefits from 
a standard nomenclature (Stefani et al., 2012). In some cases, it has been shown to have 
good concordance with other genotyping methods including PFGE and MLST (Melin et 
al., 2009; Narukawa et al., 2009; Strommenger et al., 2006) and its sensitivity is 
considered to lie somewhere between these two methods (Deurenberg et al., 2007). 
Development of the clustering algorithm Based Upon Repeat Patterns (BURP) has 
facilitated cluster analysis based on spa sequencing data and been used to show 
concordance of spa sequence typing with other methods (Deurenberg et al., 2007; Stefani 
et al., 2012; Strommenger et al., 2006;). The spa server database, curated by the 
SeqNet.org initiative contains information from thousands of spa sequences (Deurenberg 
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et al., 2007; Stefani et al., 2012). Overall, spa typing is considered to be a good clinical 
typing option. However, in some cases spa sequencing type leads to misclassification of 
lineages and it lacks discrimination in local situations where one or a small number of 
clones are endemic (Stefani et al., 2012). 
Multi Locus Sequence Typing (MLST). MLST is a highly discriminatory 
method used for analysis of clonal evolution of MRSA (Deurenberg et al., 2007; Stefani 
et al., 2012) As previously mentioned it is used in sequence type (ST) typing in 
Staphylococcus aureus and as such is associated with a standardized nomenclature 
(Stefani et al., 2012). In MLST typing, seven housekeeping genes are sequenced and the 
allele combination identified is used to assign an ST number to the isolate under 
examination (Faria et al., 2008). Closely related STs will be grouped in the same clonal 
complex (CC) (Faria et al., 2008; Stefani et al., 2012).  
SCCmec typing. Methicillin resistance in Staphylococcus aureus is achieved via 
the SCCmec that contains the mec A gene complex and the ccr gene complex. There are 
currently eleven known SCCmec types ranging in size from 20 to 60 kb (Garcia-Alvarez 
et al., 2011; IWG-SCC, 2009; Li et al., 2011; Shore & Coleman, 2013; Shore et al., 
2011). Each has been assigned a unique Roman numeral reflecting the order in which it 
was identified (IWG-SCC, 2009). HA-MRSA is generally associated with expression of 
SCCmec Types I, II or III while CA-MRSA is generally associated with Types IV and V. 
Each SCCmec type encodes resistance to different antibiotics (Zhang, McClure, Elsayed, 
& Conly, 2009).  
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During the last two decades, several genotyping studies that target different genes 
were conducted in the USA and Europe to accurately classify MRSA as CA-MRSA or 
HA-MRSA, and to understand the molecular characteristics of the most predominant 
strains. However, the same type of genotyping studies were not introduced in the Middle 
East, and in particular in Saudi Arabia, until 2012 when the first genotyping study that 
targeted different MRSA genes was conducted in the central province area of Saudi 
Arabia to characterize and classify 107 MRSA strains that were isolated from 107 
patients (Monecke et al., 2012).  
HARMONY, the International Union of Microbiology Societies' European 
Staphylococcal typing network, has suggested that a combination of MLST and SCCmec 
typing should be used as a reference typing system for multicenter MRSA surveillance 
MRSA (Cookson et al, 2007) and that it should be possible to integrate findings from 
PFGE and spa typing- economically more affordable methods- with MLST and SCCmec 
sequencing findings. MLST and SCCmec both have the disadvantage of being low 
throughput and expensive methods (Stefani et al., 2012). A multi-typing approach is also 
advocated by the European Centre for Disease Prevention and Control (ECDC) while 
SeqNet.org urges standardization of laboratory methods to facilitate quality control and 
comparability (Stefani et al., 2012). 
Findings of an expert panel meeting held by the International Society of 
Chemotherapy in 2011 suggested that within countries, there should be three levels of 
typing laboratories at local, regional, and national levels, all with different functions and 
using typing techniques appropriate to their function and available resources (Stefani et 
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al., 2012). At the local level, where the main function should be new strain detection and 
identification of species, time, location, and unusual characteristics, PCR-based methods 
are suggested as they are rapid, relatively inexpensive, and readily communicated to labs 
at regional and national level. PCR- based methods include multiplex PCR (M-PCR), 
real-time PCR, hyper variable region (HVR) and the spa typing (Stranden, Frei, Adler, 
Fluckiger, & Widmer, 2009). The method of choice in my study was based on multiplex 
PCR. 
Multiplex PCR. The technical basis of multiplex PCR is the use of multiple 
oligonucleotide primers in the same PCR, which allows simultaneous amplification of 
several target genes. In a study of MRSA, genes targeted included 16S rRNA, mecA and 
PVL genes, giving rapid and reliable results for example in detection of USA300 
(Bonnstetter et al., 2007).  
Another study on mecA and coagulase genes showed excellent concordance 
between disk diffusion tests to measure oxacillin susceptibility and mecA detection by 
PCR, while results for coag detection by PCR were concordant with phenotypic tests for 
all isolates (Rallapalli, Verghese, & Verma, 2008). Studies suggest that speedy detection 
of MRSA using in-house or commercial PCR analysis is substantially compatible for 
patient management (Malhotra-Kumar et al., 2008). The commercially available Gene 
Xpert MRSA kit (Cepheid) uses a multiplex, real-time PCR method with primers. This is 
designed to detect each SCCmec type as well as the chromosomal orfX-SCCmec 
junction, which simultaneously gives information on both the SCCmec identity and on 
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whether the SCCmec is correctly integrated with respect to orfX, thus confirming 
methicillin resistance (Biendo et al, 2013).  
A recent update to the Gene Xpert system simultaneously detects spa, thus 
confirming the presence of Staphylococcus aureus, presence of mecA and the junction 
between SCCmec and orfX, and overcoming previous drawbacks in the system that 
falsely led to MSSA strains with an ‘empty’ cassette, lacking mecA, as MRSA (Biendo et 
al., 2013). In blood cultures this method yielded genotypic results with excellent 
concordance with phenotypic methods.  
Thus, multiplex PCR methods seem to offer the advantages of rapidly obtainable 
results that are concordant with phenotypic data. Among various other PCR based typing 
techniques, random amplified polymorphic DNA (AP-PCR/RAPD), polymerase chain 
reaction-restriction fragment length polymorphism (PCR-RFLP) and multilocus variable-
number tandem repeat analysis (MLVA) are also suggested to be useful for typing of 
MRSA strains. 
AP-PCR/RAP. This rapid and straightforward technique is potentially applicable 
to almost all MRSA strains (van Belkum et al., 1995). It involves use of small arbitrary 
primers of unknown homology to the target sequence to randomly amplify the target 
DNA segments. The number and size of the fragments produced during PCR are the 
foundation for MRSA isolate typing of a MRSA isolate. In a study to evaluate AP-PCR 
for Staphylococcus aureus typing, it was suggested that the technique could be useful in 
studying outbreak strains but not for use as a reference method due to poor inter-
laboratory reproducibility (van Belkum et al., 1995).  
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PCR-RFLP. This technique relies on amplifying a defined fragment of DNA 
followed by consequent restriction enzyme digestion of the amplified product and 
analysis of restriction fragment length polymorphisms (Mehndiratta et al., 2009; Stefani 
et al., 2012). This method has been used on the coagulase (coa) and spa genes to 
distinguish between MRSA strains (Mehndiratta et al., 2009). PCR-RFLP of spa gene in 
particular has been reported to be valuable in differentiating between strains which were 
otherwise difficult to type (Mehndiratta et al., 2009).  
Multilocus VNTR analysis (MLVA). MLVA is a PCR-based method that relies 
on the polymorphism of tandem repeated DNA sequences (Schouls et al., 2009). In terms 
of MRSA it is seeing increasing use as it is a high-throughput, rapid method (Stefani et 
al., 2012). However, there is some concern about reproducibility and nomenclature and 
also there is a lack of any standard methodology, as a number of schemes are in use 
(Stefani et al., 2012). Against these disadvantages, it has been shown that this method 
potentially has a discriminatory power in excess of either spa or PFGE-based methods, 
while at the same time showing good concordance with results from both of these 
methods (Schouls et al., 2009). 
Concordance of Phenotyping and Genotyping of MRSA 
Generally accepted characteristics of HA-MRSA and CA-MRSA as inferred from 
phenotyping and genotyping studies are summarized in Table 3. Phenotyping by criteria 
including health care risk factors, infection type (CDC, 2005), and susceptibility pattern 
(Clinical Laboratory Standards Institute (Clinical and Laboratory Standards Institute, 
2005) have been widely used to classify MRSA into HA-MRSA and CA-MRSA. 
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However, experience throughout the world of the spread of CA-MRSA into health care 
settings and emergence of HA-MRSA in the community has challenged assignment of 
MRSA purely in terms of the health care risk factor and infection type phenotyping 
methods (Campanile et al., 2011; Hetem et al., 2012; Nair et al., 2011; Otter & French, 
2011; Song et al., 2011). In Table 3, I present the characteristics of CA and HA-MRSA. 
Table 3 
Characteristics of CA-MRSA and HA-MRSA 
Characteristic CA-MRSA HA-MRSA 
Common 
manifestations 
SSTI, necrotizing pneumonia Nosocomial bacteraemia, 
pneumonia, wound 
infections 
Antibacterial 
susceptibility 
Frequently susceptible to 
non-β-lactam antibacterials, 
low prevalence of iMLSβ 
resistance 
Broad resistance to non-β-
lactam antibacterials, 
resistance common iMLSβ 
SSCmec type IV, V I, II, III 
Accessory gene 
regulator type 
agr III agr I, II 
Genotype (PFGE) USA300, USA400, 
USA1000, USA1100 
USA100, USA200, 
USA500, USA600, 
USA800 
Sequence type (MLST) ST1, ST8, ST30, ST59, ST80 ST5, ST36, ST45 
Virulence genes/factors pvl, sea, seb, sec, seh and 
Type I ACME common; 
higher expression of PSM; 
more rapid in vitro growth 
pvl uncommon, Type I 
ACME absent 
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For example, in a study of 616 patients in University of Chicago hospitals, it was 
found that many patients with health care risk factors carried MRSA that was 
clindamycin-resistant, PVL positive, contained SCCmec IV and/or was assigned as ST8 
by MLST, all features of CA-MRSA (David et al., 2008a). Therefore, exposure to health 
care risk factors is becoming increasingly unreliable as a predictor of HA-MRSA versus 
CA-MRSA. The result is that CA-MRSA becomes underestimated, as the risk factors and 
infection type methods have a higher tendency to identify HA-MRSA than the 
susceptibility pattern method or genotyping methods (Sievert 2008).  
David et al (2008a) further confirmed that skin and soft tissue infections (SSTI) 
are the most common types of infections for both CA-MRSA and HA-MRSA, 
challenging the infection type phenotyping method. Genotyping methods such as 
multiplex PCR and PFGE are highly reliable in classifying MRSA. It is imperative to 
identify reliable phenotyping criteria confirmed with genotyping results and thus 
dependable for use in the field. In some cases, concordance between phenotyping and 
genotyping methods has been confirmed. For example, in a study where genotype of 
MRSA was predicted using a fluoroquinolone susceptibility test, the results of 
antibiogram and PFGE were significantly correlated suggesting that antibiogram can be 
an effective tool for use as an epidemiological marker (Chomvarin et al., 2005). 
Concordance between the Gene Xpert multiplex PCR genotyping method and 
phenotyping by antibiotic susceptibility using the disk diffusion method has also been 
recently shown (Biendo et al., 2013).  
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The International Subcommittee on Phage Typing of Staphylococci standardized 
phage typing as a phenotyping method in 1972. The challenge is to successfully 
compromise between phenotyping and genotyping methods in a way that achieves the 
most reliable results but is realistic in terms of available resources in local and regional 
situations. Genotyping methods have long been recognized as more reliable when 
compared to phenotypic methods (Weller, 2000). However, phenotyping criteria can be 
tested against genotyping methods in order to choose the best combination of infection 
type, risk factors and susceptibility pattern as the phenotypic characters of MRSA keep 
changing constantly. The challenge in my study was to identify a verifiable MRSA 
phenotyping method, supported by a genotyping ‘gold standard’ classification method, 
for MRSA strains isolated in the Saudi Aramco community in the Eastern province of 
Saudi Arabia. 
Epidemiology of MRSA in Saudi Arabia 
Prevalence of CA-MRSA has been rising in Saudi Arabia in recent years 
(Monecke et al., 2012). As documented in other countries, healthy individuals have been 
observed to acquire MRSA in the absence of health care associated risk factors 
(Bukharie, 2010). For example, between 2000 and 2008 in the Eastern Province, CA-
MRSA infections increased dramatically in King Fahad Hospital (Bukharie, 2010). In 
Dhahran Medical Centre, MRSA accounted for 6%. Meanwhile in the western province 
of Saudi Arabia, the prevalence of CA-MRSA was found to be 15.8% of all MRSA 
isolates (Bukharie, 2010). A study from seven hospitals in Riyadh indicates that among 
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all Staphylococcus aureus isolates, the prevalence of MRSA ranged from 12% to 49% 
and the prevalence in tested hospitals ranged from 27%–33% (Baddour et al., 2007). 
Comparing all MRSA isolates, community-acquired infections comprise 62 
percent (Al‐Tawfiq, 2006). The proportion of CA-MRSA dramatically increased from 
41.7% in 1999 to 66.6% in 2002 (Bukharie, 2010a, p. 379). By 2008, 73% of MRSA 
isolates were community acquired strains and the prevalence of CA-MRSA infections 
rose from 9.9 per 10,000 admissions to 67 per 10,000 admissions between 2001 and 2008 
(Bukharie, 2010a, p. 379).  
Saudi Arabia lacks a MRSA national control program. A search of the National 
Library of Medicine identified only 35 reports of MRSA infections in Saudi Arabia from 
the year 1990 to April 2007 (Baddour et al., 2007). In contrast, the United Kingdom had 
480 reports and United States 826 reports over a comparable period (Baddour et al., 
2007). Expert advice suggests that within countries there should be three levels of typing 
laboratories at the local, regional, and national levels, with differing functions and using 
typing techniques appropriate to their function and available resources (Stefani et al., 
2012). A classification scheme for Saudi Arabia which is appropriate for use at local, 
regional, and national levels is needed to harmonize surveillance and treatment programs. 
This classification scheme must be both practical and reliable. Current MRSA 
classification criteria are not guaranteed to be accurate and misclassification is thus a risk. 
For example, colonization with an infecting organism may last for months or years, 
causing patients to be misclassified of having HA-MRSA infection, when they actually 
acquired the endogenous MRSA strains from the community. In addition, patients with a 
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prior history of MRSA infection may be labelled as having recurrent health care-
associated infections, when the infection was acquired in the community (Stryjewski & 
Chambers, 2008).  
International experience suggests that health care risk factors has become a less 
reliable indicator as CA-MRSA strains merge with health care settings and the 
boundaries between ‘CA-MRSA’ and ‘HA-MRSA’ in terms of these types of risk factors 
become blurred (David et al., 2008a; Diep & Otto, 2008). Even in terms of antibiotic 
resistance typing, caution is needed. Despite the fact that the antibacterial susceptibility 
phenotypes can distinguish between the CA- and HA-MRSA strains, still certain CA-
MRSA isolates have been observed to show rising resistivity to the antibiotics (David et 
al., 2008a; Diep & Otto, 2008). A 2007 study showed that isolates of MRSA that were 
phenotypically analogous to community associated strains have become predominantly 
related with HA-MRSA (Maree et al., 2007).  
Other pathological traits of CA-MRSA are not traditionally associated with HA-
MRSA, such as expression of certain toxins (Diep & Otto, 2008). For example, Panton-
Valentine toxin (PVL) is expressed in CA-MRSA strains due to acquisition of the 
prophage-encoded adjacent lukS and lukF genes which express it (Chambers, 2005; Otto, 
2013). It is now regarded as a relatively stable marker of CA-MRSA and is proposed to 
contribute to increased virulence of CA-MRSA. For example, PVL-expressing strains 
have been associated with necrotizing pneumonia in previously healthy young people 
(Gillet et al., 2007; Labandeira-Rey et al., 2007; Lina et al., 1999).  
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PVL is a two-component leukocidin toxin that acts by forming pores in the 
mitochondria (Genestier et al., 2005). By studying the MRSA genotypes from Riyadh 
hospitals in the central province of Saudi Arabia, Moussa et al. (2009) found that, the 
majority of strains of CA-MRSA carry the PVL genes and SCCmec type IV element 
(Moussa & Shibl, 2009). More recently, in a study to characterize the population 
structure of MRSA in Riyadh, microarray analysis was carried out on clinical and 
environmental MRSA isolates collected in KFMC hospital (Monecke et al., 2012). A 
great diversity of clonal complexes was identified and this study confirmed the 
remarkable prevalence of PVL in the population as well as a high rate of antibiotic 
resistance markers in community-associated strains. 
Epidemiological studies, in addition to clinical data, would benefit from 
molecular genotypic techniques and identification of various marker genes (e.g. SCCmec 
type, virulence/toxin genes) to achieve a complete and reliable characterization of MRSA 
isolates in Saudi Arabia. Standard definitions for CA- and HA-MRSA should be used 
whenever possible, including molecular genotype assignment, SCCmec type, and the 
presence or absence of various genes such as PVL, type I ACME and agr type.  
Since some phenotyping methods for identification of MRSA strains and 
antibiotic resistance detection can take more than 48 hours, molecular based genotyping 
techniques such as those discussed above are used for fast and accurate identification and 
characterization of MRSA isolates (Fluit, Visser, & Schmitz, 2001). To date, among all 
the genotyping methods, PFGE is recognized as the ‘gold standard’ and is the most 
extensively used typing technique. (Fluit, Visser, & Schmitz, 2001). PFGE is often 
68 
 
coupled with other molecular typing techniques as a reference method, as it is the most 
sensitive and specific so far (Molina et al., 2008). Within the last decade, numerous 
different genotyping methods have been devised and used to distinguish among MRSA 
types, as described in the section ‘Genotyping of MRSA’.  
Before the development of PCR, several efficient typing methods were used, 
which include bacteriophage typing, capsular typing, PFGE, and zymotyping, for 
discriminating between MRSA strains (Weller, 2000). PCR-based methods are fast and 
reliable methods, relatively inexpensive, and have high throughput. Therefore, they are 
considered a method of choice for typing of strains at a local level (Stefani et al., 2012). 
For my research, I used a multiplex-PCR method as a ‘gold standard’ genotyping method 
against which to measure concordance of proposed phenotyping criteria for use in MRSA 
classification in local situation of the Saudi Aramco community in the Eastern province 
of Saudi Arabia. It was thus in line with expert international recommendations (Stefani et 
al., 2012). 
Future Considerations 
Staphylococcus aureus is a human pathogen that can be found everywhere around 
us and thus contributes a significant fraction of our public health history (Monecke et al., 
2011). . This bacterial organism has developed mechanisms to escape different 
antimicrobial agents and continues to evolve to ensure its continued existence (Monecke 
et al., 2011; Stefani et al., 2012). On the basis of current epidemiological data, the 
incidence and prevalence of MRSA will persist and increase (CDC, 2005). The 
intermixing of risk groups and environments for HA-MRSA and CA-MRSA has already 
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begun and boundaries are blurring between the two. Thus an evidence-based 
characterization and understanding of the existing epidemiology of MRSA is indicated, 
so that the changes can be tracked and described appropriately. Without this knowledge 
valuable and successful interceptive and preventive programs cannot be developed or 
implemented. The accurate assessment of MRSA will be the cornerstone to implement 
community-based control strategies. These strategies will be designed to minimize the 
ability of MRSA strains to be transmitted from the community into the health care 
settings. Also, these strategies will help determine the best approach for containing and 
preventing the spread of CA-MRSA within the community. 
 Summary 
In this chapter, I covered major themes in the current literature on MRSA with a 
view to placing my research project in context. The purpose of my study was to establish 
a set of verified MRSA phenotyping variables, supported by a genotyping ‘gold standard’ 
classification method, for MRSA strains isolated in the Saudi Aramco community in the 
Eastern province of Saudi Arabia. Results of this study allowed reliable classification of 
MRSA as HA-MRSA or CA-MRSA. The literature review included a historical overview 
of the worldwide emergence of HA-MRSA and CA-MRSA, of the problem of multiple 
drug resistance and research aiming to identify new antibiotics and treatment options. 
The issue of the multiplicity of MRSA strains and variations in worldwide 
geographic distribution was covered, including an update on current knowledge of 
MRSA phenotypic and genotypic data within Saudi Arabia. Considering the worldwide 
increase in cases of CA-MRSA and the challenges inherent in introducing international 
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consistency in the use of typing methods and classification, I highlighted the importance 
of establishing a reliable and inexpensive classification method for use in Saudi Arabia. 
The new classification method would, in turn, expedite accurate diagnoses and 
administration of appropriate treatment, and help identify outbreaks and epidemics in a 
timely fashion. To place genotypic studies in context and show the importance of 
genotypic identification in accurately classifying MRSA, the genetic elements of MRSA 
were reviewed with special attention to the staphylococcal cassette chromosome mec 
(SCCmec) and Panton-Valentine leuokocidin (PVL) genes. Current phenotyping and 
genotyping methods and concordance or discordance between them were also reviewed. 
Limitations in the methods were considered. In particular, the challenges inherent 
in classification of MRSA as ‘HA-MRSA’ and ‘CA-MRSA’, given the limitations of 
phenotyping methods, such as the health care risk factors method advocated by the CDC, 
were addressed. These limitations helped me to demonstrate the necessity of identifying 
phenotypic methods that give results that are concordant with genotyping data in the 
specific context of the Saudi Aramco community in the Eastern province of Saudi Arabia. 
Overall, while many studies exist on the risk factors, epidemiology, and genetics of HA-
MRSA and CA-MRSA, there are few studies specifically addressing the situation in 
Saudi Arabia. The literature review presented in this chapter contextualized the need for 
testing of the current phenotyping methods against a ‘gold standard’ genotyping method 
in the Eastern province of Saudi Arabia.  
I describe the methodology I used to answer my research questions in chapter 3. 
This included samples and data to be used, a description of the three most commonly 
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used phenotyping methods, health care risk factors, infection type, and antibiotic 
susceptibility; the multiplex PCR genotyping data; analysis of concordance of data from 
each phenotyping method with each other and with genotyping data; and sensitivity and 
specificity of the three methods. I also identified the combination of MRSA phenotypical 
classification methods or individual variables that best predict HA- and CA-MRSA in 
Saudi Arabia’s Eastern Province, compared to the multiplex-PCR data. 
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Chapter 3: Research Method 
The purpose of this quantitative, secondary data analysis study was to characterize 
the MRSA strains within the Saudi Aramco community and to accurately identify MRSA 
strains infection as HA-MRSA or CA-MRSA by comparing and contrasting the three 
existing phenotyping methods against a gold standard Multiplex PCR method. The 
phenotyping methods tested were the health care risk factor, infection type (CDC, 2005), 
and antibiotic susceptibility pattern methods (Clinical and Laboratory Standards Institute, 
2005).  
In this chapter, I explain the overall rationale for the selection of the study design, 
and I describe the study population, sampling methods, and the data collection 
procedures. Next, I discuss the methods I used to address each of the four research 
questions.  
Research Design and Rationale 
My study was a quantitative, secondary data analysis. The aim of the research was 
to characterize the two  forms of MRSA infections, HA-MRSA and CA-MRSA, in the 
Saudi Aramco population. Compared with cohort studies that are usually used to study 
incidence, causes, and prognoses and are preferred when the exposures or the risk factors 
are rare, case control studies are not suitable to measure multiples outcomes, always need 
controls, and are more suitable when the outcomes are rare (Newman, 2001). A cohort 
approach would have been preferable in this study; however, because I used secondary 
data to determine exposures and outcomes concurrently, my research study was cross-
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sectional. Quantitative studies using secondary data are useful for establishing 
associations rather than causality and for determining prevalence, rather than incidence; 
further, they are appropriate when the outcomes are frequent, such as with MRSA 
infection (Newman, 2001). This research design was appropriate for this study because it 
assessed the prevalence of HA-MRSA and CA-MRSA within the Saudi Aramco 
population through a rapid characterization of HA- and CA-MRSA infections using pre-
existing datasets. The selected design provided a method to assess the relationship 
between various diagnostic methods across a large population in a system in which it 
would be unethical to perform controlled experiments.  
A combination of methods was used to relate demographic characteristics of the 
patient population to MRSA infection phenotype and genotype. This combination of 
methods generated novel findings regarding the specificity and sensitivity of affordable 
phenotypic tests for differentiating HA- and CA-MRSA by comparing them with the 
genotypic gold standard (Newman, 2001).  
 
Study Population 
The samples for this study were collected from patients attending the John 
Hopkins Aramco Health Center, a 405-bed, acute-care hospital in Dhahran city, in the 
Eastern Province of Saudi Arabia. The samples were from patients in the study 
population, approximately 350,000 people who are employees, or dependents of the 
Saudi Aramco Energy Corporation, which is headquartered in Dhahran (Saudi Aramco, 
2014). Most of the population is of Asian origin, being either Saudis or nationals of other 
Arab or Asian nations; expatriates from Western countries are a minority.  
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Power analysis 
For this study, all the available data for the period between January 2012 and 
December 2013, 133 MRSA samples, were used. The power of the study to measure the 
predictive ability of the model created in response to the final research question was 
constrained by this fixed sample size. Power is the ability to detect a difference if one 
exists and specifically relates to the ability to reject the null hypothesis (Newman, 2001). 
Research Question 4 was the only question in this study with a null and alternative 
hypothesis, so I conducted a power analysis for logistic regression with the parameters, α 
= .05, effect size = .15 (medium effect size), and a maximum of eight predictors using 
G*Power® ((Erdfelder, Faul, & Buchner, 1996). The resulting power from this 
calculation was .99 and the associated x-y plot is presented in Figure 2. 
 
Figure 2. X-Y plot of power based on sample size. 
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Generally, to reject the null hypothesis, a p Value of .05 is needed. A power of at 
least 0.8 is commonly considered desirable. Therefore, I could detect a medium 
difference (effect size = .15) in predictive ability between multiple logistic regression 
models with a sample of 133. 
Data Collection 
After attaining formal approval from the Saudi Institutional Review Board, I 
obtained secondary data from all samples isolated between January 1, 2012, and 
December 31, 2013, and I stored them in epidemiology and microbiology databases at the 
Johns Hopkins Aramco Health Center. This time corresponded to the period when the 
health center began collecting all MRSA samples to validate the multiplex PCR system, 
for which all isolated MRSA samples were analyzed for the PVL and mecA genes. 
Staphylococcus aureus infections were tested for sensitivity to the following antibiotics: 
penicillin, oxacillin, gentamicin, ciprofloxacin, levofloxacin, moxifloxacin, clindamycin, 
erythromycin, quinipristin, linezeloid, vancomycin, and tetracyclin. Samples were 
defined as MRSA if the Staphylococcus aureus strain was found to be resistant to 
cefoxitin; it was assumed that they were also resistant to oxacillin. However, the 
molecular biologists who analyzed the original samples during data cleaning procedures 
were further excluded 24 cases , due to borderline resistance to oxacillin. Other data 
cleaning criteria during the original data collection efforts included samples with no 
definition of infection site and colonization. 
The epidemiological data included the following independent variables: health 
care risk factors, hospital admission profile, whether they had been hospitalized for at 
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least 48 hours prior to diagnosis or had been transferred from a different hospital, 
infection type or bodily location of the infection, and antibiotic susceptibility profile. 
They also included the covariates age, gender, survival status, and pre-existing illnesses. 
Table 4 presents a sample data line.  
Table 4 
Sample Data Line 
Variables  Sample values 
Date  13 Jun 
MR   
Age  Boy 
Gender  Male 
Health risk factors  HCA 
Infection  Pneumonia 
Type  Sputum 
Hospitalized  No 
Visited clinic during the last year  Yes 
Survival  Yes 
Pre-existing illness  DM 
P  ≥ 0.5R 
OX  ≥ 4 
GM  ≤0.5 
CIP  ≥ 8 
LEV  ≥ 8 
MOXI  ≥ 8 continued 
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Table 4 continued   
Variables  Sample values 
CC  ≤ 0.25 
E  ≥ 8 
Quini  ≤ 0.25 
Vance  15 
Tetra  ≤ 1 
Tigecy  ≤ 0.125 
Rif  ≤ 0.5 
 
Bacterial samples were stored by the molecular biology and microbiology 
divisions at the Johns Hopkins Aramco Health Centre (formerly Dhahran Health Center), 
and Multiplex PCR methods were carried out on these samples to allow genotyping 
information to be extracted. The extraction and analysis of the genotypic information 
formed part of the methodology of this study (Appendix A). 
Study Variables 
The major classification variables in this study were the three phenotyping 
methods: health care risk factors, infection type, and antibiotic susceptibility. These are 
presented in Table 5. 
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Table 5 
Study Variables 
Variable name Source Potential 
responses 
Level of measurement 
Gender Medical 
records 
Male             
Female 
Dichotomous 
Race Medical 
records 
Asian 
White 
Black            
Categorical 
Age Medical 
records 
Age in years Continuous 
Survival Medical 
records 
Yes                       
No 
Dichotomous 
Pre-existing condition,     
Any of the following: 
Diabetes (DM) 
Chronic Renal Insufficiency 
Dialysis 
Cardio-vascular Disease (CVD) 
Coronary Heart Failure 
COPD 
Medical 
records 
Yes                       
No 
Dichotomous 
Health care Risk Factors:  
Surgery Hemodialysis 
Peritoneal dialysis, Hospitalization, 
Residency in a long-term care 
facility within the last year 
Presence of indwelling 
percutaneous devices or catheters 
at the time of diagnosis or previous 
isolation of MRSA 
Medical 
records 
Yes                       
No 
Dichotomous 
 
 
 
 
 
 
 
continued 
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Table 5 continued 
Variable name Source Potential 
responses 
Level of measurement 
Infection type: 
Bacteremia 
Pneumonia 
Skin/Soft Tissue 
Surgical Site 
Medical 
records 
Type Categorical 
Drug resistance: 
Ciprofloxacin 
Clindamycin 
Gentamicin 
Levofloxacin 
Trimeth-Sulfamethoxazole 
Sensitivity 
test results 
Yes 
No 
Each type is recorded as 
a Dichotomous variable 
as there may be more 
than one per sample 
Classification  Genotyping 
and 
phenotyping 
HA-MRSA 
CA-MRSA 
Dichotomous 
    
The operational definitions of the health care risk factors and infection type 
methods were as defined in the CDC criteria (CDC, 2005). The following sections 
explain in detail how each variable was measured and used to designate samples as ‘HA-
MRSA’ (HA=1) or ‘CA-MRSA’(CA=0). These designations were then used for 
concordance/discordance analyses, as described in detail in the relevant sections of the 
Data Analysis. 
Classification by Health Care Risk Factors 
 Health care risk factors phenotyping is currently the methodology used at the 
Johns Hopkins Aramco Health Center for designation of MRSA as HA or CA. Cases 
were labelled as HA-MRSA in the hospital database on the basis of health care risk 
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factors if the patient had at least one of the following established risk factors: 
hospitalization >48 hours prior to the current infection (the patient was not MRSA-
infected at the time of hospitalization but culture and infection were identified > 48 hours 
after admission), presence in an intensive care unit (ICU) >48 hours prior to the current 
infection, hospitalization in the previous year (admitted and discharged from a hospital at 
any time during the year prior to the current infection), surgery during the previous year, 
dialysis during the previous year, presence of a percutaneous device or indwelling 
catheter in the previous year, and status as a resident of a long-term care (LTC), nursing 
home or rehabilitation facility in the previous year (CDC, 2005).  
Cases with none of the established factors for all seven HA-MRSA risk factors 
were considered CA-MRSA (Naimi et al., 2003). For the purposes of this study, in order 
to verify that the classification as HA-MRSA or CA-MRSA was correct, I re-assessed the 
electronic and/or physical records for each sample and verified that the designation was 
made correctly on the basis of at least one of the established risk factors being present for 
a designation of HA-MRSA, or none being present for a designation of CA-MRSA. 
Classification by Infection Type using Clinical Information  
As stated previously, the samples were classified in the database as HA-MRSA or 
CA-MRSA according to the health care risk factors method, which is the current standard 
method used in the Johns Hopkins Saudi Aramco Health Centre. In this study, I classified 
the cases by the infection type method using clinical data available in the hospital 
database as follows. A sample was designated as CA-MRSA on the basis of infection 
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type if a skin or soft tissue infection was diagnosed, including abscess, cellulitis, 
folliculitis, and impetigo, or if a wound infection had “skin” identified as the culture site.  
Cases with other, more serious infections, including bacteremia, meningitis, 
osteomyelitis, pneumonia, septic arthritis, and surgical site infection, were labelled as 
HA-MRSA (CDC, 2005). CA-MRSA can in some situations cause more serious 
infections like pneumonia or bacteremia, but these infections are typically caused by HA-
MRSA and are usually accompanied by the HA-MRSA risk factors listed previously. 
Therefore, if a case had both a skin or soft tissue infection and more invasive infection 
concurrently, it was considered HA-MRSA to give more weight to the more serious 
infection type (David et al., 2008). This allowed distribution of HA-MRSA and CA-
MRSA by the infection type method to be defined by the variable described above and 
the results compared to the other two methods. 
Classification by Susceptibility Pattern Using Clinical Information  
The operational definition of the antibiotic susceptibly method was according to 
the CLSI criteria (Clinical and Laboratory Standards Institute, 2005). Cases were 
classified as HA-MRSA or CA-MRSA by the antibiotic susceptibility pattern method 
using clinical data available in the hospital database as follows. Staphylococcus aureus 
samples were primarily tested for antibiotic sensitivity using the VITEK II system. All 
the antibiotics mentioned in the ‘Data collection’ section were tested. VITEK II tests for 
sensitivity were performed by calculating the minimum inhibitory concentration (MIC) of 
each drug, and the interpretation of each MIC value is assessed based on the Clinical 
Laboratory Standards Institute (CLSI) guidelines. Cases were classified as CA-MRSA on 
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the basis of susceptibility patterns if their isolates were resistant only to β-lactams. This is 
the basic resistance pattern that defines MRSA (Clinical Laboratory Standards Institute 
(Clinical and Laboratory Standards Institute, 2005). Cases were labelled as HA-MRSA if 
resistance to additional antimicrobial classes beyond β-lactams was also reported. This 
higher resistance included, but was not limited to, aminoglycosides, folate pathway 
inhibitors, lincosinamide, fluoroquinolones, and tetracyclines (Naimi et al., 2003). This 
allowed distribution of HA-MRSA and CA-MRSA by the antibiotic susceptibility 
method to be defined by the variable described above and the results compared to the 
other two methods. 
Data Analysis  
Statistical analyses was carried out using SPSS® 21 statistical software (IBM, 
2012). The description of the study design was divided into four sections, each pertaining 
to one of the primary questions I addressed in this research. In Table 6, I present how I 
used each of the study variables to answer the four research questions.  
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Table 6 
Use of Study Variables per Research Question 
Research question Variable(s)/Type of 
variable/Level of 
measurement 
Type of 
analysis 
Statistical tests 
1. What is the genotypic distribution 
of MRSA in a sub-population of Saudi 
Arabia’s Eastern Province? 
Age/NA/Continuous Univariate Mean and 
Standard 
Deviation 
Gender, hospital admission 
profile, survival, 
preexisting illnesses, health 
care risk factors, 
susceptibility profile(each 
drug) /NA/Dichotomous 
Frequencies 
Infection 
type/NA/Categorical 
Frequencies 
2. What is the concordance between 
each pair-wise combination of the 
three phenotyping methods, health 
care risk factor, infection type, and 
susceptibility pattern, used to classify 
CA- vs HA-MRSA in Saudi Arabia?  
Genotype Classification as 
HA-MRSA and CA-
MRSA/ 
Dependent/Dichotomous 
Bivariate Cohen's Kappa 
 
Three Phenotyping 
Methods' Classification as 
HA-MRSA and CA-
MRSA/Independent/ 
Dichotomous 
 
 
 
 
 
 
 
continued 
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Table 6 continued 
Research question Variable(s)/Type of 
variable/Level of 
measurement 
Type of 
analysis 
Statistical tests 
3. What is the sensitivity and 
specificity of each phenotyping 
method (health care risk factor, 
infection type, susceptibility pattern) 
used to classify CA-MRSA vs HA-
MRSA in Saudi Arabia? 
Genotype classification as 
HA-MRSA and CA-
MRSA/Dependent/ 
Dichotomous 
Bivariate Sensitivity and 
specificity 
Three phenotyping 
methods' classification as 
HA-MRSA and CA-
MRSA/Independent/ 
Dichotomous 
4. Is it possible to predict HA-MRSA 
and CA-MRSA in the Eastern 
Province of Saudi Arabia using a 
combination of MRSA phenotypical 
classification factors? 
Health Care Risk Factors
   
Multivariate 
Block 1 
Multiple 
logistic 
regression 
Infection Type Multivariate 
Block 2 
-2 Log 
Likelihood 
Susceptibility Pattern Multivariate 
Block 3 
Hosmer and 
Lemeshow 
Age/Independent/ 
Continuous; 
Gender, hospital admission 
profile, survival, 
preexisting 
illnesses/Independent/ 
Dichotomous 
Multivariate 
Block 4 
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Research Question 1 
What is the genotypic distribution of MRSA in a sub-population of Saudi Arabia’s 
Eastern Province? 
I previously carried out multiplex PCR on the stored 133 MRSA samples in the 
molecular biology department in the Johns Hopkins Aramco Health Center study to 
identify and classify circulating MRSA using the gold standard molecular method 
(Popovich, 2007). For this study, I classified the samples as CA-MRSA or HA-MRSA 
according to their mec-A and pvl gene sequences from the results of the multiplex PCR 
assay. The multiplex PCR methodology was summarized in appendix A. Demographic 
distribution and clinical information were obtained by matching PCR results to patient 
information records from the Johns Hopkins Aramco Health Center database. Univariate 
analysis, including mean and standard deviation for continuous variables and frequencies 
for dichotomous and categorical variables, was carried out to determine the distribution 
of HA-MRSA and CA-MRSA as defined by multiplex PCR genotyping results by age, 
gender, health care risk factors, infection type, hospital admission profile, survival, 
preexisting illnesses, and susceptibility profile.  
The validity of the genotype assignment I used to answer Research Question 1 
depended on the accuracy of the PCR genotyping. The method used is standard and well 
tested, and little error was anticipated (Popovich, 2007; Stefani et al., 2012).  
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Research Question 2  
What is the concordance between each pair-wise combination of the three phenotyping 
methods, health care risk factor, infection type, and susceptibility pattern, used to classify 
CA- vs HA-MRSA in Saudi Arabia?   
All cases in the epidemiology dataset were defined as either HA-MRSA or CA-
MRSA using one of three phenotyping classification criteria: health care risk factor, 
infection type, and susceptibility pattern (Sievert, 2008; Sievert et al., 2010). Covariates 
were age, gender, survival status during MRSA infection period and pre-existing illnesses 
(specifically diabetes mellitus, chronic renal insufficiency, dialysis, cardiovascular 
disease, chronic heart failure, and chronic obstructive pulmonary disease). Thus, I used 
three criteria to classify MRSA type and assessed the similarity between classifications 
based on these three different characteristics.  
I conducted univariate and bivariate analysis to compare the demographic and 
clinical distributions for the MRSA samples in the Saudi Aramco community, based on 
HA-MRSA and CA-MRSA.  
I defined frequencies and percentages for each of the phenotyping characteristics, 
gender, health care risk factors, infection type, hospital admission profile, survival, 
preexisting illnesses, and susceptibility profile. In addition, I evaluated the distribution of 
age to assess for any patterns. For concordance analysis, I designated samples as HA-
MRSA or CA-MRSA and compared results for each of the three phenotyping methods to 
each other to determine concordance or discordance. I considered p≤ 0.05 a statistically 
significant difference.  
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Concordance Analysis. I constructed a concordance matrix similar to published 
literature (Sievert, 2008; Sievert et al., 2010) to examine agreement (i.e., concordance) 
among all three phenotypic methods and each pair of methods for the Saudi Aramco 
community specifically. This matrix contained the number and percentage of MRSA 
cases identified as HA-MRSA or CA-MRSA by all three phenotypic methods, those that 
were concordant between the three methods. The matrix also denoted the number and 
percentage of cases identified as HA or CA by each pair of methods or by only one 
method. The use of all three phenotyping methods and the inclusion of covariates was 
used to confirm the overall distribution of HA-MRSA and CA-MRSA in the population 
and added to the validity and reliability of the study instrument. For example in the USA, 
all three methods yielded demographic, clinical, and microbiological variable 
distributions that were consistent with patterns in the literature (Sievert et al., 2010).  
In addition, Cohen’s kappa and its associated confidence interval was calculated 
for each pair of methods, to provide a metric of concordance that accounted for the fact 
that sometimes two methods can agree by chance alone (Kwiecien et al., 2011). Thus, the 
Cohen’s kappa measured the normed difference between the rate of agreement that is 
actually observed between the phenotypic methods and the rate of agreement that one 
might expect purely by chance (Kwiecien et al., 2011). For a given pair of methods, 
health care risks, infection type and susceptibility pattern, a two-by-two table was 
constructed denoting the number of cases identified as HA and CA by each method. Then 
marginal values, column and row totals, were calculated.  
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The probability of agreement, po, is propA + propD. However, we would expect 
agreement at random with some probability, pE (Kwiecien et al., 2011). This can be 
calculated as the probability with which each method classifies the case as HA 
independently plus the parallel probability for CA. 
 pE = propAB*propAC + propBD*propCD 
The excess agreement, beyond chance, is then pO-pE. This value is normalized to 
calculate the final Cohen’s kappa according to the following equation: 
Cohen’s kappa = p0-pE/(1-pE).  
 The 95% confidence interval for Cohen’s kappa is calculated according to the 
following equation: 
 CI = Cohen’s kappa +/- 1.96*sqrt ((p0(1-p0)/ (n(1-pE)^2))  
Research Question 3 
What is the sensitivity and specificity of each phenotyping method (health care risk 
factor, infection type, susceptibility pattern) used to classify CA-MRSA vs HA-MRSA in 
Saudi Arabia? 
The sensitivity and specificity of each phenotyping method was measured using a 
conventional two-by-two table. Multiplex PCR genotyping served as the gold standard 
method. For each phenotyping method, I calculated the sensitivity, which is the 
proportion of actual positives that are detected, as the number of infections identified as 
positive by both phenotype and genotype, true positives, divided by the number of 
infections that were identified as positive by genotype alone based on the gold standard 
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and representing the true number of infections in the population (Newman, 2001). 
Specificity, which is the proportion of actual negatives that are detected, was calculated 
as the number of infections identified as negative by both the genotype and phenotype 
tests, true negatives, divided by the number of infections that were identified as negative 
by genotyping alone representing the true number of patients infection-free (Newman, 
2001).  
I also calculated 95% confidence intervals for these proportions, assuming 
normally distributed error around the estimated sensitivity and specifity, p_hat. 
This can be written as: 
, where n is the number of observations. 
Research Question 4 
How well does a combination of demographic and phenotyping variables of the current 
three phenotyping methods (health care risk factors, infection type, and susceptibility 
pattern) predict MRSA genotyping classification as CA-MRSA or HA-MRSA? 
H0: Demographic and phenotyping variables do not significantly predict MRSA 
genotyping classification. 
Ha: Demographic and phenotyping variables significantly predict MRSA 
genotyping classification. 
I used bivariate statistics, including chi-square and t tests to test the sensitivity and 
specificity of the HA/CA designations generated from each of the major classification 
variables, health care risk factors, infection type and antibiotic susceptibility, against the 
outcome variable, HA/CA status based on the genotypic Multiplex PCR test. My main 
90 
 
aim was to validate each phenotyping method against the genotyping method to 
determine if one of the methods is optimally concordant with the genotypic method in 
designating samples as HA-MRSA or CA-MRSA.  
However, if one or more methods demonstrated superior sensitivity and 
specificity, I further explored the potentially contributing parameters/variables. For 
example, the susceptibility method depends on ten or more antibiotics; however, a subset 
may be identified as crucial.  
In the first instance, the statistical significance between the outcome variable and 
the predictor variables was established by calculating the bivariate correlations of all the 
possible predictor variables in order to determine those that are significant, age, gender, 
health care risk factors, infection type, hospital admission profile, survival, preexisting 
illnesses, and susceptibility profile. The magnitude of the odds ratios were also 
established using SPSS® to compute a multivariate logistic regression model, with all 
possible predictor variables initially and a backward conditional method to determine the 
final model.  
Having established the predictive ability of each phenotyping method, I used 
Multiple Logistic regression. This allowed me to assess the best combination of 
phenotypic characteristics to predict whether an infection was HA or CA. The response 
or outcome variable was HA/CA status based on the genotypic Multiplex PCR test, while 
each of the three classification schemes, health care risk factors, infection type, and 
antibiotic susceptibility profile, was treated as separate dichotomous classification 
predictor variables and entered into the model in blocks (Sievert, 2008). Combinations of 
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these variables were tested to identify the model with the best fit and predictive power. 
The three methods introduced into the model using separate blocks and a backwards 
conditional approach allowed me to parse the model and include only those variables 
from across the three methods in a final model that could be recommended for testing in 
the Saudi Aramco population. For example, combining individual antibiotic 
susceptibilities from the susceptibility method with the infection site information could 
result in a model with increased predictive power over that generated by a model that 
uses either of these phenotyping methods alone. 
Other predictor variables, added to the model generated from testing of the base 
classification variables were age, gender, survival status during MRSA infection and pre-
existing illnesses (yes, if reported any of the following: diabetes mellitus, chronic renal 
insufficiency, dialysis, cardiovascular disease, chronic heart failure, chronic obstructive 
pulmonary disease; no, if none of these reported). These constituted an additional block 
of variables and were therefore controlled for in the final model. Each of the models 
produced were compared for best fit using -2 log Likelihood, and the final model's 
relative predictive power using Hosmer and Lemeshow (Newman, 2001). I presented the 
variables included in each block of the logistic regression in Table 7. 
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Table 7 
Variables in Each Block 
Block Independent variable(s) 
1  Health Care Risk Factors: Surgery, 
hemodialysis, peritoneal dialysis, 
hospitalization, residency in a long-term care 
facility within the last year, presence of 
indwelling percutaneous devices or catheters at 
the time of diagnosis or previous isolation of 
MRSA 
2 Infection Type: Bacteremia, Pneumonia, 
skin/soft Tissue, surgical site  
3 Antibiotic Susceptibility: Ciprofloxacin, 
Clindamycin, Gentamicin, Levofloxacin 
Trimeth-Sulfamethoxazole 
4 Covariates: Age, gender, hospital admission 
profile, survival, preexisting illnesses 
 
The link function was the logit function, defined as: 
Logit transformation: ln(mu/(1-mu)) 
The full model, which included the listed clinical and demographic characteristics 
as covariates, was as follows: 
Genotype = β1*I(ph1) + β2*I(ph2) + β3*I(ph3) + β4*(ph1xph2) + β5*(ph1xph3) + 
β6*(ph2xph3) + β7*age + β8*gender + β9*survival status + β10*pre-existing illness, 
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where the βs are the coefficients, I is an indicator function, ph1 refers to phenotype 1 
(health care risk factors method), ph2 to phenotype 2 (infection type), ph3 to phenotype 3 
(antibiotic susceptibility), etc., and (ph1xph2) indicates an interaction term.  
The results of this model yielded the combination of phenotype variables that best 
predicted genotype, and therefore CA/HA status. The model could then be applied to the 
study population in the future to quickly and cheaply assess the HA/CA status of a new 
MRSA case without requiring the time-consuming and expensive procedure of 
genotyping. The sample size was adequate to conduct multiple comparisons, as needed 
using Bonferroni to adjust the p value (Newman, 2001). As the main outcome of this 
research question was the predictive ability of the models, I was not as concerned with 
the p-values of the individual variables. 
Threats to Internal and External Validity 
The major threats to internal validity included discrepancies in the medical 
records, missing information, and information bias. The use of secondary data introduced 
the potential for misclassifications and missing data, which could contribute bias to 
outcomes. The potential for information bias could have resulted from non-uniform 
criteria on the part of health care providers. Health Care professionals have different 
levels of medical record specificity and accuracy. Individual effort and competency 
played a role in the completeness of each patient's individual medical records.  
While I planned to compare the patient population at the Saudi Aramco facility to 
the patient population in other facilities in the area, I could not ensure that the samples I 
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used for this research were representative. This could result in a threat to external validity 
and reduced my ability to generalize the results.  
Ethical Considerations 
In order to gain access to the data set, I followed the procedure of applying for 
Saudi IRB approval through a Saudi Aramco IRB representative. The Saudi IRB is a 
comittee founded by Saudi Aramco Health Center with the aim of encouraging research. 
The request was reviewed and I was interviewed to explain the purpose the study. The 
research was approved and I received an official written approval (see Appendix B). 
Since the present study had no direct recruitment of any human or animal subject and did 
not include identifying information regarding the patients, I applied for an expedited IRB 
review from Walden University. This application was in addition to the official Saudi 
IRB written approval I had already acquired (see Appendix B).The data continued to be 
maintained in a secure fashion; the database that contains patient information collected 
from different resources was stored on a computer without an internet connection in order 
to avoid misuse by third parties via the internet. The entire data set was then burned to a 
password protected CD and deleted from the computer. Data was maintained on the 
secured, password protected CD for the duration of this research and will be further 
maintained up to 5 years after its completion.  
Summary 
This quantitative, secondary data analysis study utilized a combination of 
molecular and phenotypic lab techniques with statistical analysis and modeling to assess 
the strength of various types of data (i.e., demographic, genotypic, phenotypic) for 
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differentiating between HA- and CA-MRSA. Specifically, analysis of multiplex-PCR 
data generated from 133 samples from MRSA patients attending the Johns Hopkins 
Aramco Health Centre was used to assign HA-MRSA or CA-MRSA genotypic identity to 
each sample. The genotypic information obtained from this exercise was used as the gold 
standard to test the results obtained from database information on all of these samples by 
applying the three phenotyping methods that could be used for MRSA identification. 
These phenotyping methods were the health care risk factor, infection type (CDC, 2005) 
and antibiotic susceptibility pattern methods (Clinical and Laboratory Standards Institute, 
2005). Other predictive variables including age, gender, and survival status during MRSA 
infection period (died/survived) and pre-existing illnesses were also tested. In this way, a 
model was proposed for a combination of phenotypic variables that best predicts 
genotyping results in terms of identification of MRSA as HA-MRSA and CA-MRSA. 
After cross validation using new data, this model could then be used as a rapid, reliable, 
and inexpensive test for MRSA status in the Saudi Aramco population in the Eastern 
Province of Saudi Arabia. 
The analyses I present in chapter 4 utilized John Hopkins Health Care Center 
MRSA infection data, and MRSA multiplex PCR classification data to compute the 
results of the statistical analyses used to answer the four research questions in detail. 
96 
 
Chapter 4: Results  
Introduction 
The purpose of this quantitative, secondary data analysis study was to characterize 
the MRSA strains within the Saudi Aramco community and to identify them accurately 
as HA-MRSA or CA-MRSA by comparing and contrasting the three existing 
phenotyping methods against the gold standard Multiplex PCR method. The three 
existing phenotypic methods in question were the health care risk factor, infection type 
(CDC, 2005) and antibiotic susceptibility pattern methods (Clinical and Laboratory 
Standards Institute, 2005). Currently, the standard phenotyping method used in the Johns 
Hopkins Saudi Aramco Health Centre, from which the samples for this study were 
derived, is the health care risk factor method. However, individually each of the existing 
phenotyping methods has been shown to have the potential for MRSA misclassification 
(Sievert, 2008; Sievert et al., 2010). In addition, a discordance between methods used in 
classifying MRSA as HA-MRSA or CA-MRSA has been observed (Sievert, 2008; 
Sievert et al., 2010). For example, in studies conducted in Michigan, USA, while the 
distribution of HA-MRSA versus CA-MRSA was similar for the health care risk factor 
and infection type classifications, it was considerably different for the susceptibility 
method.(Sievert, 2008; Sievert et al., 2010). There is also a variability in the 
epidemiology of MRSA between countries (Maree et al., 2007; Pan et al., 2003 & 2005; 
Labandeira-Rey et al., 2007; Song et al., 2011; Stefani et al., 2012; Tietz, Frei, & 
Widmer, 2005).  
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While molecular methods of classification such as Multiplex PCR could be 
considered the gold standard, these methods are expensive and resource intensive (Stefani 
et al., 2012). Thus, previous literature suggested a need for a reliable, inexpensive, and 
readily usable classification method to determine distribution of HA-MRSA and CA-
MRSA in the population under study. This classification method should either show the 
concordance of existing phenotypic methods, or combine elements of the phenotyping 
methods shown to be concordant, with the results of Multiplex PCR-based genotyping. 
This need informed the above stated purpose of this study. 
To achieve this purpose, I sought answers to the following four research questions:  
• Research Question 1: What is the genotypic distribution of MRSA in a sub-
population of Saudi Arabia’s Eastern Province? 
• Research Question 2: What is the concordance between each pair-wise 
combination of the three phenotyping methods, health care risk factor, infection 
type, and susceptibility pattern, used to classify CA- vs HA-MRSA in Saudi 
Arabia? 
• Research Question 3: What is the sensitivity and specificity of each phenotyping 
method (health care risk factor, infection type, susceptibility pattern) used to 
classify CA-MRSA vs HA-MRSA in Saudi Arabia? 
• Research Question 4: How well does a combination of demographic and 
phenotyping variables of the current three phenotyping methods (health care risk 
factors, infection type, and susceptibility pattern) predict MRSA genotyping 
classification as CA-MRSA or HA-MRSA? 
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The null and alternative hypotheses associated with Research Question 4 were: 
H0: Demographic and phenotyping variables do not significantly predict MRSA 
genotyping classification. 
Ha: Demographic and phenotyping variables significantly predict MRSA genotyping 
classification. 
In this chapter, I will describe the results of the statistical analyses used to answer 
the four research questions in detail. In chapter 5, I will interpret and discuss these 
results. Data collection and baseline descriptive and demographic characteristics of the 
sample are reported, with consideration of the representativeness of the population 
sample. The results are then described and organized by research questions/hypotheses. I 
used tables and figures to illustrate results as appropriate. Finally, I summarized the 
responses to the four research questions.  
Data Collection 
I obtained secondary data from all samples isolated between January 1, 2012 and 
December 31, 2013 and stored in epidemiology and microbiology databases at the Johns 
Hopkins Aramco Health Center. Data abstraction began after formal approvals from The 
Saudi and Walden Institutional Review Boards. During the period between January 2012 
and December 2013, the Johns Hopkins Aramco Health Center began collecting all 
MRSA samples for validation of the multiplex PCR system. All isolated MRSA samples 
were analyzed by this system for the PVL and mecA genes, using the method described 
in Appendix A. Staphylococcus aureus infections were tested for sensitivity to the 
following antibiotics: penicillin, oxacillin, gentamicin, ciprofloxacin, levofloxacin, 
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moxifloxacin, clindamycin, erythromycin, quinipristin, linezeloid, vancomycin, and 
tetracyclin. Samples were defined as MRSA if the Staphylococcus. aureus strain was 
found to be resistant to cefoxitin; it was assumed that they were also resistant to oxacillin. 
However, 24 cases were excluded by the molecular biologists who analyzed the original 
samples during data cleaning procedures, due to borderline resistance to oxacillin. Other 
isolates with no definition of infection site and colonization were also excluded for the 
original sample. This data cleaning process left 133 MRSA samples, which were used for 
subsequent data analyses.  
Baseline Characteristics of the Sample 
The samples for this study were obtained from patients attending the Aramco 
Dhahran Health Center (now the Johns Hopkins Aramco Health Center), a 405-bed, 
acute-care hospital in Dharan, in the Eastern Province of Saudi Arabia. These patients are 
a representative sample of the study population, i.e. approximately 350,000 people who 
are employees, dependents or annuitants of the Saudi Aramco energy corporation 
headquartered in Dhahran (Saudi Aramco, 2014). Most of the population are of Asian 
origin, being either Saudis or nationals of other Arab or Asian nations. While those 
included in the study represent a sub-population in the Eastern Province, the large size of 
the population and their wide geographical distribution throughout the Eastern Province 
makes them representative of the province as a whole. 
The epidemiological data included the following independent variables: health 
care risk factors, hospital admission profile, whether they had been hospitalized for at 
least 48 hours prior to diagnosis or had been transferred from a different hospital, 
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infection type, or bodily location of the infection, and antibiotic susceptibility profile. 
They also included the covariates age, gender, survival status, and pre-existing illnesses. 
A sample data line is shown in Table 4 of Chapter 3.  
The descriptive statistics for the study sample are presented in Table 8. 
Table 8 
Descriptive Statistics of the Study Sample (N = 133) 
Variable Value Frequency Percent 
Date 2012 49 36.8 
2013 74 55.6 
2014 14 7.5 
Gender Male 71 51.9 
Female 66 48.1 
Admission Profile ≥48 hours 53 39.8 
Surgery Yes 20 15 
Catheterized Yes 19 14.3 
Dialysis Yes 10 7.5 
Hx_MRSA Yes 23 17.3 
Bacteremia Yes 12 9 
Pneumonia Yes 28 21 
Skin/Soft Tissue Yes 40 30.1 
Surgical/Deep Wound Yes 53 39.8 
Hospitalized Yes 47 34.6 
Clinic Visit past year Yes 127 93.2 
Survival Yes 130 97.7 
Comorbities Yes 61 45.9 
Drug Resistance Beta lactams 133 100 
   continued 
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Table 8 continued    
Variable Value Frequency Percent 
Drug Resistance Aminoglycoside 34 25.6 
 Cycline 42 31.6 
 CIP (Quinolone) 30 22.6 
 LEV (Quinolone) 27 20.3 
 MOXI (Q) 23 17.3 
 Macrolide 36 27.1 
 Nitrufuran 2 1.5 
 Quinolone 33 24.8 
 Sulfa 23 17.3 
MRSA Health Care Risk 
Factors 
HA 72 54.1 
CA 61 45.9 
MRSA Infection Type Risk 
Factors 
HA 96 69.2 
CA 41 30.8 
MRSA Susceptibility Risk 
Factors 
HA 64 48.1 
CA 69 51.9 
MRSA Genotyping HA 63 47.4 
CA 70 52.6 
 
Results 
The statistical analyses were carried out using SPSS® 21 statistical software 
(IBM, 2012). The results will be divided into four sections, arranged according to 
research question. Table 6 in Chapter 3 presented how each of the study variables was 
used to answer the four research questions. 
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Research Question 1 
What is the genotypic distribution of MRSA in a sub-population of Saudi Arabia’s 
Eastern Province? 
The results of this analysis are summarized in Table 9.  
  
103 
 
Table 9 
Distribution of HA-MRSA and CA-MRSA as Defined by Genotyping using Multiplex PCR 
(N = 133) 
Variable Values HA-MRSA 
(N=63) 
CA-MRSA 
(N=70) 
p Value  
Gender  
 
Male 41 28 .004 
Female 22 42  
Age Mean +/- SD 35.1 +/- 27.3 34.2 +/- 23.9 .839 
Admission 
Profile 
 
≥ 48 hours  33 20 .005 
< 48 hours 30 50  
Survival  
 
No 0 3 .245 
Yes 63 67  
Pre-existing 
illness 
No    34       27       .075 
Yes 29 43  
Health Care 
risk factors 
HA 42 30 .006 
CA 21 40  
Infection type 
risk factors 
HA      48       44       .096 
CA 15 26  
Susceptibility 
pattern  
HA      49       15           <.001 
CA 14 55  
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As Table 9 shows, there are observed statistically significant differences in the 
distribution of the frequencies for all variables except “survival” and “infection type” 
according to the type of MRSA classification. Of note, are the differences observed for 
health care risk and susceptibility pattern. For these two phenotyping methods, the 
frequency of HA and CA are statistically significant. Among the results for susceptibility 
pattern phenotyping, 49 of 63 cases (77.78%) identified as HA by genotyping were HA-
MRSA by phenotyping as well, while 55 of 70 cases (78.57%) identified as CA by 
genotyping were also CA-MRSA by phenotyping. 
Mean age for those designated as HA-MRSA was 35.1 years versus 34.2 years for 
CA-MRSA (Table 9). In Figure 3, I present the distribution of age for both HA-MRSA 
and CA-MRSA.  
 
 
Figure 3. HA-MRSA and CA-MRSA distribution by age. 
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As suggested by the p Value associated with age in Table 9, there is not a 
statistically significant difference between mean ages, though there are some minor 
differences in the distributions. Among cases identified as HA-MRSA, the age 
distribution is approximately bimodal with the highest frequencies observed under 20 and 
over 40 years of age. For CA-MRSA, it is a single mode with the majority of cases 
occurring between 20 and 40, and a defined positive skew. 
Research Question 2  
What is the concordance between each pair-wise combination of the three phenotyping 
methods, health care risk factor, infection type, and susceptibility pattern, used to classify 
CA- vs HA-MRSA in Saudi Arabia? 
Concordance analysis for three phenotyping methods. I present a concordance 
matrix in Table 10.  
Table 10 
Concordance Matrix (n = 51) 
 Health Care 
Risk Factors 
Infection 
Type Risk 
Factors 
Susceptibility 
Risk Factors 
% Cases 
matching 
Concordant  HA HA HA 29 (22%) 
 CA CA CA 22 (16%) 
 
In this table, I present the number and percentage of cases that were designated as 
the same type of MRSA by the three phenotyping methods. Concordance or agreement 
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on the designation of type of MRSA among all three methods for the designation of HA-
MRSA was 22%, while for the designation of CA-MRSA the overall concordance was 
16%. Thus, all three methods agree on the designation of MRSA as HA or CA in less 
than 25% of the cases. As the ideal situation is to have 100% concordance, this is very 
low, though the statistical interpretation of this requires the use of Kendall’s tau, which is 
the difference between the number of concordant pairs and the number of discordant 
pairs divided by the total number of pair combinations (Newson, 2002). Like r, Kendall’s 
tau varies between -1.0 (all pairs discordant) and +1.0 (all pairs are concordant). I discuss 
this in more detail following my discussion of discordance. 
 In Table 11, I indicate in which of the three phenotyping methods the discordance 
occurs, first for the designation of HA and then for the designation of CA. 
Table 11 
Discordance Matrix (n =86) 
 Health Care 
Risk Factors 
Infection 
Type Risk 
Factors 
Susceptibility 
Risk Factors 
Number and 
percent of cases 
discordant 
Discordant HA HA HA CA 31 (23%) 
 HA CA HA 9 (7%) 
 CA HA HA 15 (11%) 
Discordant CA CA CA HA 17 (13%) 
 CA HA CA 11 (8%) 
 HA CA CA 3 (2%) 
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In each of the three rows identified as “Discordant HA”, one of the three 
phenotyping methods does not agree with the other two in the designation of HA-MRSA. 
These are each associated with a percentage that indicates how frequently this type of 
discordance occurred among the samples. Susceptibility was discordant with the other 
two methods in 23% of the cases, while Infection Type was discordant in 7% of the 
cases, and Health Care was discordant in 11% of the cases. Thus, susceptibility was the 
most frequently discordant with the other two in designating HA-MRSA. I could find no 
standard for discordance; my observation is a relative one suggesting that susceptibility 
pattern produces a different distribution pattern than the other two phenotyping methods. 
In each of the three rows identified as “Discordant CA”, one of the three 
phenotyping methods does not agree with the other two in the designation of CA-MRSA. 
These are each associated with a percentage that indicates how frequently this type of 
discordance occurred among the samples. The desired discordance is 0%. Susceptibility 
was discordant with the other two methods in 13% of the cases, while Infection Type was 
discordant in 8% of the cases, and Health Care was discordant in 2% of the cases. Thus, 
susceptibility was also the most frequently discordant with the other two in designating 
CA-MRSA. Again, this is suggestive that susceptibility pattern produces a different 
distribution pattern than the other two phenotyping methods. 
To consider the magnitude of the concordance and discordance for each of the 
pairs, I computed Kendall’s tau. As discussed previously, Kendall’s tau is the difference 
between the number of concordant pairs and the number of discordant pairs divided by 
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the total number of pair combinations (Newson, 2002). Kendall’s tau ranged from -.001 
to .063, representing HA using susceptibility and CA using health care respectively. All 
can be interpreted as no agreement between pairs.  
Agreement. To further address this research question, I used Cohen’s kappa (κ). 
Cohen's kappa (κ) can range from -1 to +1. Based on the guidelines from Altman (1999), 
and adapted from Landis & Koch (1977), a kappa (κ) of negative means none, 0-.20 is 
slight, 0.21-0.40 is fair, 0.41-0.60 is moderate, 0.61-0.80 is substantial, and 0.81-1 is 
almost perfect agreement. The value for kappa and the associated p value for each 
combination are presented in Table 12. The value for all three phenotyping measures and 
the genotype is presented in Table 13. Pairwise Cohen’s kappa= 0.317, p < .001 
suggesting fair agreement was obtained for health care risk and infection type methods. 
Similarly, Cohen’s kappa= 0.101, p = 243 suggesting slight agreement, was obtained for 
comparison of the susceptibility pattern and health care risk methods. Finally Cohen’s 
kappa= -0.008, p = .919, suggesting no agreement, was obtained for comparison of the 
susceptibility pattern and infection type methods (Table 12). The results of the 
comparison of the three phenotyping methods to the genotyping method in terms of either 
HA-MRSA or CA-MRSA individually gave Cohen’s kappa= 0.373, p <.001 for both 
HA-MRSA and CA-MRSA, with an overall agreement with Cohen’s kappa= -0.298, p 
<.001. (Table 13). These measures are all suggestive of fair agreement with the 
genotyping method.  
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Table 12 
Pairwise Agreement Between Phenotyping Methods (n = 133) 
Methods compared Percent 
pairwise 
agreement 
Cohen’s kappa p Value 
Health Care Risk and Infection Type 66.9 .317 <.001 
Health Care Risk and Susceptibility 54.9 .101 .243 
Infection Type and Susceptibility 48.9 -.008 .919 
 
Table 13 
Agreement Between 3 Phenotyping Methods and Genotyping Measured by Cohen’s 
kappa (n = 133) 
Category Cohen’s kappa p Value 
HA_MRSA .373 <.001 
CA_MRSA .373 <.001 
Overall Agreement -.298 <.001 
 
Research Question 3 
What is the sensitivity and specificity of each phenotyping method (health care risk 
factor, infection type, susceptibility pattern) used to classify CA-MRSA vs HA-MRSA in 
Saudi Arabia? 
Sensitivity and specificity of phenotyping methods. The results of the 
sensitivity and specificity measurements for each phenotyping method are shown in 
Tables 14, 15, and 16 for health care risk factor, infection type, and susceptibility pattern 
respectively. I will interpret the results of the evaluation of sensitivity and specificity of 
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the phenotyping methods in chapter 5 to determine the appropriateness of each of the 
three phenotyping approaches as a screening tool. In this context, however, sensitivity 
represents the ability to identify the case as HA if it is indeed HA per the gold standard, 
while specificity is the ability to identify cases as CA if they are CA. Since true results 
are desired for cases designated as either HA or CA, in this study, I am looking for 
methods with both a high sensitivity and a high specificity. FDA approved techniques 
usually yield 82 to 100 percent sensitivity and 64 to 99 specificity (Marlowe & 
Bankowski, 2011). 
Table 14 
Sensitivity and Specificity of Health Care Risk Factors Phenotyping Method 
 MRSA (genotyping)  
Phenotyping (Health 
Care risk method) 
HA CA 
HA True HA = 42 False HA = 30 
CA False CA = 21 True CA= 40 
 Sensitivity = 0.6667 Specificity = 0.5714 
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Table 15  
Sensitivity and Specificity of Infection Type Phenotyping Method 
Phenotyping 
(Infection type 
method) 
MRSA (genotyping) 
 HA CA 
HA True HA = 48 False HA/CA = 44 
CA False CA/HA = 15 True CA = 26 
 Sensitivity = 0.7619 Specificity = 0.3715 
 
Table 16  
Sensitivity and Specificity of Susceptibility Pattern Phenotyping Method 
Phenotyping 
(Susceptibility 
Pattern method) 
MRSA (genotyping) 
 HA CA 
HA True HA = 49 False HA/CA = 15 
CA False CA/HA = 14 True CA = 55 
 Sensitivity = 0.7778 Specificity = 0.7857 
 
A comparison of the sensitivity and specificity as well as associated 95% 
confidence intervals is presented in Table 17.  
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Table 17 
Comparison of Phenotyping Methods as Measured Against Genotyping Results 
MRSA strain  Phenotyping 
method 
Proportion 
correctly 
identified 
95% Confidence intervals 
 
HA-MRSA HRSA 0.6667 0.5866 0.7468 
 IFRF 0.7619 0.6885 0.8343 
 Susceptibility  0.7778 0.7071 0.8485 
CA-MRSA HRSA 0.5714 0.4873 0.6555 
 IFRF 0.3714 0.2893 0.4534 
 Susceptibility  0.7857 0.7160 0.8554 
 
As discussed with Tables 14, 15, and 16, my goal in response to Research 
Question 3 is to identify the phenotyping method that is most successful in identifying 
true HA and CA cases. The results presented in Table 17 suggest that among the 
phenotyping methods, only susceptibility has a sensitivity and specificity similar to the 
ranges accepted by the FDA ((Marlowe & Bankowski, 2011). 
In Figure 4, I present a bar graph, which graphically demonstrates the percentage 
of HA-MRSA and CA-MRSA correctly identified for each phenotyping method when 
they are compared to the genotyping method. 
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Figure 4. HA-MRSA and CA-MRSA correct identifications by three phenotyping 
methods. 
ROC curve. In Figure 5, I present an ROC curve of the ability of the three 
phenotyping methods to identify correctly the infection as CA-MRSA. The ROC curve 
provides a visible image of the sensitivity and specificity of screening tools. The 
reference is the point where sensitivity and specificity are equal. The lines to the left of 
the reference line have higher sensitivity than specificity, while those to the right have 
higher specificity than sensitivity. The lines representing each of the three phenotyping 
methods can be compared to see which one is most appropriate to use for screening. 
While all phenotyping methods have higher ability to identify HA-MRSA than CA-
MRSA correctly, the Infection type is less likely and the Susceptibility is more likely to 
identify both HA-MRSA and CA-MRSA correctly.  
67%
76% 78%
57%
32%
79%
Healthcare Infection Type Susceptibility
HA_MRSA CA_MRSA
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Figure 5. ROC curve comparing phenotyping methods on their ability to identify CA-
MRSA. 
Research Question 4 
How well does a combination of demographic and phenotyping variables of the current 
three phenotyping methods (health care risk factors, infection type, and susceptibility 
pattern) predict MRSA genotyping classification as CA-MRSA or HA-MRSA? 
H0: Demographic and phenotyping variables do not significantly predict MRSA 
genotyping classification. 
Ha: Demographic and phenotyping variables significantly predict MRSA genotyping 
classification. 
To answer this research question, I performed multiple logistic regression using 
block entry to determine the best model after checking the assumptions required were 
met. I first determined that the dependent variable was binomial, the independent were 
continuous or nominal, and that the observations were independent. Using SPSS, I then 
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determined there was a linear relationship between the dependent and independent 
variables without multicollinearity or extreme outliers. 
In Table 18, I present the blocks of variables that were included for multiple 
logistic regression. 
Table 18  
Variables Entered in Each Block for Multiple Logistic Regression 
Block Independent variable(s) 
1 Health Care Risk Factors 
2 Infection Type Risk Factors 
3 Antibiotic Susceptibility: Ciprofloxacin, Clindamycin, 
Gentamicin, Levofloxacin 
Trimeth-Sulfamethoxazole 
4 Demographics: Age, hospital admission profile, pre-
existing illness 
 
Full model using block entry. In Table 19, I present the results of the full model 
determined using block entry multivariate binary logistic regression. This regression 
yielded the combination of phenotype variables that best predicted the genotype as 
defined by multiplex PCR, and therefore CA/HA status. 
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Table 19 
Odds Ratios Computed Using Multivariate Binary Logistic Regression with Block Entry 
Step Variable B EXP(B) 95% Confidence Interval 
    Lower  Upper 
Block 1 MRSA_HCRF .100 1.105 .310 3.836 
Block 2 MRSA_IFRF .488 1.630 .542 4.898 
Block 3 MRSA_Susceptibility 2.739 15.474 5.995 39.938 
Block 4 Gender .549 1.731 .230 1.450 
Admission Profile 1.056 2.874 .764 10.815 
Pre-existing Illness .149 1.161 .460 2.932 
 
In Table 19, the lowest OR (EXP (B)) is associated with the first block, which has 
the health care risk factors phenotyping methods. In contrast, Block 3, which adds the 
susceptibility phenotyping method, is associated with the highest OR. After adding all the 
blocks, only susceptibility was found statistically significant, though the OR associated 
with Admission Profile suggests it may be statistically significant in a reduced model. 
These results suggest that susceptibility phenotyping is most effective in determining 
whether MRSA is HA or CA without having to use genotyping methods. 
The Cox & Snell and the Negellkerke R Squares comparing the strength of each 
block included in the multivariate models described above are presented in Table 20. 
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Table 20 
Pseudo R Square Associated with Each Block 
Step Cox & Snell R Square Nagelkerke R Square 
Block 1 .056 .075 
Block 2 .061 .081 
Block 3 .330 .440 
Block 4 .348 .464 
 
Among the Pseudo R Square values presented in Table 20, the largest change 
occurred after the addition of block three. Using the Cox & Snell R Square, this change 
was .269, while using Nagelkerke, it was .359. These pseudo R squares can be used to 
determine which model fits the data best in terms of explaining the variance associated 
with the dependent variable. While these Pseudo R Square values cannot be interpreted as 
the percent of the variance explained by the model as a true R square can, they do 
indicate the relative improvement in the predictive ability associated with the addition of 
a block. The addition of Block 3 caused the greatest improvement in predictability. There 
was little improvement associated with Block 4. 
In Table 21, I present the results of the Hosmer and Lemeshow Test of Model Fit 
after the entry of each of blocks 2 through 4.  
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Table 21 
Hosmer and Lemeshow Test of Model Fit 
Step Chi square Degrees of 
freedom 
Significance 
Block 2 5.597 2 .061 
Block 3 4.765 5 .445 
Block 4 3.688 7 .815 
 
In Table 21, chi square was used to compare the results expected based on the 
model to those actually observed. The magnitude and significance of the chi square are 
used to estimate the model fit. Models with lower magnitude and a p value greater than 
.05 exhibit a better fit than those with greater magnitude and statistically significant 
differences (Newman, 2001). The model with all four blocks has the best fit, though the 
model with block 3 is also not statistically significant indicating an acceptable fit. 
A scatter plot of the change in deviance by the predicted probability for the full 
model is presented in figure 6. 
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Figure 6. Scatter plot of the change in deviance and predictive probabilities for the full 
model. 
  The curve that extends from the lower left to the upper right represents the cases 
in which the dependent variable was assigned a value of 0. This corresponds to the 
genotyping designation of HA-MRSA. The curve that extends from the lower right to the 
upper left represents the cases in which the dependent value was assigned a value of 1. 
This corresponds to the designation of cases as CA-MRSA. The quadratic like curves of 
the plots are similar. Each of the scatter dots represents a case, with those that do not fit 
the logistic regression model, also known as outliers, in the top left or top right corners of 
the plots. There are nine cases identified as HA-MRSA and eight identified as CA-MRSA 
with a change in deviance greater than one. 
Reduced model. A reduced model was also produced using the backwards 
conditional method. I also created a multivariate binary logistic regression model using 
the backward conditional method to yield the combination of variables that best predicts 
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genotype, and therefore CA/HA status. I present the results in Table 24. This second 
approach was used to confirm the assignment of odds ratios in the block entry model. In 
each step 1-5, variables were removed from the original full model to yield the final 
reduced model. The susceptibility pattern method (MRSA_Susceptibility) had an EXP 
(B) of 15.549 (95% CI 6.292-38.424) and admission profile had an EXP (B) of 3.942 
(95% CI 1.568-9.911). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
121 
 
Table 22 
Odds Ratios of Variables included in the Reduced Models at Each Step 
Step Variable B EXP(B) 95% Confidence interval 
    Lower  Upper 
1 MRSA_HCRF .100 1.105 .310 3.836 
MRSA_IFRF .488 1.630 .542 4.898 
MRSA_Susceptibility 2.739 15.474 5.995 39.938 
Gender .549 1.731 .230 1.450 
Admission Profile 1.056 2.874 .764 10.815 
Pre-existing Illness .149 1.161 .460 2.932 
2 MRSA_IFRF .486 1.625 .541 4.879 
MRSA_Susceptibility 2.740 15.480 5.997 39.959 
Gender .570 1.768 .734 4.258 
Admission Profile 1.124 3.076 1.125 8.409 
Pre-existing Illness .148 1.159 .458 2.931 
3 MRSA_IFRF .436 1.546 .539 4.440 
 MRSA_Susceptibility 2.708 15.005 5.995 37.783 
 Gender .576 1.778 .740 4.274 
 Admission Profile 1.113 3.004 1.116 9.069 
4 MRSA_Susceptibility 2.671 14.460 5.813 35.975 
 Gender .615 1.850 .775 4.415 
 Admission Profile 1.268 3.555 1.394 9.069 
5 MRSA_Susceptibility 2.744 15.549 6.292 38.424 
 Admission Profile 1.372 3.942 1.568 9.911 
 
The ORs (EXP(B)) presented in this table demonstrate to what extent each of the 
independent variables are associated with the dependent variable. Note that the ORs and 
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their associated CI change with each iteration. These changes reflect the effect the 
removal of some of the independent variables from the model have on the observed 
associations. The magnitude of the OR reflects the direction and strength of the 
associations, while the lower and upper bounds of the CI suggest the significance. 
Susceptibility was found to be a statistically significant predictor of MRSA status in all 
models. This is in agreement with the conclusions drawn from the full model. Unlike the 
full model, however, Admission profile became significant only after the removal of Pre-
existing illness. The final model (5) is the most parsimonious and the only one in which 
both independent variables have statistically significant ORs. I examined the changes in 
the predictive ability of the independent variables included in the model using Cox & 
Snell and Negelkerke R Squares. I also tested if this model can be applied to this 
population in the future to quickly and cheaply assess the HA/CA status of a new MRSA 
case without requiring the time-consuming and expensive procedure of genotyping, using 
the Hosmer and Lemeshow test to evaluate the final model fit after each step in the 
iterative process.  
The results of the comparison of the Cox & Snell and Negelkerke R Squares 
calculated with each model iteration using the backwards conditional method are 
presented in Table 23. These values suggest that there is little difference in the models 
ability to predict HA or CA-MRSA. Though the R square associated with Model 5 is 
lower it is not low enough to justify including variables in the model which do not have 
statistically significant ORs, such as those included in models 3 and 4. 
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Table 23 
Pseudo R Square Associated with Each Block 
Step Cox & Snell R Square Nagelkerke R Square 
1 .348 .464 
2 .347 .464 
3 .347 .463 
4 .344 .459 
5 .334 .446 
 
Table 24 presents the results of the Hosmer and Lemeshow Test of Model Fit 
after the entry of each of steps 1 through 5. As with Table 21, these numbers reflect each 
model’s ability to explain the variability of the logit associated with the designation of 
HA or CA-MRSA.  
Table 24 
Hosmer and Lemeshow Test of Model Fit 
Step Chi square Degrees of 
freedom 
Significance 
1 3.688 7 .815 
2 2.836 8 .944 
3 2.967 8 .936 
4 2.119 6 .908 
5  .807 2 .668 
 
The chi square statistic describes the model fit by comparing the expected 
outcomes based on the model inputs to the actual assignment of HA and CA-MRSA 
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using genotyping. All models are not statistically significant suggesting they fit the data. 
The models with more than two variables have higher chi square, but again the 
differences observed do not justify including non-significant independent variables in the 
model. 
A scatter plot of the change in deviance by the predicted probability for the 
reduced model is presented in Figure 7. 
 
 
Figure 7. Scatter plot of the change in deviance and predictive probabilities in the 
reduced model 
As with figure 6, the scatter plot of the change in deviance allowed me to identify 
cases that poorly fit by the model. These are considered outliers. Larger changes in 
deviance indicate poorer fits. The curve that extends from the lower left to the upper right 
represents the cases in which the dependent variable was assigned a value of 0. This 
corresponds to the genotyping designation of HA-MRSA. The curve that extends from 
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the lower right to the upper left represents the cases in which the dependent value was 
assigned a value of 1. This corresponds to the designation of cases as CA-MRSA. In this 
plot there are four outliers, two associated with the designation of HA-MRSA and two 
with the designation of CA-MRSA. Were there more outliers, further investigation might 
be warranted, but the existence of four outliers, two in each direction, in a dataset with 
133 records is unlikely to have an effect on my conclusions (Newman, 2001). 
Finally, the comparison of the results of the final full model to the final reduced 
model is presented in Table 25. 
Table 25 
Comparison of Full and Reduced Models 
Model  Included variables Odds ratios  
(p Value) 
Nagelkerke 
R Square 
Hosmer and 
Lemeshow 
test results (p 
Value) 
Full MRSA_HCRF     
 
1.105 (.878) .464 3.688 (.815)  
MRSA_IFRF 1.630 (.542) 
MRSA_Susceptibility 15.474 (<.001) 
Gender 1.731 (.242) 
Admission Profile 2.874 (.008) 
Pre-existing Illness 1.161 (.861)   
Reduced MRSA_Susceptibility 15.549 (<.001) .446 .807 (.668) 
Admission Profile 3.942 (.004) 
 
As demonstrated in Table 25, the full and the reduced models both suggest the 
same model may be most effective in accurately predicting HA and CA designations 
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based on genotyping using Multiplex PCR. Both the full and the reduced models confirm 
my previous conclusions that Susceptibility is the phenotyping method of choice. In both 
models, Susceptibility (OR~15.5, p <.001) is a significant predictor of HA or CA-MRSA, 
though in the full model it is the only statistically significant predictor, while in the 
reduced model Admission Profile (OR 3.94 p=.004) was statistically significant as well. 
In both models, the Nagelkerke R square is similar and suggests an acceptable degree of 
predictability. Finally, while the chi square is much higher in the full model, after 
adjustment for the degrees of freedom, those values are also similar. In the absence of 
significant differences in model fit and predictability, the reduced model is preferable as 
it requires fewer variables and therefore less data to complete. 
Based on the results of the multiple logistic regression, I am able to reject the null 
hypothesis in favor of the alternative one associated with this research question. 
Demographic (Admission profile) and phenotyping (Susceptibility pattern) significantly 
predict MRSA genotyping classification. 
Summary 
Through the process of this study a verified MRSA phenotyping method 
supported by a genotyping ‘gold standard’ classification method for MRSA strains 
isolated in the Saudi Aramco community in the Eastern province of Saudi Arabia was 
established. Three commonly used phenotyping methods, health care risk factors, 
infection type (CDC, 2005), and susceptibility pattern (Clinical Laboratory Standards 
Institute (Clinical and Laboratory Standards Institute, 2005) were used to classify the 
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MRSA strains into CA-MRSA or HA-MRSA. I present a summary of my findings for 
Research Questions 1, 2, 3, and 4 in Table 26. 
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Table 26 
Summary of Findings Research Questions 1, 2, 3, and 4 
Research question Statistical results Conclusions  
What is the genotypic distribution of 
MRSA in a sub-population of Saudi 
Arabia’s Eastern Province? 
Health Care Risk Factor  
HA = 66.67% correct 
CA = 57.14% correct 
Susceptibility pattern phenotyping had the 
highest percent of correct designations 
when compared to genotyping. 
Infection Type 
HA = 76.19% correct 
CA = 37.14% correct 
Susceptibility Pattern 
HA = 77.78% correct 
CA = 78.57% correct 
What is the concordance between each 
pair-wise combination of the three 
phenotyping methods, health care risk 
factor, infection type, and susceptibility 
pattern, used to classify HA or CA-
MRSA in Saudi Arabia? 
Concordance = 22% 
 
While the observed concordance between 
pairs based on percent concordant and 
Kendall’s tau suggest little to no agreement 
between phenotyping methods, Cohen’s 
kappa suggests fair agreement between 
phenotyping and genotyping. 
Kendall’s tau -.001 to .063 
 
Cohen’s kappa = .373 p<.001 HA and 
CA-MRSA and -.298 p < .001 overall 
  continued 
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Table 26 continued   
Research question Statistical results Conclusions  
What is the sensitivity and specificity of 
each phenotyping method (health care 
risk factor, infection type, susceptibility 
pattern) used to classify CA-MRSA vs 
HA-MRSA in Saudi Arabia? 
Health Care Risk Factor  
HA = 66.67% (sensitivity) 
CA = 57.14% (specificity) 
The calculation of sensitivity and specificity 
confirms the conclusions drawn in response 
to RQ 1. That is, Susceptibility has the 
highest sensitivity (ability to correctly 
predict HA) and the highest specificity 
(ability to correctly predict CA) 
Infection Type 
HA = 76.19% (sensitivity) 
CA = 37.14% (specificity) 
Susceptibility Pattern 
HA = 77.78% (sensitivity) 
CA = 78.57% (specificity) 
How well does a combination of 
demographic and phenotyping variables 
of the current three phenotyping 
methods (health care risk factors, 
infection type, and susceptibility pattern) 
predict MRSA genotyping classification 
as CA-MRSA or HA-MRSA? 
Full Model 
OR Susceptibility = 15.474 (p<.001) 
Nagelkerke R Square = .464 
Hosmer and Lemeshow = 3.688 (p = 
.815) 
While both the full and reduced model were 
predictive of HA and CA-MRSA 
classification using genotyping and had a 
reasonably good fit, only in the reduced 
model was the OR associated with 
Admission Profile significant. The reduced 
model also has the advantage of requiring 
only two variables and thus increased ease 
of use.  
Based on both model results, I am able to 
reject the null hypothesis associated with 
this RQ. 
Reduced Model 
OR Susceptibility = 15.549 (p<.001) 
OR Admission Profile = 3.942 ( = .004) 
Nagelkerke R Square = .446 
Hosmer and Lemeshow = .807 (p = 
.668) 
 
130 
 
As suggested in this table, all of my findings associated with the four research 
questions suggest that it is possible to predict the designation of HA or CA-MRSA 
resulting from genotyping using Susceptibility Pattern phenotyping. In the reduced 
multiple logistic regression model, I also identified Admission Profile as a significant 
predictor of genotyping results. 
In Chapter 5, I summarize, analyze, and interpret key findings from these results 
and discuss whether they confirm, disconfirm, or extend existing knowledge per the 
literature review and the Ecological Theory that was the framework for this study. I also 
acknowledge and discuss the limitations of the study in terms of generalizability and/or 
trustworthiness, validity, and reliability. Recommendations for further research grounded 
in the strengths and limitations of the study and the literature reviewed in chapter 2 will 
be suggested, specifically as related to MRSA testing in Saudi Arabia within the Saudi 
Aramco community. In this context, implications for positive social change and 
recommendations for practice will be discussed, along with methodological, theoretical, 
and/or empirical implications. Finally, conclusions will be drawn to capture the key 
essence of the study. 
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Chapter 5: Discussion, Conclusions, and Recommendations 
Introduction 
The purpose of this quantitative, retrospective cohort study was to characterize the 
MRSA strains within the Saudi Aramco community and to classify them accurately as 
HA-MRSA or CA-MRSA by comparing and contrasting the three existing phenotyping 
methods against the gold standard Multiplex PCR method. My goal was to identify the 
phenotyping method with the highest sensitivity and specificity for use in this population. 
Thus, this research will contribute to identify a simple, less expensive, accurate, and 
feasible method for full MRSA assessment in Saudi Arabia.  
In this chapter, I summarize, interpret, and discuss key research findings. My 
conclusions were drawn in the context of previous research and the theory that framed 
this research. In addition, I include recommendations for the application of the study 
findings and future research. Finally, I discuss the impact of my study results and its 
potential implications for positive social change. 
Research Questions 
The research questions I formed to address the purpose of my research were the 
following: 
• Research question 1: What is the genotypic distribution of MRSA in a sub-
population of Saudi Arabia’s Eastern Province? 
• Research Question 2: What is the concordance between each pair-wise 
combination of the three phenotyping methods, health care risk factor, infection 
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type, and susceptibility pattern, used to classify CA- vs HA-MRSA in Saudi 
Arabia? 
• Research Question 3: What is the sensitivity and specificity of each phenotyping 
method (health care risk factors, infection type, and susceptibility pattern) used to 
classify CA-MRSA vs HA-MRSA in Saudi Arabia? 
• Research Question 4: How well does a combination of demographic and 
phenotyping variables of the current three phenotyping methods (health care risk 
factors, infection type, and susceptibility pattern) predict MRSA genotyping 
classification as CA-MRSA or HA-MRSA? 
H0: Demographic and phenotyping variables do not significantly predict 
MRSA genotyping classification. 
Ha: Demographic and phenotyping variables significantly predict MRSA 
genotyping classification. 
Summary of Key Findings 
The key findings from the study can be concisely summarized with respect to 
individual research questions. For Research Question 1, the key finding was that of the 
three phenotyping methods, the susceptibility pattern phenotyping method most closely 
resembled that obtained using the genotyping gold standard. For Research Question 2, the 
concordance analysis indicated that the susceptibility pattern method was the most 
discordant of the three phenotyping methods tested. For Research Question 3, the 
susceptibility pattern method emerged as the most sensitive and specific of the three 
phenotyping methods. Lastly, for Research Question 4, a reduced model comprising the 
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combination of susceptibility pattern phenotyping with hospital admission profile 
emerged as the most effective combination of the variables tested to accurately predict 
HA-MRSA and CA-MRSA, as defined by the genotyping gold standard. In the remainder 
of this section, these findings are interpreted and discussed in detail. 
Interpretation and Discussion of Key Findings 
The statistical analysis in response to Research Question 1 produced the 
distribution of HA-MRSA and CA-MRSA, as defined by the gold standard multiplex 
PCR genotyping method, by gender, age, hospital admission profile, survival, pre-
existing illness and the three phenotyping methods, health care risk factors, infection type 
and susceptibility pattern. The distributions are presented in Table 9. Differences, though 
not tested for statistical significance, were observed in the distributions of all but the 
survival variable. The findings related to the three phenotyping methods are key to this 
research, as I am attempting to identify the phenotyping variables which best predict the 
MRSA profile obtained by genotyping. While the MRSA distribution with regards to 
each of the three phenotyping method variables was similar for HA-MRSA, the 
susceptibility pattern data differed from the other two variables for CA-MRSA. Only 
using the susceptibility pattern did I find a distribution similar to that expected based on 
the gold standard genotyping, with the majority of cases correctly identified as either HA-
MRSA or CA-MRSA according to the comparison to the genotyping data. Neither the 
health care risk factors method nor the infection type method gave a distribution similar 
to the genotyping method. This has implications for any use of these methods for 
classification of MRSA in a Saudi Arabia health facility context, in particular for 
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designation as CA-MRSA. Genotyping methods based on DNA analysis allow for 
accurate and precise MRSA classification, due to markers that are less prone to change 
over time (Tenover et al., 1994). A recent genotyping study in Saudi Arabia has found 
that HA-MRSA resistance markers (e.g., aacA-aphD, aadD) are now common among 
CA-MRSA strains (Monecke et al., 2012). It would be expected that presence of these 
resistance markers in both HA and CA-MRSA would negatively impact on the accuracy 
of the susceptibility pattern method. Nevertheless, in this case the susceptibility pattern 
method emerged as the most similar to the genotyping method in the predicted 
distribution of CA-MRSA and HA-MRSA.  
Worldwide experience of the spread of CA-MRSA into health care settings and 
the emergence of HA-MRSA in the community has challenged assignment of MRSA 
purely in terms of the health care risk and infection type phenotyping methods 
(Campanile et al., 2011; David et al, 2008a; Donnio et al., 2004; Hetem et al., 2012; 
Maree et al., 2007; Nair et al., 2011; Otter & French, 2011; Song et al., 2011). The results 
in response to Research Question 1 in my study extend this pattern in that neither of these 
phenotyping methods give results consistent with those generated by genotyping. In a 
study conducted at Chicago hospitals, many MRSA infections in patients with health care 
risk factors had many features of CA-MRSA, including clindamycin-resistance, PVL 
positivity, and SCCmec IV (David et al., 2008a). Similarly, in the genotyping study 
carried out at King Fahad Medical City in Riyadh, there was a high prevalence of PVL-
expressing strains, normally considered to be an indicator of CA-MRSA, in the health 
care setting (Monecke et al., 2012). The effect of the increasing unreliability of health 
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care risk factors as a predictor of HA-MRSA versus CA-MRSA is that CA-MRSA 
prevalence is underestimated. The health care risk factors and infection type methods 
have a higher tendency to identify HA-MRSA than the susceptibility pattern or 
genotyping methods (Sievert 2008). This is borne out in my results in response to 
Research Question 1, in which use of the infection type method actually resulted in the 
majority of CA-MRSA cases being identified as HA. One of the challenges to the 
infection type method comes from confirmation that skin and soft tissue infections (SSTI) 
are the most common types of infections for both CA-MRSA and HA-MRSA (David et 
al., 2008a). Meanwhile for the health care risk factors method, 30 out of 70 of those 
designated as CA-MRSA by genotyping were identified as HA by phenotyping. Several 
studies have shown that phenotyping markers are more prone to change over time than 
genotyping markers (Devita, Lawrence, & Rosenberg, 2009). Such a change is due to 
loss of extrachromosomal genetic elements and later their horizontal transmission (Devita 
et al., 2009) and can explain the discrepancy between the classification methods that 
depend on the phenotyping markers (Tenover et al., 1994). This discrepancy was more 
closely considered in Research Question 2. 
Also notable in my analysis of the data for Research Question 1 was the 
difference in the distributions of age for HA-MRSA versus CA-MRSA as designated by 
genotyping, presented in Figure 3. Among cases identified as HA-MRSA, the age 
distribution is approximately bimodal with the highest frequencies observed under 20 and 
over 40 years of age (Figure 3). By contrast, for CA-MRSA, it is a single mode with the 
majority of cases occurring between 20 and 40, and a defined positive skew (Figure 3). 
136 
 
This type of distribution is largely consistent with the results of others, for example in the 
study by Huang et al. (2006) in California, in which CA-MRSA was most prevalent in 
those aged between 18 to 49 and HA-MRSA among those aged from 40 years up (Huang 
et al., 2006). In a study undertaken in Riyadh, Saudi Arabia, the most prevalent HA-
MRSA strain identified, CC8/ST239-III, was also found more commonly in older than 
average patients, with a mean age of 43 years (Monecke et al., 2012). 
My results on distribution of HA-MRSA and CA-MRSA with respect to 
genotyping data are consistent with studies of others on phenotyping and genotyping 
concordance, which suggested that antibiotic susceptibility pattern (Clinical Laboratory 
Standards Institute (CLSI), 2005) may be particularly helpful in classification, especially 
given the increasingly questioned predictability of health care risk. (Campanile et al., 
2011; David et al, 2008a; Donnio et al, 2004; Hetem et al., 2012; Maree et al., 2007; Nair 
et al., 2011; Otter & French, 2011; Song et al., 2011). I considered concordance 
specifically in response to Research Question 2. 
In Research Question 2, I further explored the issue of agreement or disagreement 
between the phenotyping methods, using a concordance and a discordance matrix. These 
matrices are presented in Tables 14 and 15 respectively. As described in Chapter 4, the 
results of the concordance analysis indicated that the susceptibility pattern method gives a 
different classification profile compared to the other two methods, being the most 
discordant of the three methods. This is compatible with the findings generated in 
response to Research Question 1, which indicated that the susceptibility pattern method 
gives a distribution that is closer than the other two phenotyping methods to that obtained 
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by genotyping. It is also consistent with the results of a study conducted at the Michigan 
Department of Community Health in the United States, which showed that the health care 
risk factors and infection type methods were more concordant with each other than either 
are with the susceptibility pattern method (Sievert et al., 2010). Each of the three 
classification methods is inconsistent with the other two, for a number of cases. One 
important reason that contributes to discordance between methods is the evolving and 
increased rate of invasive CA-MRSA strains (Seybold et al., 2006). Emergence of the 
health-care-associated community-onset (HACO) group due to the interchange of genetic 
lineages of MRSA among community and hospital niches, and the evolution of multi 
drug resistant CA-MRSA strains which can invade hospitals, also affects the distribution 
of MRSA clones (David et al., 2006; Hudson et al., 2013).  
When agreement between methods was formally tested by pairwise Cohen’s 
kappa analysis, presented in Tables 16 and 17, the results confirmed that there was higher 
agreement between the health care risk and infection type methods than between either of 
those and the susceptibility pattern method. My Cohen’s kappa data confirms that the 
susceptibility pattern method diverges from the other two methods and that as a result, 
overall agreement between the three methods is low. The susceptibility pattern method 
may be divergent from the other two methods either because the rate of multidrug 
resistant CA-MRSA is significantly increased within the Johns Hopkins Saudi Aramco 
Health Centre compared to the rate of invasive CA-MRSA, or due to the emergence of 
invasive CA-MRSA as a nosocomial infection (Hudson et al., 2013). This would be 
isolated after 48 hours from deep sites, giving it the characteristics of HA-MRSA and 
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explaining the ‘false’ higher concordance between the health care risk factors method and 
infection type method. This discordance of the susceptibility pattern method was 
consistent with what I expected given my results from Research Question 1, in which of 
the three phenotyping methods only the susceptibility pattern yielded a MRSA 
distribution pattern similar to that observed for the genotyping method, and the results of 
others also suggesting that the health care risk factors and infection type methods are 
more concordant with each other than either are with the susceptibility pattern method 
(Sievert et al., 2010). My results are also consistent with other studies showing 
concordance between antibiotic susceptibility phenotyping and genotyping and/or poor 
predictability of the health care risk factors method (Campanile et al., 2011; David et al, 
2008a.; Donnio et al, 2004; Hetem et al., 2012; Maree et al., 2007; Nair et al., 2011; Otter 
& French, 2011; Song et al., 2011). In a study where genotype of MRSA was predicted 
using a fluoroquinolone susceptibility test, the results of antibiogram and PFGE were 
significantly correlated (Chomvarin et al., 2005). Concordance between the Gene Xpert 
multiplex PCR genotyping method and phenotyping by antibiotic susceptibility using the 
disk diffusion method has also been shown (Biendo et al., 2013). My results also indicate 
concordance between the susceptibility pattern phenotyping methods and genotyping as 
carried out by multiplex PCR. 
In response to Research Question  3, I considered the sensitivity and specificity of 
each of the three phenotyping methods. Generally speaking, less invasive screening tools 
need to have higher sensitivity, i.e. the ability to identify all potential cases. In the context 
of my study, however, sensitivity represents the ability to correctly identify a MRSA case 
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as HA-MRSA using a given phenotyping method, if it is indeed HA-MRSA as defined 
per the genotyping gold standard. Specificity, meanwhile, is the ability to correctly 
identify a MRSA case as CA-MRSA using a given phenotyping method, if they are 
indeed CA-MRSA as defined by the genotyping gold standard. Since the goal of my 
study was to identify a phenotyping method that could be used to accurately classify 
MRSA cases as HA-MRSA or CA-MRSA, I am looking for methods that have both a 
high sensitivity and a high specificity.  
My tests of the sensitivity and specificity of the three phenotyping methods in 
response to Research Question 3 indicated that all three phenotyping methods had similar 
ability to identify HA-MRSA Using the infection type method, however, made it 
significantly less likely than for the other two that CA-MRSA would be identified 
correctly. This is compatible with the results of Research Question 1, in which only 26 
out of 70 (37.14%) cases identified as CA-MRSA by genotyping were designated CA-
MRSA by infection type phenotyping. I found that the susceptibility pattern method is, 
by contrast, significantly more likely to correctly identify CA-MRSA, compared to the 
health care risk method sensitivity. This is what I would have expected given the data 
from Research Question 1, showing that 55 out of 70 (78.57%) cases designated as CA-
MRSA by genotyping were also designated as CA by susceptibility pattern phenotyping. 
It is also consistent with the concordance data from Research Question 2, suggesting that 
the susceptibility pattern method differs significantly from the other two methods in its 
ability to classify either HA or CA correctly per the gold standard. Thus, the results from 
Research Question 3 added another element to the emerging consensus that the 
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susceptibility pattern method is the most effective of the three phenotyping methods in 
the context of this study, as it has higher specificity and is therefore less likely to 
misclassify CA-MRSA cases. This finding suggests that the rate of multidrug resistant 
CA-MRSA is low, however the rate of invasive CA-MRSA is increased within the Johns 
Hopkins Saudi Aramco Health Centre population, impacting negatively on the health care 
risk factors method and the infection type method sensitivity and specificity. Currently, 
the most commonly used phenotyping method used in Saudi Arabia for MRSA 
classification is the health care risk factors method. However, the selection of 
phenotyping method to classify MRSA and guide infection control depends on methods 
validated for the USA hospitals (Bukharie, 2010). This is despite the fact that prevalence 
and incidence of HA-MRSA versus CA-MRSA varies widely between countries (Maree 
et al., 2007; Pan et al, 2003 & 2005; Labandeira-Rey et al., 2007; Song et al., 2011; 
Stefani et al., 2011; Tietz, Frei, & Widmer, 2005). Consistent with international 
experience, previous studies in Saudi Arabia have shown that prevalence of CA-MRSA is 
increasing, while the lines between ‘HA-MRSA’ and ‘CA-MRSA’ are blurring in terms 
of health care risk factors (Al‐Tawfiq, 2006; Baddour et al., 2007; Bukharie, 2010; David 
et al., 2008; Monecke et al; 2102; Moussa & Shibl, 2009; Stefani et al;, 2012). All these 
factors suggest that the health care risk method is not the most ‘fit for purpose’ in the 
Saudi Arabian context; my results add to the evidence that this is the case. The results 
generated in my study in response to Research Question 3 confirm that the health care 
risk factors method does not have high specificity in terms of identifying CA-MRSA. 
Also the MRSA profile generated from the health care risk factors method from research 
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question 1 showed that only 40 out of 70 (57.14%) of those designated as CA-MRSA by 
genotyping were also identified as CA by phenotyping. This was highlighted in Figure 4, 
which is a graphical representation of the correctly identified HA-MRSA versus CA-
MRSA distribution generated for each phenotyping method, compared to the genotyping 
results. To further consider the ability of each of the three phenotyping methods to 
correctly identify a MRSA case as CA-MRSA, I produced a ROC curve, presented in 
Figure 5, which clearly shows that the susceptibility method is more sensitive than either 
of the other two phenotyping methods and therefore has more utility in correctly 
identifying a MRSA case as CA-MRSA. This is again compatible with the findings from 
Research Question 1 and 2. 
The multivariate binary logistic regression analyses in response to Research 
Question 4 were also consistent with my other findings for the previous three research 
questions. In this case, both the block method and the backward conditional method 
showed that the susceptibility pattern phenotyping variable was significantly more 
predictive than either of the other two phenotyping methods. By contrast, for both the 
health care risk factor and the infection type phenotyping methods, the 95% CI include an 
OR of 1, suggesting that when results of either of these methods are coded ‘1’ for HA-
MRSA, it is no more likely that the genotyping method will also give a HA rather than a 
CA result, or when it is coded ‘0’ for CA-MRSA, it is again no more likely that the 
genotyping method will also give a CA rather than a HA result.  
In using the block entry multivariate binary logistic regression method, I tested 
the strength of each block using both the Cox & Snell and the Negellkerke R Squares 
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(Table 20). It emerged that the largest change for each Pseudo R Square test occurred 
after the addition of block three, which is the antibiotic susceptibility method. This again 
confirmed the utility of using this phenotyping method to accurately classify MRSA 
according to a genotyping gold standard as opposed to either of the other two 
phenotyping methods. Further confirmation was obtained when I used chi square in the 
Homer and Lemeshow Test of Model Fit to compare the results expected based on the 
model to those actually observed (Table 21) indicating that both the block containing 
antibiotic susceptibility pattern and the block containing the variables gender, admission 
profile and pre-existing illness (Table 18) could contribute to a useful model for 
prediction of MRSA type. 
This was clarified when I used a reduced model by the backwards conditional 
method. Of the variables included in the reduced model, only admission profile had an 
OR whose 95% CI did not include 1. The results of the comparison of the Cox & Snell 
and Negelkerke R Squares calculated with each model iteration using the backwards 
conditional method show that neither of these Pseudo R Square tests change significantly 
through each iteration, as might be expected as the most predictive variables, i.e. 
susceptibility pattern phenotyping and admission profile, remain in each iteration.  
The data I generated in response to Research Question 4 identified a reduced 
model, using the variables susceptibility method phenotyping and admission profile, as 
effective in prediction of HA-MRSA and CA-MRSA as defined by a genotyping gold 
standard. The theoretical basis of this study relied on both ecological theory and ASP 
theory. The ecological theory would favor HA-MRSA in a health care environment, 
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where the use of antibiotics is common. HA-MRSA usually carries either SSCmec II or 
III, which have acquired genes for resistance to antibiotic classes beyond the β-lactams 
(Hiramatsu et al., 2002). CA-MRSA, on the other hand, tends to carry SSCmec IV and V, 
which are relatively small, leaving it potentially susceptible to clindamycin and other 
non-β-lactam antibiotics (Naimi et al., 2003). The emergence from Research Question 4 
of the antibiotic susceptibility method and hospital admission profile as strong predictors 
for the classification of HA-MRSA versus CA-MRSA is therefore consistent with 
ecological theory. However, caution is always needed, as the classification of ‘HA-
MRSA’ and ‘CA-MRSA’ has been challenged by studies showing that MRSA isolates 
characterized as containing SCCmec IV and PVL, thus genotypically ‘CA-MRSA’, are 
arising in the health care environment (David et al, 2008a). For example in Saudi Arabia, 
a case has been reported in which a CA-MRSA strain was transmitted directly from a 
father to his child in a neonatal intensive care unit (Al-Tawfiq, 2006). A genotypic 
analysis of 107 MRSA isolates from King Fahad Medical City in Riyadh, Saudia Arabia 
also revealed a high prevalence of PVL-expressing strains, normally considered to be an 
indicator of CA-MRSA (Monecke et al., 2012). Thus, the relatively limited information 
available on MRSA profiles in Saudi Arabia health facilities is consistent with 
international experience of crossover of CA-MRSA strains into hospitals and other health 
care settings (David et al, 2008a; Monecke et al., 2012). The combination of the 
antibiotic susceptibility with the admission profile, as proposed from my results in 
response to Research Question 4, should be effective to help avoid erroneous 
classification of CA-MRSA in health care settings as HA-MRSA. The high specificity 
144 
 
identified for the antibiotic susceptibility method in Research Question 3 is reassuring in 
this context.  
By contrast, in the multivariate logistic regression analysis in Research Question 
4, the health care risk factors phenotyping did not emerge as predictive of genotyping 
classification results. Genotyping methods such as multiplex PCR are highly reliable in 
classifying MRSA (Stefani et al., 2012). It is therefore important to identify reliable 
phenotyping criteria that have been independently confirmed with genotyping results. 
The results for Research Question 3 and 4 of my study, demonstrating the concordance 
and predictive value of the antibiotic susceptibility pattern method for genotyping 
classification, are consistent with other studies showing concordance between antibiotic 
susceptibility phenotyping and genotyping and/or poor predictability of the health care 
risk factors method (Campanile et al., 2011; David et al, 2008a.; Donnio et al, 2004; 
Hetem et al., 2012; Maree et al., 2007; Nair et al., 2011; Otter & French, 2011; Song et 
al., 2011). In East Asia, there is evidence of spread of ‘HA-MRSA’ and ‘CA-MRSA’ 
from the community to the hospital and vice versa (Song et al., 2011). In the current 
study, the suitability of the three phenotyping methods in the Saudi Aramco community 
from the Eastern province of Saudi Arabia, was considered in comparison to a ‘gold 
standard’ genotyping multiplex PCR method. Genotyping by this method took into 
account some of the mobile genetic elements of Staphylococcus aureus that have driven 
the emergence of MRSA, i.e. PVL and mecA, which are key to how HA-MRSA and CA-
MRSA fit into both the ecological and antibiotic selection pressure framework. Thus, the 
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concordance of the susceptibility method with the multiplex PCR genotyping method 
further confirmed its consistency within the theoretical framework of the study.  
While based on the conservative definition of HA-MRSA, CDC estimates suggest 
that up to 85% of MRSA infections would be classified as HA-MRSA (CDC, 2005), the 
genotyping results of my study suggest a much more even distribution. Results of 
previous studies in MRSA assignment in Saudi Arabia have shown that community-
acquired infections comprised 62% (Al‐Tawfiq, 2006). The proportion of CA-MRSA 
dramatically increased from 41.7% in 1999 to 66.6% in 2002 (Bukharie, 2010a, p. 379). 
In my study, genotyping analysis in the Saudi Aramco sub-population indicated that CA-
MRSA lies somewhere in between these figures at 70 out of a total of 113 (52.6%) of 
MRSA infections (Table 9). For men, the percentage is lower, as 28 out of the total 69 
men (40.6%) were identified as having CA-MRSA, while for women it is higher as 42 
out of the total of 64 women (65.6%) were identified as having CA-MRSA (Table 9). 
This is not entirely consistent with previous studies in which the proportion of males with 
CA-MRSA tends to be significantly higher, particularly in urban areas, due for example 
to factors such as their greater likelihood of engaging in contact sports (Cooke & Brown, 
2010; Davis et al., 2007; Hidron et al., 2009; Thomas et al., 2007). While gender did not 
emerge as a predictive variable in the logistic regression analysis, this data suggests that 
gender may yet be relevant in CA-MRSA and HA-MRSA distribution; consideration of 
larger groups of patients over time should clarify the point.  
A combination of antibiotic susceptibility pattern and hospital admission profile 
emerged as the suggested model for phenotyping classification of MRSA in the Saudi 
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Aramco population. This finding is consistent with both the theoretical framework 
presented and the literature reviewed in chapters 1 and 2. 
 
Limitations of findings 
The study was limited due to the ever-changing molecular characteristics of 
MRSA from geographical and temporal perspectives, particularly the evolutionary 
success of CA-MRSA strains that makes their growth rates 1.33 faster than HA-MRSA 
strains (D'Agata, Webb, Horn, Moellering & Ruan, 2009). Therefore, the profile 
generated for samples collected in 2012 and 2013 may not be the same as the profile that 
exists currently. However, the concordance of the proposed phenotyping characterization 
based on prediction of genotyping results should minimize the impact of this limitation. 
Phenotyping by any of the recognized common methods is complicated by factors 
including emergence of invasive and multidrug resistant CA-MRSA strains in health care 
settings as a cause of health care associated infection (Gillet et al, 2010; Seybold et al, 
2006), as observed both in the USA (David et al, 2008a; Maree et al., 2007; Nair et al., 
2011; Otter & French, 2011) and in Europe (Campanile et al., 2011; Donnio et al., 2004; 
Hetem et al., 2012) and in Saudi Arabia itself (Monecke et al., 2012), and also increased 
circulation of HA-MRSA in the community (Miller et al, 2007; Seybold et al, 2006). 
This study was limited to patients attending the Aramco Dhahran Health Center, 
an acute-care hospital in Dharan, in the Eastern Province of Saudi Arabia. While these 
patients were a representative sample of the study population, i.e. approximately 350,000 
people who are employees, dependents or annuitants of the Saudi Aramco energy 
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corporation, which is headquartered in Dhahran (Saudi Aramco, 2014), they may not be 
representative of Saudi Arabia as a whole. 
Recommendations  
As this study was confined to a sub-population and results may not necessarily be 
representative of the country as a whole, future studies should focus on a nationally 
representative sample of hospitals and other health care facilities in Saudi Arabia. In 
addition, similar studies comparing phenotypic methods of classifying MRSA as HA-
MRSA or CA-MRSA to a gold standard genotyping technique should be performed in 
hospitals and other facilities, such as long-term care facilities, in all regions of the 
country. In this way, locally, regionally, and nationally applicable sets of phenotyping 
variables could be adopted appropriate to urban versus rural areas or different types of 
health care settings (Stefani et al., 2012).. 
 Saudi Arabia currently lacks a MRSA national control program. If appropriate 
phenotyping variables verified against gold standard genotype classification were 
identified in institutions across the country, it would inform potential implementation of 
the expert advice. This suggests that within countries there should be three levels of 
typing laboratories at local, regional, and national levels (Stefani et al., 2012). These 
laboratories should play different roles and be set up to perform typing techniques within 
their scope with regards to function and available resources (Stefani et al., 2012). This 
type of practical and reliable classification scheme, adapted to be applicable to Saudi 
Arabia rather than imported from other countries, will assist in beginning to harmonize 
surveillance and treatment programs.  
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In this study, hospital admission profile emerged as a predictive variable in 
determining MRSA status. This finding should be further examined in the context of 
other health care facilities to determine if the result was unique to the Aramco Dhahran 
Health Center or if it is a general phenomenon in other hospitals in Saudi Arabia. 
Likewise, the general applicability of the antibiotic susceptibility method of phenotyping 
in predicting MRSA status needs to be determined.  
Long term studies of the susceptibility pattern and hospital admission profile 
should be performed in the Aramco Dhahran Health Center and periodically checked 
against the Multiplex PCR screening method, to confirm the long-term robustness of the 
these two variables in accurately predicting MRSA status. This is of particular 
importance in view of the constant evolution of CA-MRSA antibiotic resistance profiles, 
which might also complicate findings from the susceptibility pattern classification of 
MRSA. These concerns are even more relevant given the rise of CA-MRSA in Saudi 
Arabia (Bukharie, 2010a, p. 379). 
In this study, the genotyping analysis in the Saudi Aramco sub-population for 
men suggested that the majority of MRSA infections were HA-MRSA; 28 out of the total 
69 men (40.6%) were identified as having CA-MRSA (Table 9). For women the opposite 
was the case; 42 out of the total of 64 women (65.6%) were identified as having CA-
MRSA (Table 9). While gender did not emerge as a predictive phenotyping variable in 
the logistic regression analysis, the difference in gender distribution of HA-MRSA and 
CA-MRSA in my data suggests that gender may be relevant in CA-MRSA and HA-
MRSA distribution in Saudi Arabia. Expansion of studies to cover larger areas of the 
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country, with larger numbers of people and more institutions included, should clarify 
whether this type of distribution is consistently observed and has any statistical 
significance. This possibility should be pursued in any future studies covering other 
centers and/or data collected over a longer timeframe. 
In terms of implications for practice, the underlying reason for this research study 
was the development and testing of a rapid, efficient, inexpensive, and reliable method of 
identification of HA-MRSA and CA-MRSA strains circulating in the region. From the 
results of the study, I recommend that a phenotyping method based on antibiotic 
susceptibility pattern and hospital admission profile be tested with a view to replacing the 
existing health care risk factors phenotyping that is currently most common, if this new 
method proves to be robust in the longer term. Results of the concordance analysis 
suggest, specificity analysis and multivariate logistic regression suggest that the health 
care risks factor and infection type methods should be discarded as phenotyping methods 
in this population. It is also important to consider that the theory of antibiotics pressure is 
useful in explaining why some CA-MRSA strains are becoming resistant to different 
groups of antibiotics, which might also interfere with the susceptibility pattern 
classification of MRSA. The minor discordance between the suggested combination of 
antibiotic susceptibility profiling and hospital admission profile for MRSA phenotyping, 
compared to the genotyping analysis, suggests that it would be of benefit to carry out 
genotyping analysis every two or three years to compare to and verify the new proposed 
phenotyping method. 
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Implications for Social Change 
The goal of MRSA management programs at any health care facility is the 
reduction of spread of the disease and hence reduction of the burden of high medical 
costs and reversal of the increasing trend of MRSA morbidity and mortality. The results 
of this study have identified phenotyping variables that can be applied to distinguish 
between HA-MRSA and CA-MRSA and hence gauge distribution for each MRSA type, 
seasonality, and potential shifts in therapeutic drug resistance. This should help in the 
formulation of prevention strategies to reduce MRSA transmission and help in 
understanding and preventing MRSA outbreaks through comparative analyses of data 
from previous studies worldwide. Such comparative analyses will also advance 
knowledge on genetic, epidemiological, and clinical characteristics. 
The results of my study have implications for positive social change in that 
antibiotic susceptibility pattern and hospital admission profile have been identified as 
variables that could form the basis of an MRSA screening program for the Saudi Aramco 
population. This has the potential to be extended to the Eastern Province of Saudi Arabia, 
where the Aramco Dhahran Health Center is situated. A reliable and affordable MRSA 
screening program based on concordance of phenotyping classification with a genotyping 
gold standard would provide a rational basis for MRSA surveillance and characterization 
and effective targeting of therapies, as well as education of health workers, in Saudi 
Arabia. Extending the findings of this study to other health care facilities throughout the 
country would potentially contribute to the development of such a screening program. 
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Conclusions 
The purpose of this study was to identify which of the three phenotyping methods, 
health care risk factors, infection type and antibiotic susceptibility pattern, or 
combination thereof, was best able to characterize the MRSA strains with reference to the 
profile generated using a Multiplex PCR genotyping method, within the Saudi Aramco 
community. An additional goal was to help identify the phenotyping variables which 
were most predictive of genotype and provide an accurate method for development of an 
effective screening, prevention, control, and treatment program in this population. 
Accurate phenotyping and the ability to rapidly and efficiently assign MRSA cases to 
HA-MRSA or CA-MRSA is vital for monitoring trends in MRSA within health care 
settings and in the community and making choices of appropriate antibiotic treatment, 
outbreak monitoring, and prediction or recognition of epidemics.  
MRSA is on the rise. I carried out the study against a background of rising levels 
of MRSA in Saudi Arabia, bringing a high financial costs in morbidity and mortality 
burdens (Bukharie, 2010). The results of my study suggest a potential phenotyping-based 
method, built on antibiotic susceptibility pattern and hospital admission, with which 
MRSA could be accurately identified as HA-MRSA and CA-MRSA. As these have 
different genetic properties which confer different antibiotic sensitivities and virulence 
properties, the availability of such a method would assist in effective diagnosis and 
tailoring of therapy. For an effective screening and surveillance program and effective 
therapy it is vital that a reliable and affordable screening method suited to local 
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conditions is available. My study lays a foundation on which such a screening method 
could be built.  
Epidemiology of MRSA varies widely between countries (Maree et al., 2007; Pan 
et al, 2003 & 2005; Labandeira-Rey et al., 2007; Song et al., 2011; Stefani et al., 2011; 
Tietz, Frei, & Widmer, 2005). The current screening practices in Saudi Arabia depends 
on the use of phenotyping methods validated for hospitals in the United States (Bukharie, 
2010). Thus, the health care risk factor phenotyping method is the most commonly used 
in the Johns Hopkins Aramco Hospital. However, no unified method has been adopted 
and the recognized discrepancies in MRSA classification between phenotyping methods 
have not been taken into consideration (Devita, Lawrence, & Rosenberg, 2009; Sievert, 
2008).  
The results of my study show that the health care risk factors method is unsuited 
to the correct classification of MRSA within this community, particularly in regard to 
CA-MRSA identification. According to the results generated in response to my Research 
Question 1, only two thirds of the cases designated as CA-MRSA by genotyping were 
also identified as CA by health care risk factors phenotyping. The total was even lower 
for infection type phenotyping, for which only 37.14% of cases designated as CA by 
genotyping were also identified as CA by infection type phenotyping. By contrast, most 
of the cases designated CA by genotyping were also recognized as CA by susceptibility 
pattern phenotyping.  
The results generated in response to my Research Question 2 confirmed that the 
susceptibility pattern method was the most discordant of the three methods. Consistent 
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with these results for Research Question 1 and 2, the data I generated in response to 
Research Question 3 confirmed that the susceptibility pattern method was significantly 
more specific for identification of CA-MRSA than either of the other two phenotyping 
methods. Of several variables tested in this study, I confirmed in response to my 
Research Question 4 that the antibiotic susceptibility pattern phenotyping method, in 
combination with hospital admission profile, is the most predictive of MRSA 
classification obtained by Multiplex PCR genotyping in a sample of the Saudi Aramco 
population.  
My study has fulfilled the original purpose of characterizing the MRSA strains 
within the Saudi Aramco community and accurately identifying MRSA strains as HA-
MRSA or CA-MRSA by comparing and contrasting the three existing phenotyping 
methods against a gold standard Multiplex PCR method. It has also fulfilled the goal of 
helping to identify the phenotyping variables which were most predictive of genotype and 
provide an accurate method for development of an effective screening, prevention, 
control, and treatment program in this population. It has led to the identification of the 
antibiotic susceptibility pattern phenotyping method in combination with hospital 
admission profile as the potential basis of a reliable, inexpensive, and readily usable 
phenotyping classification method, validated against a genotyping gold standard, for 
determination of distribution of HA-MRSA and CA-MRSA in the Saudi Aramco 
community. Based on my study results, I therefore recommend that a phenotyping 
method based on antibiotic susceptibility pattern and hospital admission profile should be 
tested in this community with a view to replacing the existing health care risk factors 
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phenotyping that is currently most common, if this new method proves to be robust in the 
longer term. Furthermore, I recommend that similar studies should be carried out in other 
communities and settings across Saudi Arabia with a view to establishing a national 
phenotyping program underpinned by comparison of phenotyping data to a genotyping 
gold standard. 
The study facilitated a more comprehensive understanding of epidemiological 
characteristics of MRSA in Saudi Arabia. The standardized phenotyping technique 
identified in this study to classify MRSA infections as either HA-MRSA or CA-MRSA 
will provide new evidence to facilitate targeting of control efforts and preventive 
methods, which will better contend with this adept and evolving bacterial organism.  
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Appendix A: Multiplex PCR Methodology 
The primers for the amplification of the mec-A gene and pvl gene were MECAP4 
(5'-TCCAGATTACAACTTCACCAGG-3') and MECAP7 (5'- CCACTTCATATC 
TTGTAACG-3'), as described by Oliveria et al. (2002), and luk-PV-1 (5'- 
ATCATTAGGTAAAA TGTCTGGACATGATCCA-3') and luk-PV-2 (5'- GCATCAA 
GTGTATTGGATAGCAAAAGC-3'), as described by McLure et al. (2006), respectively.  
PCR was performed using a Qiagen Multiplex PCR kit (Hilden, Germany) with the 
following slight modifications. A 25-μl final reaction volume consisted of 12.5 μl 
mastermix, 2.5 μl primer mix (0.2 μM of each primer), 3 μl DNA template and 7 μl 
RNase free water. DNA samples were subjected to thermocycling conditions with an 
initial inactivation step (95o C, 15 min), 35 repetitions of a three-step cycle of 
denaturation (94o C, 30 sec), annealing (60o C, 90 sec) and extension (72o C, 90 sec) 
with a different final extension (72o C, 10 min) and a step that involved soaking at 4oC. 
After these steps, 5 μl of amplified products were mixed with 2 μl of ethidium bromide 
(Fermentas, St. Leon-Rot, Germany) and loaded on a 2% agarose gel (Amresco, Solon, 
USA) along with GeneRuler TM 100 bp Plus DNA Ladder (Fermentas, St. Leon-Rot, 
Germany); electrophoresis was performed at 100 volts for 50-60 min and visualized 
under a UV transilluminator (Bio-Doc analyzer, Biometra, Goettingen, Germany). 
